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THESIS ABSTRACT
Cerebral malaria (CM) is one of the most common lethal complications of the 
complex syndrome named severe malaria. The pathogenesis of severe malaria is 
thought to be due to the ability of infected red blood cells to sequester in the small 
blood vessels of vital organs. Sequestration, resulting from the interaction between 
parasite proteins on the surface of parasitized red blood cells (PRBC) and host 
endothelial cell adhesion molecules can cause activation of intracellular signalling 
pathways in endothelial cells including induction of apoptosis in endothelial cells 
which may be responsible for the blood-brain barrier breakdown seen in CM.
The aim of the thesis is to get a better understanding of the pathogenesis of cerebral 
malaria which may lead to new therapeutic interventions for the disease. We used co­
culture models to study the interaction between malaria infected erythrocytes and 
endothelial cells. The results showed that the cytoadherence of infected erythrocytes to 
endothelial cells can induce apoptosis of endothelial cells which was confirmed by 
endothelial cell morphological changes, annexin V binding and caspase activity. It was 
found that the ability of parasites to induce endothelial apoptosis is dependent on the 
infected erythrocyte membrane remaining intact, but is independent of parasite 
viability. Apoptosis of endothelial cells induced by malaria parasites has been shown 
to involve both receptor-mediated (caspase-8) and mitochondrial mediated (caspase-9) 
pathways. Measurement the mitochondrial membrane potential (ATV) of apoptotic 
endothelial cells showed the dissipation of the mitochondrial AT confirming the 
involvement of a mitochondrial mediated pathway. Further studies to unveil the 
signalling pathways underlying endothelial apoptosis, using various inhibitors, 
implicatied calcium signalling and NF-kB signalling pathway in apoptosis induced by 
parasites. Immunocytochemical staining of 4-hydroxynonenal (4-HNE), a marker of 
oxidative stress, also showed the association of oxidative stress with these events.
To study the endothelial cell membrane receptor mediating PRBC attachment and 
apoptosis of endothelial cells, the apoptogenic malaria parasites were enriched by 
panning on endothelial cells. The enriched parasites were shown to have a higher level 
of cytoadherence and still retained their apoptogenic property. It was found that 
cytoadherence of the enriched parasites to endothelial cells in our models is probably 
ICAM-1 independent. Unfortunately, antibodies against CD31, CD36 and CD 105 
failed to inhibit cytoadherence of parasites. Thus the precise adhesion molecule(s) on 
endothelial cells which is/are involved in this event remain undefined.
In conclusion, we have shown that cytoadherence of infected erythrocytes can occur 
by as yet undefined adhesion receptors on the surface of endothelial cells (but which is 
probably ICAM-1 independent) and this interaction can in turn induce apoptosis. The 
cell apoptosis involves receptor-mediated and mitochondrial mediated pathways as 
well as oxidative stress, calcium signalling and NF-kB signalling. The definitive 
molecular basis for the effects seen in co-culture and the relevance to clinical cerebral 
malaria require further investigation.
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CHAPTER Is INTRODUCTION
1.1 MALARIA
Malaria is caused by protozoan parasites of the genus Plasmodium. There are five 
species of Plasmodium that infect human and cause disease which are: Plasmodium 
falciparum, Plasmodium vivax, Plasmodium malariae, Plasmodium ovale (de Souza 
& Riley, 2002) and Plasmodium knowlesi (Cox-Singh et al., 2008, Singh et al, 2004). 
Using PCR genotyping techniques, human infection with P. knowlesi, which is 
commonly misdiagnosed by microscopy as P. malariae, has been identified (Cox- 
Singh et al, 2008, Singh et al, 2004). Recently, P. knowlesi has been reported to 
cause severe disease in a human host (Cox-Singh et al, 2010). Base on the 
dimoiphism in defined genes, P. ovale has been divided into classic and variant types 
(Win et al, 2004). There is recent evidence indicating that these two parasite types 
might be in fact two distinct species which were named P. ovale curtisi (classic type) 
and P. ovale wallikeri (variant type) (Sutherland et al, 2010). However, among the 
human malaria parasites, P. falciparum is the only species which sequesters in 
microvasculature and causes the most severe form of the disease, cerebral malaria (de 
Souza & Riley, 2002).
1.1.1 Plasmodium falciparum life cycle
The vector of P. falciparum transmission is the female Anopheles mosquito. To 
facilitate the ingestion of blood, the mosquito injects saliva which contains 
vasodilators and anti-coagulants on biting a mammalian host. If the mosquito is 
infected with P. falciparum, sporozoites which reside in its salivary glands are injected 
into the host skin. From there, they travel through the blood stream to the liver.
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Sporozoites interact with heparan sulphate proteoglycans (HSPGs) on the liver cells 
via their surface protein, circumsporozoite protein (CSP) prior to invasion. Once 
inside the liver, the sporozoite passes through several hepatocytes before establishing 
in one, where it forms a parasitophorous vacuole. Within this, the sporozoite develops 
and multiplies forming thousands of merozoites. These are released into the blood 
stream where they invade red blood cells (RBC) (Prudencio et al, 2006). The 
merozoites attach to the RBC surface and must undergo apical reorientation in order to 
make its apical pole attach to RBC surface. After that, a junction between the 
invading merozoite and the RBC membrane is formed. The movement of the junction 
around the penetrating merozoite allows the merozoite to enter into the RBC forming a 
parasitophorous vacuole (Gaur et al, 2004). Inside the host RBC, the merozoite 
develops through ring, trophozoite, and schizont stage parasites. In P. falciparum, the 
mature trophozoite stages express parasite-derived adhesion surface molecules on the 
surface of their RBC which can bind to host endothelial cell adhesion receptors 
resulting in sequestration of parasitized red blood cells (PRBC) in microvasculature. 
After completion of the blood stage cycle, merozoites are released, which rapidly 
infect other RBC. Some parasites differentiate into sexual erythrocytic stages 
(gametocytes). The gametocytes: male (microgametocytes) and female 
(macrogametocytes), are ingested by a female Anopheles mosquito during a blood 
meal. In the mosquito’s stomach, the male and female gametocytes fuse and develop 
into motile ookinete which invade a single epithelial cell in the mosquito’s midgut. 
The ookinete then differentiates into an oocyst producing thousands of sporozoites. 
Sporozoites move to mosquito’s salivary glands ready to infect another host in the 
next blood meal (Cirimotich et al, 2010, Scherf et al, 2008).
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Garnet ocytes
Figure 1.1 Life cycle of P. falciparum (Scherf et al., 2008).
1.1.2 P. falciparum cytoadherence
During the trophozoite and schizont stages, parasites disappear from the peripheral 
circulation and sequester in the microvascular beds in vital organs such as the brain 
where it can cause the severe disease, cerebral malaria (Newton et al., 2000). 
Sequestration of PRBC is a result of cytoadherence of PRBC to the endothelial cells 
lining blood vessels. Endothelial cells express many different receptors on their 
surface. Some of them are increasingly expressed in response to activation by 
inflammatory cytokines including TNF-a which is known to be up-regulated in 
malaria (Chakravorty et al., 2008). Many endothelial cell receptors have been reported 
to serve as ligands for PRBC adhesion. In most cases, adhesion between PRBC and 
host receptors has been shown to be mediated by P.falciparum erythrocyte membrane 
protein 1 (PfEMP-1), which is the protein displayed on the surface of the PRBC
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(Rowe et al, 2009). The detail regarding some of the endothelial cell receptors 
involved in cytoadherence and PfEMP-1 as well as the effects of cytoadherence on 
endothelial cells is briefly described in sections 1.1.2.1, 1.1.2.2 and 1.1.2.3, 
respectively.
1.1.2.1 Host adhesion receptors
The molecules on endothelial cells that have been reported to participate in adhesion 
of PRBC include: thrombospondin; CD36; ICAM-1 (intercellular adhesion molecule 
1), VCAM-1 (vascular cell adhesion molecule 1); PEC AM-1 (platelet/EC adhesion 
molecule)/CD31 and NCAM (neural cell adhesion molecule); P-selectin and E- 
selectin; and chondroitin sulphate A (CSA) (Rowe et ah, 2009). A brief detail of each 
molecule is described below.
Thrombospondin (TSP)
Thrombospondin (TSP) is a large adhesive glycoprotein which is released into 
plasma in response to platelet activation by thrombin (Rowe et al., 2009). TSP has 
been implicated in binding under both static assay (Roberts et al.t 1985) and flow 
conditions (Rock et al., 1988). The possible candidates of parasite ligands for TSP are 
PfEMP-1 (Baruch et al, 1996), red-cell-derived phosphatidylserine (Eda & Sherman, 
2002) and altered Band 3 protein (Eda et al, 1999).
CD36
CD36 is an 88 kDa highly glycosylated, cell surface class B scavenger receptor 
expressed on endothelial and epithelial cells, macrophages, monocytes, platelets, 
erythrocyte precursors and adipocytes (Greenwalt et al, 1992). It has been revealed
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that most patient isolates tested have some ability to bind to CDS6 (Chakravorty et al., 
2008). However, the role of CDS 6 in malaria pathogenesis remains unclear (Serghides 
et al, 2003). Studies conducted in Africa showed no difference in CDS 6-binding 
ability between parasite isolates from severe and uncomplicated malaria patients 
(Newbold et al9 1997, Rogerson et al, 1999). In contrast, other studies showed a 
positive correlation between CDS6 binding and severe malaria (Ho et al, 1991, 
Ockenhouse et al, 1991). A recent study demonstrated that platelet-expressed CDS6 
can act as a bridge mediating binding of PRBC to endothelial cells lacking in CDS 6 
(Wassmer et al, 2004).
ICAM-1
ICAM-1 (CD54) is a member of the immunoglobulin superfamily, expressed on 
endothelial cells and leukocytes (Rowe et al., 2009). Adhesion to ICAM-1 has been 
suggested to be linked with cerebral malaria. Post-mortem studies showed increased 
parasite sequestration in the brain of patients with severe malaria who also showed 
increased ICAM-1 expression (Turner et al, 1994). Isolates from CM patients have 
also shown the ability to adhere in vitro to ICAM-1 (Newbold et al., 1997). The 
binding site for PRBC on ICAM-1 is the N-terminal external Ig domain of the protein 
which is distinct from the binding sites for its natural ligand LFA-1 (lymphocyte 
function-associated antigen 1) (Berendt et al, 1992, Ockenhouse et al, 1992a). 
ICAM-1 levels on many types of endothelial cells can be stimulated by cytokines, 
including TNF-a and IL-1 (interleukin 1) which are up-regulated during malaria 
infection (Chakravorty et al., 2008). Furthermore, ICAM-1 levels can also be 
stimulated directly by the PRBC (Tripathi et al, 2006, Viebig et al, 2005).
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VCAM-1
VCAM-1 (CD 106) is also a member of the immunoglobulin superfamily and is 
expressed on endothelial cells in response to inflammatory mediators. PRBC isolated 
from patients with severe complicated malaria have been shown to bind to VCAM-1 
(Ockenhouse et al, 1992b). However, a study with African isolates showed low levels 
of VCAM-1 binding and did not appear to be associated with severity of the disease 
(Newbold et al., 1997).
PE CAM-1
Platelet endothelial cell adhesion molecule 1 (PECAM-1 or CD31) is another 
glycosylated member of the Ig superfamily. It is expressed on endothelial cells, 
monocytes, platelets and granulocytes. The protein is normally concentrated at the 
endothelial junction in the microvasculature, but stimulation with IFN-y can 
redistribute the receptor to the surface of endothelium, leading to an increase in 
binding. PRBC have been shown to bind to PECAM-1 transfected cells and directly to 
recombinant PECAM-1 absorbed onto plastic (Treutiger et al, 1997).
P-selectin
P-selectin (CD62P), a glycoprotein, is expressed on activated platelets and 
endothelial cells and is important for leukocyte trafficking. This protein has been 
shown to mediate rolling of PRBC on endothelial cells and facilitates adhesion to 
CDS 6 (Udomsangpetch et al, 1997, Yipp et al., 2007). The site of binding for PRBC 
on P-selectin has not been mapped, however, it is thought to be on the lectin domain 
but distinct from that of the natural ligand, PSGL-1 (Ho et al, 1998). Another member
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of the selectin family that has been suggested to implicate in PRBC cytoadherence is 
E-selectin (Ockenhouse et ah, 1992b).
CSA
Chondroitin sulphate A (CSA) is the carbohydrate found on placental 
syncytiotrophoblasts. Adhesion of PRBC to CSA has been linked to a specific disease, 
placental malaria which leads to maternal anaemia, low birth weight and increase in 
neonatal mortality (Chakravorty et ah, 2008).
Other cytoadherence receptors
Other endothelial receptors which have been proposed to be involved in 
cytoadherence of PRBC include integrin av(33 (Siano et al, 1998), fibronectin (Eda & 
Sherman, 2004), NCAM (Pouvelle et at, 2007) and gClqR-HABPl-p32 (Biswas et 
al, 2007). However, neither the PRBC ligand for these receptors or the role of these 
receptors in severe malaria has been established yet (Rowe et al., 2009).
1.1.2.2 P. falciparum erythrocyte membrane protein 1 (PfEMP-1)
PfEMP-1 is a parasite derived polypeptide of high molecular mass (200 to 350 kDa) 
which is implicated in cytoadherence to many host endothelial cells adhesion 
receptors. This protein is encoded by var genes of which only one out of a family of 
60 var genes in a parasite is expressed at a any specific time (Kirchgatter & Del 
Portillo, 2005). To evade host adaptive immunity, P. falciparum undergoes antigenic 
variation. This results in switching expression to an alternative var gene, leading to an 
expression of an antigenically distinct PfEMP-1 protein (Chakravorty et al., 2008, 
Smith et al, 2001). The variation in different PfEMP-l proteins determines the ability
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of parasites to adhere to distinct host receptors, mediating sequestration in various 
tissues (Montgomery et al., 2007).
PfEMP-1 is composed of an N terminal segment (NTS), variable numbers of Duffy 
binding like domains (DEL; a-e), one or two cysteine-rich interdomain regions 
(CIDR; a-y), a trans-membrane (TM) domain, a C2 domain and a conserved intra­
cellular acidic terminal segment (ATS) (Pasternak & Dzikowski, 2009) (Fig 1.2). At 
the N terminal end of the protein is a semi-conserved head structure consisting of a 
DBLa domain couple to CIDR domain. This head structure has been suggested to 
recognize at least eight different receptors including CD36, CD31 and complement 
receptor 1 (CR1) (Smith et al., 2001) (Fig 1.2). The DBLp type domain, which is 
normally found in tandem with a C2 domain, is known to bind to ICAM-1 (Springer et 
al, 2004).
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Figure 1.2 P. falciparum erythrocyte membrane protein 1 (PfEMP-1); protein 
architecture and binding domains (modified from Smith et al., 2001).
1.1.2.3 Effects of cytoadherence on endothelial cells
Cytoadherence of PRBC to endothelial cells is not a passive process but can cause 
activation of intracellular signalling pathways in endothelial cells. The interaction 
between PRBC and endothelial cells can lead to activation of MAP kinase signalling
8
pathways, including ERK1/2, JNK (c-Jun N-terminal kinase) and p38 pathways 
(Jenkins et al, 2007) as well as a Rho kinase signalling pathway (Taoufiq et ah, 
2008). Following the interaction of endothelial cells with the PRBC, nuclear 
translocation of the transcription factor NF-kB in endothelial cells, as part of the 
signalling cascade responsible in up-regulation of ICAM-1, has been described. This 
may explain the localization of ICAM-1 on brain endothelium in post-mortem CM 
brain samples and may also lead to greater adhesion of PRBC to endothelial cells 
(Tripathi et al, 2006). Another suggested consequence of PRBC cytoadherence to 
endothelium is the induction of apoptosis in endothelial cells, which may be 
responsible for the blood-brain barrier breakdown seen in CM (Pino et al, 2005). This 
event is described in detail in section 1.1.3.
1.1.3 Cerebral malaria
Cerebral malaria (CM) is one of the most common lethal complications of the 
complex syndrome named severe malaria. The incidence of this neurological 
syndrome is hard to assess, but the records of hospital admissions indicate that CM 
occurs in about 1% of all P. falciparum infections. However, this is responsible for 
more than two million deaths annually among children under 5 years old in Sub- 
Saharan Africa (Combes et al, 2006). The symptoms of CM can range from confusion 
or stupor to obtundation and deep coma (Medana & Turner, 2006). Post-mortem brain 
histopathology reveals that CM is characterised by a blockade of brain micro vessels 
due to an accumulation of PRBC, leucocytes and platelets. Other common findings in 
post-mortem CM patients brain examinations include brain swelling as well as 
petechial and ring haemorrhages in both cerebral and cerebellar cortices (Haidar et al, 
2007).
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There are broadly three hypotheses that have been raised to explain the pathogenesis 
of CM, i.e. sequestration of PRBC (Berendt et al, 1994), inflammation (Clark & 
Rockett, 1994) and hemostasis dysfunction (van der Heyde et al, 2006). However, 
neither one of these hypotheses by itself can explain all of the observed physiological 
and clinical manifestations of the disease. It has been proposed that the pathogenesis 
of CM can be better explained by an integration of all three hypotheses. In this 
unifying hypothesis, parasite antigens (including surface molecules on PRBC, 
merozoites and malaria toxins released during replication) activate the inflammatory 
response and platelets leading to increased levels of endothelial cell adhesion 
molecules (eCAMs). This, in turn, leads to a further increase in the level of PRBC 
sequestration in the brain microvasculature. By unknown mechanisms, the acute 
sequestration of PRBC in the brain microvasculature is thought to cause disruption of 
the blood-brain barrier (BBB) (van der Heyde et al., 2006), which is the specialized 
interface between the vascular space and the brain parenchyma playing a role in 
regulating solute and cellular transport into the brain (Hawkins & Davis, 2005).
There are studies supporting the notion that the BBB integrity is compromised in CM. 
A loss of endothelial cell junctional protein ZO-1, occludin and vinculin, in vessels 
containing sequestered PRBC, was shown by immunohistochemistry on post-mortem 
brain tissues from Vietnamese adults (Brown et al, 1999) and Malawian children 
(Brown et al, 2001) with CM. The leakage of the plasma protein fibrinogen into the 
perivascular space was detected in Vietnamese adults (Brown et al., 1999). 
Perivascular macrophages in both adults and children expressed scavenger receptor 
and sialoadhesin, which are normally not expressed in the normal central nervous 
system. Sialoadhesin is only induced on these cells in the presence of plasma proteins.
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Taken together, these results provide clear evidence of BBB breakdown, especially in 
vessels containing PRBC sequestration (Brown et ah, 1999, Brown et al., 2001). 
Furthermore, retinal haemorrhages have been found in patients with cerebral malaria 
and are a major component of malarial retinopathy (Beare et al, 2006, Glover et al, 
2010, White et al, 2009b). The retina is embryo logically derived from the same 
neuroectoderm as the brain and has an analogous cellular structure and blood-tissue 
barrier, these finding perhaps support the notion of the BBB breakdown (Maude et al, 
2009). The evidences of structural and functional breakdown of the BBB have also 
been shown in animal models. By measuring the movement of the dye Evans blue and 
radio-isotope labelled albumin, plasma protein leakage into the brain was detected in 
experimental cerebral malaria (Chang-Ling et al, 1992, Thumwood et al, 1988). 
Electron microscopy also showed endothelial damage in brain tissue of animals with 
CM (Thumwood et al, 1988). The effect of malaria parasites on the functional 
changes in permeability of BBB was assessed in vitro by measuring the electrical 
resistance of barrier-forming cell-cell contacts. Co-culture of brain endothelial cells 
together with PRBC or malaria antigen-activated leukocytes resulted in reduction of 
endothelial barrier function (Treeratanapiboon et al, 2005, Tripathi et al, 2007). The 
BBB structural changes caused by malaria parasites were also assessed by 
immunostaining of the tight junction proteins ZO-1, which showed disruption of tight 
junctional complexes in endothelial cells co-cultured with malaria antigen-activated 
leukocytes (Treeratanapiboon et al., 2005).
Recently, malaria parasite-induced apoptosis of endothelial cells has been proposed to 
be one of the factors leading to the breakdown of the BBB (Medana & Turner, 2007, 
Pino et al, 2005). In support of this, Pino and colleagues have shown that the physical
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contact between PRBC and endothelial cells results in induction of caspase 8- and 
caspase 9- dependent apoptosis of endothelial cells (Pino et al, 2003b). Apoptosis of 
endothelial cells induced by PRBC has also been showed to be mediated through an 
oxidative stress pathway (Pino et al, 2003a, Taoufiq et al, 2006). The Rho kinase 
pathway also plays a role in apoptosis of endothelial cells induced by PRBC, as 
Fasudil, the Rho kinase inhibitor, prevented endothelial cell apoptosis induced by 
either laboratory or field isolates (Taoufiq et al, 2008, Zang-Edou et al, 2010). A 
study which investigated the capacity of field isolates of malaria parasites, derived 
from patients with clinical malaria, to induce apoptosis in endothelial cells, found that 
patients with neurological manifestation were more likely to harbour apoptogenic 
parasites (Toure et al, 2008).
Apoptosis is one of the processes which lead to the formation of apoptotic bodies or 
microparticles (MP) (Coltel et al, 2006). It has been found that MP is associated with 
severe malaria. Levels of endothelial microparticles (EMP) have been shown to be 
dramatically higher in the plasma of patients suffering from the acute phase of CM 
than in plasma of patients with severe malarial anaemia, uncomplicated malaria or 
healthy control plasma (Combes et al, 2004).
In contrast to the finding of Pino and colleagues (Pino et al., 2003b), there are some 
evidences that the physical interaction between PRBC and endothelial cell might not 
be essential for induction of endothelial cells apoptosis. Soluble factors from PRBC 
have been found to induce apoptosis in both human brain vascular endothelial and 
neuroglia cells (Wilson et al, 2008). Co-culture of endothelial cells with patient sera 
from severe P. falciparum malaria or P. falciparum culture supernatant in the presence
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or absence of neutrophils led to higher endothelial apoptosis rates compared with 
control sera or control supernatants (Hemmer et ah, 2005, Hemmer et aL, 2008).
In addition to PRBC itself, the deleterious effect of platelets, which are often co­
localized with sequestered PRBC in the CM brain (Grau et al, 2003), on the BBB 
integrity has been suggested. Platelets have been shown to enhance PRBC binding to 
endothelial cells by acting like bridges (Wassmer et al, 2004), potentiating PRBC- 
induced alterations of the endothelial monolayer integrity and enhancing endothelial 
apoptosis (Wassmer et al, 2006a, Wassmer et al, 2006b). The apoptosis of the BBB 
endothelial cells in the brain areas where both PRBC and platelets are bound, may be 
responsible for some of the brain haemorrhages observed during post-mortem CM 
brain analysis (Combes et al., 2006).
The clinical studies and murine CM models also provided the link between CM and 
apoptosis. Immunohistochemistry studies of brain tissue derived from patients with 
CM showed that 40% of these cases had caspase-3 activation (Medana et al, 2001). 
The significant elevation of Fas ligand (FasL) and soluble Fas (sFas) was found in 
post-mortem cerebrospinal fluid (CSF) samples and plasma samples, respectively, 
taken from CM mortality cases (Armah et al, 2007, Jain et al, 2008). Microarray 
analysis of global gene expression patterns in the brain of mice with CM demonstrated 
that apoptosis appeared to implicate in pathogenesis of experimental CM (Lovegrove 
et al, 2007, Miu et al, 2008). In addition, immunohistochemistry analysis of caspase- 
3 activation revealed the brain endothelial cells apoptosis in experimental murine 
models of CM (Lackner et al, 2007, Potter et al, 2006a). Despite these data, there are 
important differences between murine CM models and human CM. For example, there 
is little or no PRBC sequestration in brain microvasculature of murine model whereas
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the hallmark of human CM is sequestration of PRBC in brain microvasculature. These 
findings perhaps provide a clue regarding pathogenesis of human CM (John, 2007, 
White et at, 2009a). Although the apoptotic effects of PRBC on endothelial cells has 
been demonstrated, the fine mechanism(s) and signalling pathway(s) underpinning this 
event remain elusive and need to be defined.
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1.2 APOPTOSIS
Apoptosis or programmed cell death is the process that normally occurs during 
development, aging, and as a homeostatic mechanism to maintain cell populations in 
tissues. Apoptosis also participates in defence mechanisms such as in immune 
reactions as well as the pathogenesis of diseases, for example neurodegenerative 
diseases, cardiovascular diseases, immunological diseases and cancer (Zimmermann & 
Green, 2001).
During apoptosis, cells undergo many morphological changes including cellular 
shrinkage, membrane blebbing, nuclear chromatin condensation and fragmentation. 
Finally, when extensive plasma membrane blebbing occurs, cells break into 
membrane-surrounded fragments which are called apoptotic bodies. Apoptotic bodies, 
which are subsequently phagocytosed by macrophages, parenchymal cells or 
neoplastic cells and degraded within phagosomes, contain cytoplasm with tightly 
packed organelles with or without a nuclear fragments (Elmore, 2007, Vermeulen et 
aL, 2005). Several biochemical modifications, for example, protein cleavage, protein 
cross-liking and DNA breakdown are also exhibited in apoptotic cells (Elmore, 2007). 
DNA breakdown to 180-200 bp lengths of DNA fragments by endonucleases 
generates a characteristic so-called DNA ladder which can be detected by agarose gel 
electrophoresis with an ethidium bromide stain and ultraviolet illumination (Bortner et 
aL, 1995). To allow quick phagocytosis with minimal compromise to the surrounding 
tissue, apoptotic cells undergo another biochemical change, the expression of cell 
surface markers resulting in the phagocytic recognition by adjacent cells. This can be 
achieved by exposure of phosphatidylserine, which is normally presented on the
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cytoplasmic side of the plasma membrane, on the outer leaflet of the plasma 
membrane (Bratton et al., 1997).
1.2.1 Pathways involved in apoptosis
The central initiators and executioners of apoptosis are caspases. Caspases are 
normally present in healthy cells as inactive proenzymes with little or no protease 
activity. To date, approximately 14 mammalian caspases have been identified and 
these can be broadly categorised into three groups. The first group is inflammatory 
caspases; including caspase-1, -4, -5, -11, -12, -13 and -14 which are associated with 
inflammation instead of apoptosis. The second group, linking upstream signalling 
pathways with downstream execution steps, is apoptotic initiator caspases; which 
include caspase-2, -8, -9 and -10. The last group is the apoptotic effector or 
executioner caspases; which are activated by upstream caspases and perform the 
downstream execution steps of apoptosis by cleaving multiple cellular substrates, 
consisting of caspase-3, -6 and -7 (Jin & El-Deiry, 2005, Rai et al, 2005).
To date, apoptosis has been suggested to occur through two main apoptotic pathways, 
i.e. the extrinsic or death receptor pathway and the intrinsic or mitochondrial pathway. 
However, the apoptotic process is also affected by many other signalling pathways 
including endoplasmic reticulum stress-induced apoptosis, MAPK/JNK pathway and 
NF-kB pathway (Jin & El-Deiry, 2005).
1.2.1.1 The extrinsic apoptotic pathway
Activation of the extrinsic pathway of apoptosis is initiated by binding of a specific
protein ligand to cell surface transmembrane receptors. The transmembrane receptors,
also called death receptors, trigger external apoptotic signalling and are members of
16
the tumor necrosis factor (TNF) receptor gene superfamily. The best characterised 
ligands and corresponding death receptors include FasL/FasR, TNF-a/TNFRl, 
Apo3L/DR3, Apo2L/DR4 and Apo2L/DR5. However, among these ligand/receptor 
interactions, the best characterised of the sequence in the extrinsic phase of apoptosis 
are FasL/FasR and TNF-a/TNFRl (Elmore, 2007). Upon binding of ligand to death 
receptors, cytoplasmic adapter proteins, which display corresponding death domains 
that bind with the receptors, are recruited. The binding of Fas ligand to Fas receptor 
recruits the adapter protein FADD to the receptor, and the binding of TNF ligand to 
TNF receptor allows the binding of the adapter protein TRADD which subsequently 
recruits FADD and RIP. FADD then binds to procaspase-8 resulting in the formation 
of a death-inducing signalling complex (DISC), which leads to autoproteolytic 
processing of caspase-8. The activated caspase-8 can activate a series of downstream 
caspases, which result in cleavage of structural and regulatory intracellular proteins, 
finally leading to apoptosis (Schultz & Harrington, 2003).
In this pathway, cells can be divided into two types depending on their requirement in 
the mitochondrial pathway. In type I cells, activated caspase-8 is sufficient to directly 
activate other members of the caspases family and lead to apoptosis. In type II cells, 
caspase-8 mediates cleavage of Bid which induces the translocation and insertion of 
Bax and/or Bak into the mitochondrial outer membrane. This causes the release of 
several proteins from the mitochondrial intermembrane space, for example, 
cytochrome c, which forms a complex called the apoptosome with apoptosis­
activating factor-1 (Apaf-1) and procaspase-9. This leads to the activation of caspase- 
9, which can activate the executioner caspase-3 (Jin & El-Deiry, 2005, Orrenius et al., 
2003) (Figl.3).
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1.2.1.2 The intrinsic apoptotic pathway
This cell death pathway is controlled by the Bcl-2 family of proteins. All protein 
members in this family share at least one of four conserved Bcl-2 homology (BH) 
domains (BH1, BH2, BH3 and BH4). This family can be divided into two groups 
according to their function. The first group consists of antiapoptotic members 
including Bcl-2, Bcl-XL, Bcl-w, A1 and Mcl-1. The second group is made up of 
proapoptotic members, consisting of two subgroups: one subgroup sharing 3 BH 
domains (BH1, BH2 and BH3) with Bcl-2 including Bax, Bak and Bok; and a 
subgroup sharing only the BH3 domain with Bcl-2 including Bik, Hrk, Bim, Blk, Bad 
and Bid. Antiapoptotic members act as repressors of apoptosis by blocking release of 
cytochrome c, while proapoptotic members act as promoters (Cory & Adams, 2002).
In response to apoptotic stimuli, there is formation of the mitochondrial permeability 
transition pore (FTP) which is a multiprotein complex, consisting of both inner and 
outer membrane proteins. This pore formation leads to loss of the mitochondrial 
transmembrane potential and release of apoptotic inducing factors from the 
intermembrane space into the cytosol. The apoptotic-inducing factors released from 
the mitochondria include cytochrome c, Smac/DIABLO and HrtA2/Omi. Cytochrome 
c forms the apoptosome complex with Apaf-1 and procaspase-9, leading to activation 
of caspase-9 (Vermeulen et al., 2005). Smac/DIABLO and HrtA2/Omi interact with 
IAP (inhibitors of apoptosis protein) resulting in apoptosis (Schimmer, 2004, van Loo 
et al, 2002). In addition, other apoptotic inducing factors such as AIF and 
endonuclease G are also released from the mitochondria. After release from the 
mitochondria, AIF and endonucleas G translocate to the nucleus and cause DNA 
fragmentation (Joza et ah, 2001, Li et al, 2001) (Figl.3).
18
Extrinsic
(receptor-mediated}
Intrinsic
(mitochondria-mediated}
DISC
Pro- 
caspase 8
Auoplottc stimuli
Death Igand 
Dual* i receptor
« a «<( « BO
_ \ TypellMfc _
Type I cctts | ' Cytochrome c o« ' ^ \ /
Caspase B (J|] I jeSmac^
I * >
* / Apoptosome __
Caspase- 3 'EH" ^ ' >■ .^V'~ ^1
ri^V4
'^Pro-T I — P»IAP 
V 1
v. ‘^SiCaspaso 9\f ^
EndoG
Caspase 3
Figure 1.3 Diagram showing two major apoptotic pathways: extrinsic and intrinsic 
pathways (modified from Orrenius et al., 2003).
1.2.1.3 Endoplasmic reticulum stress apoptotic pathway
In mammalian cells, the main functions of the endoplasmic reticulum (ER) are folding, 
modifying and sorting of newly synthesized proteins, as well as calcium storage and 
signalling. Disturbance in any of these functions can result in ER stress (Breckenridge 
et al, 2003). In response to the accumulation of misfolded proteins or disruption of 
calcium homeostasis, the signalling pathway called unfolded protein response (UPR) 
is activated. The activation of the UPR signalling pathway results in: reduction of
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protein synthesis to prevent additional accumulation of unfolded protein; induction of 
ER chaperones and folding catalysts; and activation of ER-associated protein 
degradation (ERAD) which decreases the folding load in the ER by enhancing 
degradation of slowly folding protein in the ER. However, if this stress cannot be 
resolved, it results in caspase-12 triggering which may activate caspase-9 and execute 
apoptosis (Rao et at, 2004, Schroder & Kaufman, 2005).
Furthermore, calcium release from the ER into the cytosol can act as a messenger that 
coordinates between the mitochondria and the ER. In the cell-death process triggered 
by staurosporine and ceramide, a small amount of cytochrome c released from 
mitochondria diffuses to ER and binds to InsPs receptors. This enhances calcium 
release from the ER which causes release of cytochrome c from all mitochondria 
inducing the formation of the apoptosome leading to caspase activation (Mattson & 
Chan, 2003).
1.2.1.4 JNK and p38 MAPK pathways
The c-Jun N-terminal kinase (JNK) and p38 MAPK, which are also known as stress- 
activated protein kinases (SAPKs), are members of the mitogen-activated protein 
kinase (MAPK) superfamily. These kinases transduce multiple signals from the cell 
surface to the nucleus in response to a variety of stimuli (Cowan Sc Storey, 2003). The 
activation of JNK and p38 MAPK occurs in response to various cellular and 
environmental stresses including change in osmolality or metabolism, DNA damage, 
heat shock, ischemia, inflammatory cytokines, UV irradiation and oxidative stress 
(Wada & Pennlnger, 2004).
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JNK and p38 MAPK are the terminal kinases of a three-tiered activation system, i.e., 
MAPKKK, MAPKK and MAPK (Fig 1.4). Kinases that activate JNK include MKK4 
and MKK7, and upstream of these kinases ai’e a number of other kinases including 
TAK, MLK-3, MEKK1, 4 and ASK. After activation, JNK translocates across the 
nuclear membrane and phosphorylates c-Jun and other nuclear transcription factors 
such as tumor suppressor p53 and MADD (a cell death domain protein) (Cowan & 
Storey, 2003). The upstream kinases activating p38 MAPK include MKK3 and MKK6 
which, in turn are activated by MEKK, MLK and ASK1. The p38 MAPK regulates 
two major groups of proteins which are transcription factors such as p53 and protein 
kinases such as MAPK-activated kinase 2 (Wagner & Nebreda, 2009).
Both JNK and p38 MAPK are involved in regulation of various cellular events, 
including apoptosis. The role of JNK and p38 MAPK in apoptosis is controversial as 
they have been implicated in both pro-apoptotic effects (Deng et ah, 2003, Grethe et 
al, 2004, Newhouse et al., 2004) and anti-apoptotic effects (Matusali et al.9 2009, Yu 
et al, 2004). The role of JNK and p38 MAPK in apoptosis may depend on cell type 
and the nature of the death stimulus (Liu & Lin, 2005, Wada & Penninger, 2004).
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Figure 1.4 The three-tiered regulatory cascade (MAPK, MAPKK and MAPKKK 
levels) and cellular responses elicited by JNK and p38 MAPK (modified from Cowan 
& Storey, 2003).
1.2.1.5 p53
The p53, also known as tumor suppressor protein 53, is a transcription factor which 
plays a role in the response of cells to stress such as DNA damaging agents, hypoxia 
or oncogene activation (Amaral et at, 2009). The p53 has a very short half-life and is 
presented at very low levels within cells. This is maintained by p53 inhibitors, Mdm2 
(mouse double minute-2) or Hdm2 in humans which function in inhibiting the 
transcriptional activity of p53 and promoting its degradation by proteosomes. This 
protein is transiently stabilised and activated in response to stress stimuli. Depending
22
on cell or stress signal types p53 activation can lead to cell cycle arrest, DNA repair, 
cellular senescence or apoptosis (Fig 1.5) (Haupt et al., 2003, Vousden & Lu, 2002). 
The p53 can promote apoptosis by both transcription dependent and transcription 
independent mechanisms. In transcription-dependent apoptosis, p53 regulates the 
expression of component of both extrinsic and intrinsic pathways including Fas (CD 
95/ APO-1), DR5, Bax, NOXA, PUMA and Bid (Haupt et al., 2003, Pietsch et al, 
2008). In transcription-independent apoptosis, p53 can directly induce apoptosis by 
translocation to the mitochondria leading to the release of cytochrome c and pro- 
caspase-3 activation (Marchenko et al, 2000, Nemajerova et al, 2005).
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Figure 1.5 p53 activation and modulation of downstream events (modified from 
Amaral et al, 2009)
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1.2.1.6 NF-kB
The nuclear factor kappa B (NF-kB) regulates several biological processes, for 
example, inflammation, immunity and apoptosis. Five members of the NF-kB family 
have been identified. These are p50, p52, p65 (also known as REL-A), c-REL, and 
REL-B. p50 and p52 are derived from proteolytic cleavage of pi05 and pi00, 
respectively (Hayden & Ghosh, 2008). The activation of NF-kB is regulated by IkB 
proteins which are bound to NF-kB under basal conditions and hold NF-kB in the 
cytoplasm. The IkB family consists of seven members, i.e., IkBol, hcBp, LcBy, IkBs, 
Bcl-3 and the precursor proteins pi00 and pi05 (Wang et al, 2009),
Stimulation of cells with tumor necrosis factor-a (TNF-a), interleukin-ip (IL-lp) or 
Toll-like receptor (TLR) ligands leads to the activation of classical or canonical 
pathway of NF-kB activation. Following the stimulation, the IkB molecules are 
phosphorylted by IkB kinase (IKK) complex, leading to polyubiquitination by the 
SCF-pTrCP E3 ligase complex. Ubiquitinated IkB is degraded by the proteosome. 
This results in the translocation of p50/p65 NF-kB dimer to nucleus and the activation 
of gene transcription. The non-canonical or alternative pathway occurs when a subset 
of TNF receptor (TNFR) superfamily members including those for BAFF, CD40 
ligands and lymphotoxin-p are activated. This pathway depends on NF-KB-inducing 
kinase (NIK) and the IKKa subunit. The phosphorylation of pi00 by IKKa leads to 
the ubiquitination and proteasomal processing to p52. This allows the translocation of 
the p52/REL-B dimer into the nucleus to activate gene transcription (Skaug et al., 
2009, Wang et al., 2009) (Fig 1.6).
The role of NF-kB in apoptosis has been studied in various cell types under a variety 
of stimuli. A number of reports support an anti-apoptotic effect of NF-kB (Lin et al..
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1995, Liu et al, 1996, Van Antwerp et al., 1996, Wang et al, 1996). However, 
besides these anti-apoptotic effects, there are many reports that reveal an implication 
of NF-kB in the induction of apoptosis (Connolly et al, 2000, Hansberger et al, 2007, 
Kuhnel et al, 2000, Stark et al, 2007).
CD40L
CD40/BAFF-R
TNFR
TRAP 2
, dAPsIKK
complex
Noncanonical
pathway
Canonical
pathway
Proteasome
Pro tea some
• Phosphorylation
• K48-linked ubiquitination
Figure 1.6 NF-kB signalling pathways (Skaug et al, 2009).
1.2.1.7 Calcium signalling
I
Calcium (Ca ) is a universal signalling molecule, regulating many aspects of cellular 
function and is one of the key elements of apoptotic signalling pathways. The 
concentration of Ca inside cells is determined by the ‘on’ reactions which introduce 
Ca2+ into the cytoplasm and ‘off reactions which removed Ca2+ from the cytoplasm 
by the action of buffers, pumps and exchangers (Berridge et al, 2000). During the ‘on’ 
reaction, stimuli induce the entry of external Ca2+ through channels located on the
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plasma membrane as well as the formation of second messengers including inositol - 
1, 4, 5 - triphosphate (Ins(l,4,5)P3) that release Ca" stored within the 
endoplasmic/sarcoplasmic reticulum (ER/SR). Most of Ca2+ released into the 
cytoplasm by the ‘on’ reactions are bound to buffers, while a small proportion binds to 
the effectors which activate various cellular processes. During the ‘off reactions, 
various exchangers and pumps remove Ca2+ from the cytoplasm. The Na+/Ca2+ 
exchanger (NCX) and the plasma membrane Ca2+ ATPase (PMCA) pump Ca2+ out of 
the cell, while the sarco-endoplasmic reticulum Ca2+ ATPase (SERCA) pumps Ca2+ 
back into the ER/SR. The mitochondria also plays a role during the recovery process 
by sequestration of Ca through a uniporter which is then slowly released back into 
cytoplasm and removed by the SERCA and the PMCA (Fig 1.7) (Berridge et al., 2003, 
Berridge et al., 2000, Bootman et al., 2001).
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Figure 1.7 Calcium signalling (modified from Berridge et al., 2003)
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There is much evidence to indicate the involvement of alterations in the cytosolic Ca2+ 
concentration and/or intracellular Ca2+ compartmentalization, including the ER, in the 
regulation of apoptosis. An increase in intracellular Ca2+ induced by artesunate 
contributed to apoptosis in endothelial cells (Wu et al, 2004). Treatment of human 
intestinal cells with BAPTA-AM, an intracellular Ca2+ chelator, inhibited apoptosis 
induced by rotavirus infection (Chaibi et al., 2005). Treatment of various types of cell 
with thapsigargin, the inhibitor of endoplasmic reticular Ca2+ ATPase or with Ca2+ 
ionophores results in apoptosis (Jiang et al, 1994, Kaneko & Tsukamoto, 1994, 
Levick etal, 1995, Martikainen & Isaacs, 1990).
1.2.2 Oxidative stress and apoptosis
In aerobic organisms, the participation of oxygen in redox reactions cannot be 
avoided, and this results in the generation of a variety of reactive oxygen species 
(ROS) including O2’, H2O2, hydroxyl radical (’OH), and nitric oxide/peroxynitrate 
(NO/ONOO"). A number of these molecules possess a beneficial role in the cell such 
as signal transduction and the bactericidal activity of phagocytes. However, when an 
excess amount of these agents is presented in the cell, it becomes toxic to the cell. To 
protect the cell from the toxicity of ROS, the mammalian cell has developed 
antioxidative defence mechanisms. When an imbalance between the production of 
ROS and the antioxidative system occurs, cells become oxidatively stressed. Oxidative 
stress can result in injury to all important cellular components, for example, proteins, 
DNA and membrane lipid (lipid peroxidation) which can result in cell death (Glutton, 
1997, Yang etal, 2003).
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The implication of oxidative stress in the induction of apoptosis has been shown in 
many studies. For instance, Guha and colleagues showed that malarial infection 
induced the generation of hydroxyl radical (•OH) in the liver. They suggested that *OH 
may be responsible for the induction of oxidative stress and apoptosis of hepatocyte as 
these events were able to be prevented by administration of free radical and *OH 
specific scavengers to infected animals (Guha et al, 2006). Oxidative stress has also 
been shown to induce apoptosis in endothelial cells which can be suppressed by 
treatment with antioxidant agents (Aoki et al, 2001, Warren et al, 2000).
1.2.3 Toll-like receptors (TLR)
Toll-like receptors (TLR) are a family of evolutionary conserved pathogen recognition 
receptors. These receptors play a major role in innate immune responses in the defence 
against bacteria, viruses, parasites and other pathogens. To date, 10 members of TLR 
in human and 13 in mouse have been identified. All TLR have their respective ligands, 
for example, LPS of gram negative bacteria is recognised by TLR4 and double 
stranded RNA (dsRNA) is recognised by TLR3 (Fig 1.8). After recognition of 
microbial pathogens, TLR triggers intracellular signalling pathways (the myeloid 
differentiation factor 88 (MyD88)-dependent and/or MyD88-independent pathways) 
which result in the induction of inflammatory cytokines (Kawai & Akira, 2006, 
Takeda et al, 2003). Almost all TLR share a common adaptor protein, MyD88, in 
their signalling pathways, except TLR3. TLR4 is a unique receptor which initiates 
signalling through both MyD88-dependent and MyD88-independent pathways (Fig 
1.8) (Akira & Takeda, 2004).
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Figure 1.8 TLR-mediated immune response (Kawai & Akira, 2006).
In addition to the function of TLR in initiating the innate inflammatory immune 
response, TLR engagement can also result in the induction of apoptosis. TLR2 
mediated apoptosis in differentiated THP-1 cells and monocyte-derived macrophages 
induced by Mycobacterium tuberculosis glycolipoprotein (Lopez et al., 2003). TLR3 
has been shown to be involved in apoptosis of human breast cancer cells induced by 
dsRNA (Salaun et al, 2006). Chlamydial heat shock protein 60 induces trophoblast 
cell apoptosis through triggering of TLR4 (Equils et al, 2006). Other TLR including 
TLR5, TLR8 and TLR9 have also been implicated in apoptosis (Fischer et al, 2005, 
Ma et al, 2006, Zeng et al, 2006).
The importance of toll-like receptors in immunity against malaria infection has been 
established. Coban and co-workers have reported that hemozoin purified from 
Plasmodium falciparum functions as a TLR9 ligand and activates innate immune
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response, resulting in production of cytokines and chemokines. These responses were 
impaired in TLR9- and MyD88-deficient mice. The author suggested that the innate 
immune response activated by hemozoin is TLR9-mediated and MyD88-dependent 
(Coban et al., 2005). The same author also illustrated that DNA-free hemozoin can 
bind to TLR9 and induce conformational changes of TLR9 as those induced by the 
canonical TLR9 ligand, CpG-DNA (Coban et al., 2010). However, Parroche and 
colleagues suggested that hemozoin itself was immunologically inert but enhanced 
innate responses by delivering malarial DNA to TLR9 (Parroche et al, 2007). Besides 
hemozoin, Plasmodium glycosylphosphatidylinositols (GPI) membrane anchor for 
functionally important proteins on the cell surface, is another TLR ligand inducing 
proinflammatory response (Gowda, 2007). GPI are recognised mainly by a TLR2/6 
heterodimer as well as TLR2/1 heterodimer, and to a lesser extent by TLR4 
(Krishnegowda et al, 2005).
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THESIS OBJECTIVES
A single cell imaging approach has been adopted to characterise PRBC-endothelial 
post-adhesive events. Specifically, the phenomenon of adhesion-mediated apoptosis 
has been studied to;
1. Provide a description of PRBC induce apoptosis of HUVEC at the single-cell 
level
2. Provide insights into the signalling mechanisms involved in adhesion-mediated 
apoptosis
3. Provide insights of the host-cell receptors involved in adhesion-mediated 
apoptosis.
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CHAPTER 2: GENERAL MATERIALS AND METHODS
2.1 Malaria culture
2.1.1 Malaria parasite isolate
The Plasmodium falciparum isolate used in this study was ITG which is a strong 
ICAM-1 binder (Gray et al, 2003). This isolate was a gift from Prof. Alister Craig 
(Liverpool School of Tropical Medicine, UK). The parasite was grown and maintained 
in culture using a modified method of Trager and Jensen (Trager & Jensen, 1976).
2.1.2 Preparation of complete medium
A complete medium was prepared by adding 12.5 ml 1 M HEPES (N-(2- 
Hydroxyethyl) piperazine-N’-^-ethanesulfonic acid)) pH 7.4 (Sigma), 0.2 ml 
gentamicin solution (50 mg/ml) (Sigma) and 37.5 ml pooled human AB serum to 500 
ml RPMI-1640 medium supplemented with L-glutamine and sodium bicarbonate 
(Sigma).
2.1.3. Preparation of serum
Blood was collected from the gastroenterology ward, Royal Liverpool Hospital, UK. 
Serum from multiple donors was pooled together in a sterile glass flask, before 
aliquots of 37.5 ml were prepared in 50 ml centrifuge tubes. Serum aliquots were 
stored at -80 °C. Prior to use, serum was thawed in a water bath at 37 °C.
2.1.4 Preparation of uninfected erythrocytes
Group O Rhesus positive human whole blood was collected from National Blood 
Service, Royal Liverpool Hospital, UK. Before adding to culture flasks, blood was
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resuspended in RPMI-1640 medium supplemented with L-glutamine and sodium 
bicarbonate (Sigma) followed by centrifugation at 3,000 rpm for 5 min. The 
supernatant and buffy coat layers were removed by aspiration. This process was 
repeated three times. Washed erythrocytes were stored at 4 °C and used within a week 
to prevent haemolysis.
2.1.5 Sub-culturing of malaria parasite
Parasites were routinely sub-cultured to keep them alive and avoid over-growth. The 
parasitemia was checked by preparing a thin blood film and counting parasites using a 
light microscope. After determination of parasitemia, parasite suspensions were 
transferred to 50 ml centrifuge tube and centrifuged at 2,000 rpm for 5 min. The 
supernatant was discarded. The parasite pellet was diluted to the appropriate 
parasitemia in 35 ml of complete medium in T75 cm2 culture flasks (Nunc) or 12 ml 
complete medium in T25 cm2 culture flasks (Nunc). Subsequently, washed uninfected 
erythrocytes were added to achieve a haematocrit of 1%.
2.1.6 Gas Phase
Following preparation of the sub-cultures, flasks were flushed with mixed gas (4% O2, 
3% CO2 in N2) (BOC, UK). The duration of gassing was 1 min for a T75 cm2 culture 
flask (Nunc) and 30 sec for a 25 cm2 culture flask (Nunc).
2.1.7 Parasite cryopreservation
Ring stage parasites (> 5% parasitemia) were centrifuged at 2,000 rpm for 5 min and 
resuspended in an equal volume of cryoprotectant solution (70 ml glycerol, 180 ml
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4.2% w/v sorbitol in 0.9% w/v sodium chloride solution). Aliquots (1ml) were placed 
into labelled screw-capped cryotubes (Nunc), and placed in liquid nitrogen storage.
2.1.8 Parasite retrieval
Cryopreserved parasites were removed from the liquid nitrogen storage, thawed at 37 
°C, resuspended in an equal volume of retrieval solution (3.5% sodium chloride) and 
left stand for 5 min at room temperature. The suspension was then centrifuged at 2,000 
rpm for 5 min. The supernatant was removed and the pellet was resuspended in 10 ml 
complete medium. The suspension was centrifuged and the supernatant discarded. The 
pellet was resuspended in 15 ml complete medium together with 0.5 ml uninfected 
erythrocytes in a T25 cm2 culture flask (Nunc).
2.1.9 Parasite synchronisation
Malaria parasites were synchronised to generate cells in the same stage of the asexual 
life cycle. Parasite culture was synchronised using sorbitol (Lambros & Vanderberg, 
1979). Synchronisation uses the principle of osmotic lysis to selectively remove 
mature forms of the parasites, leaving the younger ring stage parasites. Parasite culture 
with a mixed population of both mature (trophozoites and schizoints) and ring stages 
was centrifuged at 2,000 rpm for 5 min. The pellet was resuspended in 5X volume of 
5% w/v sorbitol (Sigma) for 20 min. Synchronised parasites were resuspended in an 
excess volume of complete medium and centrifuged to wash off sorbitol and 
particulates.
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2.2 Human Umbilical Vein Endothelial Cell (HUVEC) culture
2.2.1 Primary human umbilical endothelial cells
Primary pooled human umbilical cells were purchased from Lonza (Switzerland) as 
cryopreserved cells. The method for HUVEC cultivation followed the manufacturer’s 
instructions. Briefly, a cryovial of primary HUVEC was resuspended in 12 ml 
endothelial cell complete medium (Lonza). The resuspended endothelial cell was 
seeded into three gelatin-coated T25 cm2 vented cap flasks (Nunc) (4 ml per seeding 
vessel). This first passage is designated as passage 1. HUVEC were cultured to 
passage 3, after which they were frozen in liquid nitrogen as described in section 2.2.7.
2.2.2 Medium preparation
For HUVEC culturing the EGM-2 BulletKit was utilised (Lonza). This kit contains a 
500 ml bottle of EBM-2 endothelial medium and supplement (EGM-2 SingleQuot). 
The EGM-2 SingleQuot supplement contains 10 ml fetal calf serum (FCS), 0.2 ml 
hydrocortisone, 2.0 ml hFGF-B (human Fibroblast Growth Factor Basic), 0.5 ml 
VEGF (Vascular Endothelial Growth Factor), 0.5 ml R3-IGF-1 (Human Recombinant 
Insulin-like Growth Factor), 0.5 ml Ascorbic Acid (Vitamin), 0.5 ml hEGF (human 
recombinant Epidermal Growth Factor), 0.5 ml GA (gentamicin, amphotericin-B) 
1000 and 0.5 ml heparin. This supplement was added to a bottle of EBM-2 to make 
complete medium.
2.2.3 Preparation of seeding vessels
The seeding vessels (T75 cm2 or T25 cm2 vented cap flask (Nunc)) were coated with 
2% gelatin solution (Sigma) diluted to 1% gelatin in IX phosphate buffer saline
35
solution (PBS). The amount of gelatin solution used was 2 ml for a T25 cm2 flask and 
4 ml for a T75 cm2 flask. The coated vessels were left at 37 °C for at least 30 min. 
Excess gelatin was removed before seeding.
2.2.4 HUVEC retrieval
A cryovial of HUVEC at passage 3 was removed from the liquid nitrogen storage and 
plunged into a 37 °C water bath until almost completely defrosted. Final defrosting 
was completed at room temperature. The thawed HUVEC were immediately 
transferred to 8.5 ml of pre-warmed complete media and mixed thoroughly by 
inverting the tube and pipetting. The cell suspension was distributed between three 
gelatin-coated T25 cm vented cap flasks (3 ml per flask). Cells were allowed to settle 
for 2 hr or overnight in a 37 °C; 5% CO2, humidified incubator. After the cells had 
settled, medium was replaced with fresh medium and cultured as per 2.2.5.
2.2.5 Standard HUVEC culture
HUVEC do not tolerate rapid temperature fluctuations or nutrient-deficient medium 
and hence endothelial media was pre-warmed to 37 °C before use. HUVEC were 
monitored daily under an inverted microscope for cell growth and contamination. The 
culture medium was changed every other day after seeding to maintain sufficient 
nutrient levels. The amount of medium used was 4 ml for a T25 cm2 vented cap flask 
and 10 ml for a T75 cm2 vented cap flask. Cells were maintained until nearly 
confluent.
2.2.6 Sub-culturing of HUVEC
Once HUVEC reached 80-90% confluence, three T25 cm2 vented cap flasks with
gelatin were prepared for each confluent T25 cm2 flask. The medium was removed
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from the culture vessel and HUVEC were washed once with IX PBS to remove
complex proteins that neutralize trypsin (3 ml for T25 cm2 vented cap flask and 8 ml 
for a T75 cm2 vented cap flask). PBS was then removed from the culture vessel. 
Trypsin-EDTA solution (Sigma) was added to the flask. The flask was examined 
under inverted microscope until all cells were rounded up (about 1 min). As soon as all 
cells were rounded up, the flask was tapped sharply. Cells were checked again for 
complete detachment under an inverted microscope. When cells were deemed 
sufficiently detached, Trypsin-EDTA was neutralised with an equal volume of 
endothelial complete medium. The suspension was transferred to a 15 ml tube and 
centrifuged at 1,500 rpm for 5 min and the resultant supernatant was discarded. The 
pellet was resuspended in 0.5-1 ml complete medium and gently mixed by pipetting. 
Cells were diluted to a final volume of 2-3 ml in complete medium and the number of 
cells determined using a haemacytometer. The suspension was then adjusted to the 
required volume and added to the culture vessels. The seeded culture vessels were 
placed in a humidified incubator (37 °C, 5% CO2). Medium was replaced one day 
post-seeding and every other day thereafter.
2.2.7 HUVEC cryopreservation
When HUVEC reached confluence, they were trypsin detached (as described above), 
centrifuged and the pellet was resuspended in 3 ml of cryoprotective solution which 
comprised 8 parts fetal bovine serum, 1 part DMSO and 1 part complete medium. The 
cell suspension was aliquoted to 3 cryotubes and placed at -20 °C until frozen. 
Cryovials were then transferred to -SO °C overnight and finally stored in liquid 
nitrogen until required.
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CHAPTER 3: POST-ADHESIVE INDUCTION OF APOPTOSIS IN 
HUMAN ENDOTHELIAL CELLS BY MALARIA INFECTED
ERYTHROCYTES
3.1 INTRODUCTION
Apoptosis (programmed cell death) is a process triggered in response to specific 
stimuli. This process can mainly occur through two pathways. The first pathway 
involves the interaction between a death receptor, such as TNF receptor-1 or FAS 
receptor, and its ligand (extrinsic pathway) which lead to the activation of caspase-8. 
Another pathway depends on the participation of mitochondria (intrinsic pathway) 
which results in the triggering of caspase-9 (Schultz & Harrington, 2003). The detail 
of apoptotic pathways are described in section 1.2.1 of Chapter 1.
The potential role of apoptosis in the pathology of malaria has been suggested by a 
number of laboratories. Post-mortem studies conducted in Vietnamese patients showed 
that 40% of cerebral malaria (CM) patients had activation of caspase-3, a marker of 
apoptosis (Medana et al.t 2001). The significant elevation of Fas ligand (FasL) was 
found in post-mortem cerebrospinal fluid (CSF) samples from CM mortality cases 
(Armah et al, 2007). Soluble Fas (sFas) levels were significantly increased in plasma 
samples taken from CM patients when compared with plasma samples taken from 
healthy controls or mild malaria patients (Jain et al, 2008). Furthermore, a study to 
investigate the capacity of field isolates to induce endothelial cell apoptosis found that 
patients who have neurological manifestations were more likely to harbour 
apoptogenic strains (Toure et al, 2008).
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The study of Pino and colleagues, which co-cultured human endothelial cells with 
PRBC, illustrated that physical interactions between endothelial cells and PRBC are 
necessary to induce apoptosis of endothelial cells (Pino et al., 2003b). However, some 
studies have demonstrated induction of endothelial cell apoptosis indirectly in the 
absence of a physical interaction with PRBC. For instance, the study by Wilson and 
colleagues illustrated that soluble factors from P. falciparum-mfGcted erythrocytes can 
induce apoptosis in both human brain vascular endothelial and neuroglia cells (Wilson 
et al, 2008). The co-incubation of human endothelial cells with sera from malaria 
patients in the presence of neutrophils resulted in apoptosis of human endothelial cells 
(Hemmer et al, 2005).
The study which assessed whole-brain transcriptional responses in experimental 
murine CM showed the expression of apoptotic-related genes in CM-susceptible 
(C57BL/6) mice compared with CM-resistant (BALB/c) mice. This was confirmed by 
the histological analysis of mouse brain which demonstrated higher numbers of 
apoptotic cells in C57BL/6 mice compared with BALB/c mice (Lovegrove et al, 
2007). Studying the brains of mice with CM, Lackner and co-workers found activation 
of caspase-3 in different central nervous system cells of animals with CM (Lackner et 
al, 2007). Another study in deficient Fas and Fas ligand mice infected withP. berghei 
ANKA showed that these animals were protected from fatal CM (Potter et al, 2006b).
Although the murine model has been widely used as a model for the study of human
CM, there are markedly different histopathological features between murine and
human CM. For instance, there is little or no intracerebral sequestration of PRBC in
the murine model, whereas intense intracerebral sequestration is associated with
human CM (White et al., 2009a). As described above, there are conflicts as to whether
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cytoadherence of PRBC is essential for induction of apoptosis (Hemmer et al., 2005, 
Pino et al., 2003b, Wilson et al, 2008). In this chapter, we adopted an in vitro single­
cell imaging approach to determine PRBC-endothelial post-adhesive events. This 
approach surpasses other techniques as it allows us to closely observe the essential of 
PRBC cytoadherence in induction of endothelial cell apoptosis without signal 
interfering from the cells without PRBC cytoadherence.
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3.2 MATERIALS AND METHODS
3.2.1 Preparation of HUVEC for co-culturing
HUVEC used in the experiments were from passage 4-6. HUVEC culture 
methodologies have been described in detail in Chapter 2 section 2.2. When HUVEC 
reached to 80-90% confluence, cells were trypsinised and seeded on 40 mm diameter 
gelatin coated coverslip (Bioptechs) placed in petri dish (Nunc). The seeding density 
was 15,000-20,000 cells/cm2. Approximately 500 pi of cell suspension was gently 
loaded onto the coated coverslips. Cells were allowed to settle for 1 h at 37 °C, 5% 
CO2 in a humidified incubator. The medium was then removed and 2 ml of pre­
warmed fresh medium was added. Cells were then further cultured until they reached 
80-90% confluence.
3.2.2 Preparation of malaria parasites for co-culturing
P. falciparum strains ITG and C24 were cultured as described in Chapter 2 section 2.1. 
Parasites were cultured until they reached 5-8% parasitemia (trophozoite or schizont 
stages). Parasites were then submitted to a magnetic separation technique in order to 
obtain 80-90% parasitemia. This method is based on the paramagnetic property of 
mature parasites due to the stacking of the iron content of the haemozoin product of 
haemoglobin breakdown (Paul et al, 1981). Briefly, the parasite suspension was 
centrifuged at 2000 rpm for 5 min. The parasite pellet was re-suspended in 10 ml of 
binding solution (IX PBS containing 2% BSA (Sigma) and 20 mM glucose (Sigma)). 
The CS column was placed on a VarioMACS magnet (Miltenyi Biotec) and pre­
washed once with binding solution. The column was not allowed to dry at any time 
during the procedure. The parasite suspension was applied to the top of the column
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and the column was washed with binding solution until the flow through was clear. 
The column was removed from the magnet and the concentrated parasites were eluted 
by adding 10 ml of binding solution to the top of the column. The eluent was 
centrifuged at 2000 rpm for 5 min. The pellet was washed three times with parasite 
culture media.
3.2.3 Co-culture of HUYEC with malaria parasites
The concentrated parasites were re-suspended in 1% PCS in medium 199 to a 
parasitemia of 50% in 1% haematocrit. Endothelial medium was removed from 
HUVEC grown on coverslips at 80-90% confluence and the cells were gently washed 
once with IX PBS. Parasite suspension (2 ml) was then added to the HUVEC 
monolayer and co-cultured for 3, 6 or 24 h at 37 °C5 5% CO2 in a humidified 
incubator. In control groups, uninfected RBC were re-suspended in 2 ml of 1% PCS in 
medium 199 to get a 1% haematocrit and applied onto HUVEC monolayer washed 
with IX PBS. The co-culture dishes were agitated either clockwise or counter 
clockwise every 10-15 min to allow more cell-to-cell contact until the third hour.
3.2.4 Induction of apoptosis by camptothecin
For the positive control, HUVEC cultured on coverslips were treated with 
camptothecin (Sigma) at a concentration of 5 pM for 24 h in order to induce apoptosis.
3.2.5 Determination of apoptotic cells using confocal laser scanning microscope
After 3 h of co-cultivation, the co-culture medium was discarded. HUVEC in all 
groups of experiments were washed twice with IX PBS to remove unbound uninfected 
red blood cells or parasites. Apoptosis of HUVEC was detected using annexin V,
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Alexa fluor 488 conjugate (Molecular Probes). Annexin V is a Ca2+ dependent 
phospholipid-binding protein. It binds to phosphatidylserine translocated from the 
inner plasma membrane to the external side in apoptotic cells. To exclude necrotic 
cells, propidium iodide (PI) (Sigma) which stains nucleic acids was used (Fadok et al, 
1992, Vermes et al, 1995). Double staining of annexin V and propidium iodide was 
performed by adding 8 pi of annexin V and 2 pi of 2.5 pg/ml PI into 2 ml of annexin­
binding buffer (10 mM HEPES, 140 mM NaCl and 2.5 mM CaCl2, pH 7.2). Cells 
were incubated within this mixture at 37 °C, 5% CO2 in humidified incubator for 20 
min. The coverslips were gently washed once with annexin-binding buffer. The 
coverslips were assembled into a Bioptechs FCS2 perfusion chamber (Bioptechs), 
perfused with annexin-binding buffer and observed with Zeiss Pascal confocal laser 
scanning microscope (CLSM). Cells were viewed through a Plan-Apochromat 63x 1.2 
numerical aperture (N.A.) water objective. Fluorescence signals from annexin V and 
PI were obtained by single excitation with argon ion laser at 488 nm and collection of 
emitted light through a 505-530 nm band pass filter and a 650 nm long pass filter, 
respectively. At least 500 cells were counted for each replicate and scored according to 
the appearance of cells, i.e. attached/unattached to PRBC, blebbing and/or annexin 
V/PI staining. Endothelial cells undergoing apoptosis were characterised by blebbing 
of the cell membrane and/or staining positive for annexin V or annexin V positive 
alone. HUVEC that showed uptake of annexin V together with PI or uptake of PI 
alone were considered as necrotic cells (Jacobi et al, 2005).
The level of attachment between HUVEC and PRBC, apoptosis resulting from PRBC 
cytoadherence and apoptosis of HUVEC without cytoadherence were shown in 
percentage as calculated by:
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a. The level of attachment between HUVEC and PRBC:
number of HUVEC attached to PRBC 
total number of cell count x 100
b. The level of apoptosis resulting from cytoadherence:
number of apaptotic HUVEC attached to PRBC 
number of HUVEC attached to PRBC x 100
c. The level of apoptosis of HUVEC without cytoadherence:
number of apoptotic HUVEC unattached to PRBC ................. ......................................................................^
total number of cell count
3.2.6 Comparison between live and dead malaria parasites in inducing apoptosis 
in HUVECa
To further understand the process of malaria parasite induced apoptosis of HUVEC, 
we investigated the apoptotic potential of live and dead parasites. The parasites were 
killed using two different methods, i.e. heat killing and artesunate killing.
3.2.6.1 Malaria parasites killed by artesunate treatment
Malaria parasites (ITG strain) at ~5% parasitemia (at mature trophozoite stages) were 
incubated with 500 nM artesunate (Mepha) for 4 h. The parasites were centrifuged at 
3000 ipm for 5 min and then washed once with complete media.
3.2.6.2 Malaria parasites killed by heat
Mature stage malaria parasites were heat-killed by subjecting the parasite pellet to 60 
°C for 20 min in a water bath. The pellet was washed twice with complete media. 
a In collaboration with Dr. Pampen Viriyavejakul
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In order to determine the viability of the parasites, 200 pi each of the artesunate-killed 
or heat-killed parasites were incubated separately with equal volumes of annexin­
binding buffer containing 2.5 pg/ml propidium iodide for 20 min. A control consisting 
of untreated PRBC was prepared in parallel. Wet smear preparations were produced 
and visualised under the confocal microscope through the Plan-Apochromat 63 x 1.4 
N.A. water objective. Cell viability was calculated and expressed as the percentage of 
the total number of cells counted. Parasites stained with PI were considered as dead 
parasites.
The remaining parasites from the heat-killed and artesunate-killed parasites were 
transferred to culture flasks and grown in continuous culture for 4 weeks to confirm 
that all parasites were dead.
3.2.6.3 Heat-killed parasites binding to endothelial cells
HUVEC were grown on coverslips as described in section 3.2.1. Malaria parasites 
(ITG strain) were prepared as described in section 3.2.2 with some modifications. 
After the parasite pellet was washed with complete media, they were re-suspended to 
get 50% parasitemia in 1% haematocrit in M199 supplemented with 1% PCS. The 
sample was divided into two tubes of 2 ml each. One suspension was heat-killed by 
immersing the tube into a 60 °C for 20 min in a water bath. The other tube served as a 
control (live parasites). Live and heat-killed parasite suspensions were then added to 
the HUVEC monolayer and co-cultured for 3 h at 37 °C, 5% C02 in a humidified 
incubator. The co-culture dishes were agitated either clockwise or counter clockwise 
every 10-15 min to allow more cell-to-cell contact until the third hour. Apoptotic
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endothelial cells were determined with the aid of confocal microscopy as described in 
section 3.2.5.
3.2.6.4 Artcsunale-killed malaria parasites binding to endothelial cells
Malaria parasites (ITG strain) and HUVEC were prepared for co-culturing as 
described in section 3.2.1 and 3.2.2. The washed parasite pellet was re-suspended in 
Ml 99 supplemented with 1% PCS to get 50% parasitemia in 1% haematocrit. The 
parasites were divided in to two tubes each of 2 ml. One tube was subjected to 
artesunate-killed by incubation with 500 nM artesunate for 4 h. The other tube was 
served as a control (live parasites). Parasites in both groups were co-cultured with 
HUVEC for 3 h at 37 °C, 5% CO2 in a humidified incubator. The co-culture dishes 
were agitated either clockwise or counter clockwise every 10-15 min to allow more 
cell-to-cell contact until the third hour. The determination of apoptotic endothelial 
cells was performed with the aid of confocal microscopy as described in section 3.2.5.
3.2.7 The importance of parasite ligand binding preference in parasite induced 
HUVEC apoptosisa
The ITG parasite used in previous experiments has a preference to bind to ICAM-1 
(Ockenhouse et al, 1991). In contrast, P. falciparum isolate used in these experiments 
was C24, which strongly bind to CD36 on endothelial cells (Gray et al, 2003).
HUVEC and malaria parasites were prepared as previously described in section 3.2.1 
and 3.2.2, respectively. Both parasite lines were added on HUVEC monolayer and co­
cultured for 3 h at 37 °C, 5% CO2 in a humidified incubator. After 3 h of co-culture, 
HUVEC were stained with annexin V and propidium iodide as described in section 
a In collaboration with Dr. Pampen Viriyavejakul
46
3.2.5. Apoptotic HUVEC were determined using confocal microscopy as described in 
section 3.2.5.
3.2.8 Blocking parasite induced HUVEC apoptosis with caspase inhibitors
The general caspase inhibitor (Z-VAD-FMK) (Promega) was used to confirm that the 
apoptotic process seen in HUVEC occurred via a caspase dependent mechanism. In 
addition, more-specific caspase inhibitors, Z-IETD-FMK (caspase-8 inhibitor) (R&D 
systems) and Z-LEHD-FMK (caspase-9 inhibitor) (R&D systems) (Meguro et ah, 
2001), were also used in the experiments to determine the cellular pathway involved in 
apoptosis of HUVEC.
HUVEC and parasites were prepared as described in section 3.2.1 and 3.2.2, 
respectively. The concentrated parasites were re-suspended in 1% FCS in medium 199 
to a parasitemia of 50% in 1% haematocrit. Endothelial medium was removed from 
HUVEC grown on coverslips at 80-90% confluence and the cells were gently washed 
once with IX PBS. Parasite suspension was then added to the HUVEC monolayer and 
co-cultured for 3 h at 37 °C, 5% CO2 in a humidified incubator. The co-culture dishes 
were agitated either clockwise or counter clockwise every 10-15 min to allow more 
cell-to-cell contact until the third hour.
For apoptotic inhibition assay, Z-VAD-FMK at 20 pM, Z-IETD-FMK at 100 pM and 
Z-LEHD-FMK at 100 pM were added at the same time as co-culturing. After 3 h of 
co-cultivation, the co-culture medium was discarded. HUVEC were washed twice with 
IX PBS and stained with annexin V and propidium iodide as described in section 
3.2.5. Apoptosis of endothelial cells was determined as described in section 3.2.5.
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3.2.9 Caspase-8 and caspase-9 activities in malaria parasites induced apoptosis 
in HUVECa
To confirm the involvement of two apoptotic pathways (the extrinsic and intrinsic 
pathways) that have been observed from our single cell studies, luminescence-based 
assays were conducted to determine the activities of caspase-8 and caspase-9 from 
induced HUVEC. The assay kits used in this experiment contain the substrates of 
caspase-8 or caspase-9. Upon cleavage of the substrates by the respective caspases, 
aminoluciferin is liberated and can contribute to the generation of light in a 
luminescence reaction. The resulting luminescent signal is directly proportional to the 
amount of caspase activity present in the sample.
3.2.9.1 Preparation of cell lysate
HUVEC were grown in T25 cm2 vented cap flask as described in Chapter 2 section 
2.2. Malaria parasites were culture and subjected to magnetic separation as described 
in Chapter 2 section 2.1 and section 3.2.2, respectively. Experimental samples 
consisted of cell lysates collected from control HUVEC, HUVEC incubated with 
camptothecin, HUVEC co-cultured with normal red blood cells and HUVEC co­
cultured with parasitized red blood cells. Camptothecin was used at 10 pM. 
Uninfected red blood cells were used at 1% haematocrit, and parasitized red blood 
cells were used at 50% parasitemia at 1% haematocrit. After 24 h of co-culturing, the 
suspension was removed and centrifuged at 14,000 rpm for 45 min at 4 °C to spin 
down microparticles and floating cells. Adherent HUVEC were washed three times 
with iced cold 250 mM sucrose (Sigma) in 10 mM Tris solution (Sigma) (pH 7.4) with
a In collaboration with Dr. Pampen Viriyavejakul
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gentle rocking of the culture vessels to remove as much RBC and PRBC materials as 
possible. Cells were harvested in 15 ml of sucrose-Tris solution using a cell scrapper. 
The suspension was spun down at 1,500 rpm for 5 min. The supernatant was discarded 
and the precipitate was combined with micropaticles and floating cells.
3.2.9.2 Luminescence activities of caspase-8 and caspase-9
Caspase-Glo 8 and Caspase-Glo 9 assays (Promega) were used to determine the 
activities of caspase-8 and caspase-9, respectively. The 1:1 ratio of Caspase-Glo 8 or 
Caspase-Glo 9 assays to sample volume was used. Then, the mixture was incubated 
for 1 h at room temperature. Luminescence of each sample was measured using the 
Wallac 1450 MicroBeta Trilux Liquid Scintillation and Luminescence counter. The 
counting time was set at 20 s per sample.
3.2.10 Statistical analysis
Results were expressed as mean ± standard error of individual experimental groups. 
Statistical analysis was performed with GrapPad InStat version 3.05. Data were 
analysed by Mann-Whitney U test. A value of p < 0.05 was considered significant.
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3.3 RESULTS
3.3.1 Cytoadherence of PRBC and RBC to HUVEC
The level of binding between malaria parasites and HUVEC at 3, 6 and 24 h of co­
culturing were 3.98% ± 0.41 (SE), 4.84 ± 0.80 (SE) and 3.60% ± 0.61 (SE), 
respectively (Fig. 3.1). In control groups, co-culturing RBC together with HUVEC, the 
percentages of binding between RBC and HUVEC were 0.00% ± 0.00 (SE), 0.13% ± 
0.08 (SE) and 0.60% ± 0.40 (SE) after 3, 6 and 24 h of co-incubation, respectively 
(Fig. 3.1).
There were statistically significant differences between the amount of attached PRBC 
and attached RBC for 3 and 6 h of co-culturing (p < 0.05). However, the numbers of 
attached PRBC and attached RBC at 24 h co-culturing was not statistically significant 
different. This might due to the lesser number of replicates (n = 3) compared to 
experiments with 3 h and 6 h (n > 6) co-culture. This situation occurred because there 
was technical difficulty in counting apoptotic HUVEC after cells had been co-cultured 
with PRBC for 24 h.
The absence of attachment between RBC and HUVEC is illustrated in figure 3.2A, 
whilst PRBC-HUVEC cytoadherence is illustrated in Fig. 3.2B. Cell membrane 
blebbing and annexin V staining of attached HUVEC can also clearly be seen for 
PRBC-dependent cytoadherence.
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Figure 3.1a Comparison amount of binding of PRBC and RBC to HUVEC at different 
time points. Data are mean ± SE of at least three experiments. * denotes statistical 
difference (p < 0.05).
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3.3.2 Cytoadherence-mediated PRBC induced apoptosis of HUVEC
HUVEC undergoing apoptosis were characterised by blebbing of the cell membrane 
and/or staining positive for annexin V or annexin V positive alone. HUVEC positively 
stained with PI were considered as necrotic cells. Various features of HUVEC 
apoptosis and samples of cells stained positively with PI were showed in Fig 3.4 (A- 
E).
In positive control experiments, HUVEC were induced to apoptosis by using the 
topoisomerase I inhibitor camptothecin (Simak et at, 2002). Treatment of HUVEC 
with camptothecin caused profound changes in HUVEC morphology and staining 
compared to untreated cells. Cells became detached, together with cell membrane 
blebbing and/or positive staining with annexin V Fig 3.4 (F), These phenomena were 
also found in HUVEC that attached to PRBC. HUVEC with attached PRBC showed 
detachment from coverslip, cell membrane blebbing and/or annexin V positive as well 
as the formation of apoptotic bodies (microparticles) (Fig 3.4 (A-D)).
The degree of apoptosis resulting from cytoadherence was also assessed. The data 
demonstrated that after 3, 6 and 24 h of co-incubation, 88.77% ± 1.35 (SE), 71.65% ± 
10.83 (SE) and 67.44% ± 9.22 (SE) of HUVEC with attached PRBC demonstrated 
signs of apoptosis, respectively (Fig 3.3). Relative to attached cells, very few HUVEC 
that were unattached displayed signs of apoptosis after either 3, 6 or 24 h of co-culture 
(p < 0.05).
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Figure 3.3a Comparison of apoptosis (%) of HUVEC when attached or unattached 
during co-incubation with PRBC. Data are mean ± SE of at least three experiments. * 
denotes statistical difference (p < 0.05).
In collaboration with Dr. Pampen Viriyavejakul
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Figure 3.4 Confocal images of various morphological changes of HUVEC after 
incubation with PRBC (A-E) or camptothecin (F). (A) Cell membrane blebbing alone 
of HUVEC attached to PRBC; (B) Blebbing and annexin V positive HUVEC with 
attached PRBC; (C) Blebbing, annexin V positive and microparticles stained with 
annexin V of HUVEC attached to PRBC; (D) Blebbing and annexin V positive of 
HUVEC with multiple binding of PRBC; (E) Necrotic HUVEC showing blebbing, 
annexin V and propidium iodide positive; (F) Blebbing and annexin V positive of 
HUVEC treated with camptothecin.
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3.3.3 The role of ligand binding preference and PRBC induced HUVEC 
apoptosis
In this experiment, two parasite strains were used to co-incubate with HUVEC, 
namely ITG and C24. As stated previously, C24 malaria parasites are known to bind to 
CD36 receptors whilst ITG parasites are known binders of ICAM-1. The C24 parasite 
line was shown to have reduced binding to HUVEC compared to ITG parasites (C24 
binding was measured at 0.59% ±0.13 (SE) compared to 3.59% ± 0.64 for ITG, Fig 
3.5). However interestingly, when comparing the percentage of bound cells that 
became apoptotic, there was no statistically significant difference between the two 
parasite lines (Fig 3.6).
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Figure 3.5a Comparison of HUVEC binding between ITG and C24 parasite lines. 
Data are mean ± SE of at least five experiments. * denotes statistically significant 
difference (p < 0.05).
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Figure 3.6a Apoptosis of HUVEC induced by two parasites isolates (C24 and ITG). 
Data are mean ± SE of at least five experiments.
3.3.4 Establishing the role of parasite viability and PRBC induced HUVEC 
apoptosis
The aim of this experiment was to investigate the role of parasite viability on malaria 
parasite-induced apoptosis of HUVEC. Two procedures, i.e. heat-killing and 
artesunate-killing were used to kill parasites. The viability and appearance of the 
parasites were compared with the control/untreated parasites.
In the control group, almost all parasites were localised within RBC, whereas many of 
parasites killed by heat and artesunate appeared as ghost red cells and many appeared 
as free parasites. Table 3.1 summarises parasite viability and localisation of the
8 In collaboration with Dr. Pampen Viriyavejakul
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parasites from control, heat-killed and artesunate-killed groups. Cell viability of 
malaria parasites in control group (live parasites) was 93.92% ±1.14 (SE). In heat- 
killed and artesunate-killed malaria parasites, cell viability of parasites was 0.62% ± 
0.36 (SE) and 0.87% ± 0.27 (SE), respectively (Fig 3.7). Unsuprisingly, there was a 
statistically significant difference in parasite viability between control group and both 
modes of parasite killing (p < 0.05).
To confirm that parasites died after treatment with either heat or artesunate, both heat- 
killed and artesunate-killed malaria parasites were kept in continuous culture for four 
weeks. However, parasites in both groups failed to grown in culture.
Cell viability In RBC In ghost Free parasite
(%) ± SE (%) ± SE (%) ± SE (%) ± SE
Control 93.92±1.14 97.15±0.38 0.00±0.00 2.85±0.38
Heat-killed 0.62±0.36 10.97±2.05 31.28±5.82 57.75±6.87
Artesunate-killed 0.87±0.27 51.48±3.82 30.10±3.10 18.41±2.00
Table 3.1a Comparison of cell viability and localisation of parasite in control, heat- 
killed and artesunate-killed malaria parasites. Data are mean ± SE of four experiments.
a In collaboration with Dr. Pampen Viriyavejakul
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Figure 3.7a Cell viability of control, heat-killed and artesunate-killed malaria 
parasites. Data are mean ± SE of four experiments. * denotes statistically significant 
difference when compare to control (p < 0.05).
3.3.5 The HUVEC binding potential of heat-killed and artesunate-killed malaria 
parasites
The mean percent of control parasites (viable parasites), heat-killed parasites and 
artesunate-killed parasites bound to HUVEC were 4.57% ± 0.85 (SE), 0.44% ± 0.06 
(SE) and 3.76% ± 0.50 (SE), respectively (Fig 3.8). However, the percentage of bound 
cells that became apoptotic was similar for all treatments, irrespective of viability (Fig 
3.9).
a In collaboration with Dr. Pampen Viriyavejakul
58
control heat-killed artesunate-killed
Mode of treatment
Figure 3.8a Cytoadherence of control parasites (viable parasites), heat-killed parasites 
and artesunated-killed parasites to HUVEC. Data are mean ± SE of at least five 
experiments. * denotes statistically significant difference (p < 0.05).
uw
120.00
100.00
80.00
60.00
40.00
20.00
0.00
control heat-killed artesunate-killed
Mode of treatment
■ Attached 
U Unattached
Figure 3.9a Apoptosis of HUVEC attached and unattached to control parasites, heat- 
killed parasites and artesunate-killed parasites. Data are mean ± SE of at least five 
experiments. * denotes statistically significant difference (p < 0.05).
8 In collaboration with Dr. Pampen Viriyavejakul
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3.3.6 Blockage of PRBC-induced apoptosis of HUVEC with pan-caspase 
inhibitor Z-VAD-FMK, caspase-8 inhibitor Z-IETD-FMK and caspase-9 
inhibitor Z-LEHD-FMK.
There was no noticeable effect on morphology of HUVEC after addition of 20 pM 
pan-caspase inhibitor, 100 pM caspase-8 inhibitor or 100 pM caspase-9 inhibitor to 
the co-culture. In addition, Z-VAD-FMK, Z-IETD-FMK or Z-LEHD-FMK had no 
effect on the binding ability of PRBC to HUVEC (Fig. 3.10). The mean percentage of 
PRBC binding to HUVEC for control group of Z-VAD-FMK was 6.31% ± 0.67 (SE) 
versus 5.55% ± 0.71 (SE) in Z-VAD-FMK treated group. The mean percentage of 
PRBC binding to HUVEC for control group of Z-IETD-FMK was 5.74% ± 0.34 (SE) 
versus 6.09% ± 0.33 (SE) in Z-IETD-FMK treated group. The mean percentage of 
PRBC binding to HUVEC of Z-LEHD-FMK treated group was 5.59% ± 0.55 (SE) 
versus 5.23% ± 0.39 (SE) in control group.
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Figure 3.10 Comparison amount of binding between PRBC and HUVEC in control 
group and caspase inhibitors treated groups. Data are mean ± SE of at least three 
experiments.
However, the ability of attached PRBC to induced apoptosis of HUVEC was 
significantly decreased in the presence of pan-caspase inhibitors, caspase-8 inhibitor 
or caspase-9 inhibitor (Fig 3.11).
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Figure 3.11 Effect of caspase inhibitors on PRBC-induced HUVEC apoptosis. Data 
are mean ± SE of at least three experiments. * denotes statistically significant 
difference (p < 0.05).
The absence of annexin V staining and membrane blebbing in inhibitor-treated groups 
compared to control groups is clearly demonstrated in Fig 3.12.
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Figure 3.12 Cytoadherence of PRBC to HUVEC in control group and in the presence 
of caspase inhibitors. (A) Apoptotic HUVEC attached to PRBC shows cell membrane 
blebbing and annexin V positive; (B) HUVEC attached to PRBC in the presence of 
pan-caspase inhibitor (Z-VAD-FMK); (C) HUVEC attached to PRBC in the presence 
of caspase-8 inhibitor (Z-IETD-FMK); (D) HUVEC attached to PRBC in the presence 
of caspase-9 inhibitor (Z-LEHD-FMK).
3.3.7 Caspase-8 and caspase-9 activities in PRBC-induced HUVEC
The activities of caspase-8 and caspase-9 in HUVEC treated with camptothecin (an 
inducer of apoptosis) or following co-culture with PRBC or RBC, compared to control 
(untreated) groups are given in Fig 3.13 and Fig 3.14, respectively. The mean ± SE of
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caspase-8 and caspase-9 activities are illustrated in Table 3.2. As expected,
camptothecin treatment was shown to increase the level of both caspases compared to
untreated HUVEC. Co-incubation of RBC did not significantly increase the activities
of caspases in HUVEC compared to control groups, but interestingly, co-incubation
with PRBC significantly increased the levels of caspase activities compared to control
groups to levels even higher than the positive control camptothecin.
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Figure 3.13a Caspase-8 activity in HUVEC. Data are mean luminescence ± SE of at
least three experiments. * denotes statistically significant difference (p < 0.05).
a In collaboration with Dr. Pampen Viriyavejakul
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Figure 3.14a Caspase-9 activity in HUVEC. Data are mean luminescence ± SE of at 
least three experiments. * denotes statistically significant difference (p < 0.05).
Caspase-8 activity
Mean luminescence ± SE
Caspase-9 activity
Mean luminescence ± SE
Control 2.37 x 10z± 0.44 4.18 x lO^ ± 1.22
Camptothecin 11.98 x 10^ ±2.67 19.99 x 10^ ±7.62
RBC 3.08 x 102 ± 0.14 5.78 x 102± 1.07
PRBC 31.07 x lO^ ± 6.52 21.86 x lO^ ± 5.97
Table 3.2 Caspase-8 and Caspase-9 activities. Values are expressed as mean 
luminescence ± SE of at least three experiments.
In collaboration with Dr. Pampen Viriyavejakul
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3.4 DISCUSSION
Recently, the adhesion of PRBC to endothelial cells has been reported to induce a 
deleterious effect on endothelial cells, i.e. apoptosis of endothelial cells (Pino et al, 
2005). A physical interaction between endothelial cell and PRBC was necessary to 
induce apoptosis in endothelial cells. This was demonstrated by co-culture of 
endothelial cells either with poorly adherent parasite clone or with adherent parasite 
clone in transwell culture plate which provide a porous membrane to allow co-culture 
of different cell type without physical contact between the cells. Under non-contact or 
poorly adherent parasites co-culture conditions, there was no induction of apoptosis of 
endothelial cells (Pino et al., 2003b). We have taken these observations further. Here, 
our study confirms that the direct binding of PRBC to HUVEC induces apoptosis of 
HUVEC. HUVEC with attached PRBC showed alterations in their morphology 
leading to apoptosis. These alterations were not observed in HUVEC co-culture with 
RBC (Fig 3.2 A). The morphological changes include cell membrane shrinkage, 
blebbing and/or annexin V staining positive and generating of endothelial 
microparticles (EMPs) (Fig 3.4 (A-D)).
In contrast to earlier studies, we used the single cell approach to study this 
phenomenon which is useful in providing a detailed understanding of the cellular 
events that follow binding of PRBC to HUVEC in co-culture without the complication 
and contribution to the noise of the HUVEC without bound PRBC. Importantly, our 
HUVEC were not stimulated with TNF-a as in other studies. In addition, we 
demonstrate a quantitative correlation between PRBC-HUVEC binding and apoptosis 
i.e. all HUVEC (> 90%) with bound PRBC underwent apoptosis in this in vitro model.
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To investigate whether apoptosis of HUVEC requires the binding of PRBC to a 
specific receptor or whether it is just a general effect of PRBC binding to endothelial 
cells, we used two different parasite isolates, ITG and C24, which have specific 
binding affinity for different endothelial cell receptors, i.e. ITG has binding preference 
to ICAM-1 whereas C24 tends to bind more to CDS6 (Gray et al., 2003). Although 
HUVEC (CDS6') does not support the binding of C24 parasites to CDS 6 (Gray et al, 
2003), we found that both parasite strains can induce apoptosis in HUVEC to almost 
the same extent. Both ITG and C24 parasites are genetically identical but differ in 
their expression of var genes resulting in different binding phenotypes (Jenkins et al, 
2007). However, switching to alternative var genes, which results in expression of 
distinct PfEMP-1, can occur at a rate up to 2% per generation (Roberts et al, 1992). 
This means that a subset of C24 and ITG parasite populations used in the co-culture 
will express PfEMP-ls which are distinct from the original clones and from this pool 
probably comes PfEMP-1 responsible for binding and inducing apoptosis in HUVEC. 
This may explain why both parasite isolates can induce HUVEC apoptosis, even 
though they have nominally different binding preferences.
We assessed the ability of non-viable parasites killed by heat and artesunate to adhere 
and induce apoptosis of HUVEC. Our data indicated that dead parasites can still bind 
to HUVEC and induce apoptosis. This observation is consistent with an ultrastructural 
analysis of brains from patients with cerebral malaria which found that 
morphologically damaged parasites bound to brain endothelial cells (Pongponratn et 
al, 2003). There was a difference in the extent of binding resulting from the two 
procedures with artesunate-killed parasites retaining a greater ability to bind to 
HUVEC than heat-killed parasites. This may be readily explained by looking at the
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morphology of the parasites. Parasites killed by artesunate appeared morphologically 
unaffected compared to heat-killed parasites (Table 3.1). This finding is in agreement 
with the recent report showing that artesunate-killed malaria parasites retained the 
ability to cytoadhere even after 24 h of drug treatment. This is due to the continued 
and undisrupted presence of PfEMP-1 on the surface of PRBC after loss of parasite 
viability (Hughes et al, 2010). We concluded that induction of HUVEC apoptosis is 
not dependent on the viability of parasites and consequent active cell-cell signalling 
but is dependent only on the host red cell membrane, and presumable PfEMP-1 being 
intact.
Apoptosis is the tightly regulated form of physiological cell death in which the 
terminal stage involves activation of a family of proteases, the caspases (Hengartner, 
2000). To further establish the role of a caspase-dependent apoptotic pathway, we used 
the pan-caspase inhibitor (Z-VAD-FMK) to inhibit apoptosis of HUVEC attached to 
PRBC. The pan-caspase inhibitor had no effect on binding of PRBC to HUVEC but 
significantly reduce apoptosis of HUVEC. To sort out the cellular pathways involved, 
we used specific caspase-8 and caspase-9 inhibitors and measured caspase-8 and -9 
activities. The results indicated that both death receptor pathways mediated through 
caspase-8 and the mitochondrial pathway mediated through caspase-9 involve in the 
apoptosis of HUVEC.
In conclusion, the results in this chapter demonstrate that PRBC adhesion to HUVEC 
induce caspase-8 and caspase-9 dependent apoptosis in HUVEC. This apoptogenic 
effect of PRBC on endothelial cell might be one of the factors leading to the BBB 
dysfunction and lesion in CM. Apoptosis of HUVEC as a consequence of PRBC 
adhesion also leads to generation of endothelial microparticles (apoptotic bodies)
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which are the sub-micron elements produced after membrane remodelling during 
physiological or pathogenic processes such as apoptosis (Combes et al, 2006). This is 
consistent with the study conducted in Malawian children which found dramatically 
higher level of EMPs in plasma of children with acute phase CM than in plasma of 
children with severe malarial anaemia, uncomplicated malaria or healthy control 
condition (Combes et al, 2004). Our study also shows that the binding of PRBC to 
HUVEC is dependent on the host red cell membrane being intact but independent of 
viability of the parasites.
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CHAPTER 4: MEASURING THE EFFECT OF MALARIA
PARASITE BINDING ON THE MITOCHONDRIAL MEMBRANE 
POTENTIAL OF HUMAN ENDOTHELIAL CELLS
4.1 INTRODUCTION
In living cells, mitochondria are the site of energy production. This energy production 
is driven by the electrochemical gradient consisting of a proton gradient and a 
transmembrane electrical potential (AT) built across the inner mitochondrial 
membrane (Cooper, 2007). In many apoptotic models, the dissipation of the 
mitochondrial inner membrane potential (ATm) is one of the early events in the 
mitochondrial apoptotic pathway (intrinsic pathway). This is a result of opening of the 
mitochondrial permeability transition pore (FTP), a multiprotein complex consisting of 
both inner and outer membrane proteins, which is presented at the contact sites 
between the outer and the inner membranes (Antonsson, 2004). The opening of this 
pore also leads to the release of caspase-activating proteins such as cytochrome c and 
apoptosis-inducing factor (AIF) which locate within the intermembrane space into the 
cytosol and induce apoptosis (Green & Kroemer, 2004).
The loss of mitochondrial membrane potential can be detected by a unique cationic
dye, 5,5 ’ ,6,6’tetrachloro-1,1’ ,3,3 ’ -tetraethylbenzimidazolycarbocyanine iodide,
commonly known as JC-1. JC-1 is a lipophilic cationic dye that displays potential-
dependent accumulation in mitochondria (Cossarizza et al., 1993). This dye can
selectively enter into mitochondria and reversibly change colour from green to red as
the membrane potential increases. In healthy cells with high mitochondrial membrane
potential (180 - 220 mV, negative inside), the dye forms a complex called J-aggregates
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with a fluorescence emission in the red region. In contrast, in apoptotic cells with low 
mitochondrial membrane potential, the dye remains in a monomeric form 
characterised by emission fluorescence in the green region (Cossarizza et al.t 1993). 
Thus, apoptotic cells showing primarily green fluorescence are easily differentiated 
from healthy cells.
The data in chapter 3 indicated that apoptosis of HUVEC attached to PRBC involves 
the mitochondrial apoptotic pathway, as demonstrated by the increased activity of 
caspase 9 in HUVEC attached to PRBC and decreased numbers of apoptotic HUVEC 
attached to PRBC when treated with a caspase-9 inhibitor. As described in Chapter 1, 
apoptosis signalling can involve intrinsic or extrinsic pathways (section 1.2.1 in 
Chapter 1). In intrinsic pathways, the mitochondrion plays a critical part in signal 
transduction. In this chapter, the involvement of HUVEC mitochondria in PRBC 
cytoadherence-induced apoptosis was studied to define the apoptotic pathway in 
greater detail.
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4.2 MATERIALS AND METHODS
4.2.1 Preparation of HUVEC for co-culturing
HUVEC used in the experiments were from passage 4-6. HUVEC were cultured as 
described in Chapter 2 section 2.2. When HUVEC reached to 80-90% confluence, 
cells were trypsinised and seeded on 40 mm diameter gelatin coated coverslips 
(Bioptechs) placed in petri dishes (Nunc). The seeding density was 15,000-20,000 
cells/cm2. Approximately 500 pi of cell suspension was gently loaded onto the coated 
coverslips. Cells were allowed to settle for 1 h at 37 °C, 5% C02 in a humidified 
incubator. The medium was then removed and 2 ml of pre-warmed fresh medium was 
added. Cells were then further cultured until they reached 80-90% confluence.
4.2.2 Preparation of malaria parasites for co-culturing
P. falciparum strain ITG was cultured as described in Chapter 2 section 2.1. Parasites 
were cultured until they reached 5-8% parasitemia (trophozoite or schizont stages). 
Parasites were then submitted to a magnetic separation technique in order to obtain 80- 
90% parasitemia. Briefly, the parasite suspension was spun down at 2000 rpm for 5 
min. The parasite pellet was re-suspended in 10 ml of binding solution (IX PBS 
containing 2% BSA (Sigma) and 20 mM glucose (Sigma)). The CS column was 
placed on a VarioMACS magnet (Miltenyi Biotec) and pre-washed once with binding 
solution. The column was not allowed to dry at any time during the procedure. The 
parasite suspension was applied to the top of the column and the column was washed 
with binding solution until the flow through was clear. The column was removed from 
the magnet and the concentrated parasites were eluted by adding 10 ml of binding
72
solution to the top of the column. The eluent was centrifuged at 2000 rpm for 5 min. 
The pellet was washed three times with parasite culture media.
4.2.3 Co-culture of HUVEC with malaria parasites
The concentrated parasites were re-suspended in 1% PCS in medium 199 to a 
parasitemia of 50% in 1% haematocrit. Endothelial medium was removed from 
HUVEC grown on coverslips at 80-90% confluence and the cells were gently washed 
once with IX PBS. Two ml of parasite suspension was then added to the HUVEC 
monolayer and co-cultured for 3, 8, 18 or 24 h at 37 °C, 5% C02 in a humidified 
incubator. The co-culture dishes were agitated either clockwise or counter clockwise 
every 10-15 min to allow more cell-to-cell contact until the third hour.
4.2.4 Measurement of endothelial cell mitochondrial membrane potential (ATm) 
by confocal laser scanning microscope
After co-incubation, co-culture media were discarded. HUVEC were washed twice 
with IX PBS to wash out unbound PRBC and RBC. HUVEC were stained with the 
cationic dye 5,5 ’ ,6,6’tetrachloro-1,1’ ,3,3 ’ -tetraethylbenzimidazolycarbocyanine iodide 
(JC-1) (Molecular Probes). The dye was prepared in medium 199 plus 1% PCS at a 
concentration of 5 pM. HUVEC were left in the probe solution for 15 min at 37 °C, 
5% CO2 in humidified incubator. The coverslips were then gently washed once with 
IX PBS. The coverslips were assembled into a Bioptechs FCS2 perfusion chamber, 
perfused with medium 199 plus 1% PCS and observed with a Zeiss Pascal confocal 
laser scanning microscope (CLSM). Cells were viewed through a Plan-Apochromat 
63x 1.2 numerical aperture water objective. Fluorescence signals from JC-1 were 
collected by excitation with argon ions and HeNe laser at 488 and 543 nm and
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collection of emitted light through a 505-530 nm band pass filter and a 560 nm long 
pass filter, respectively. For positive control, the protonophore carbonyl cyanide p- 
(trifluoromethoxy) phenylhydrazone (FCCP) at a concentration of 10 pM was 
perfused in to the chamber. At least 500 endothelial cells were counted for each 
replicate and scored according to the appearance of cells, i.e. attached or unattached 
with PRBC and the red/green fluorescence of cells.
4.2.5 Statistical analysis
Results were expressed as mean ± standard error of individual experimental groups. 
Statistical analysis was performed with GrapPad InStat version 3.05. Data were 
analysed by One-way ANOVA with Tukey-Kramer Multiple Comparisons post test. A 
value of p < 0.05 was considered significant.
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4.3 RESULTS
4.3.1 Binding of PRBC to HUVEC
Apart from observing the mitochondrial membrane potential of HUVEC attached to 
PRBC, the number of HUVEC adhered to PRBC were also recorded at each co­
incubation time point. The mean percentage of HUVEC attached to PRBC were 4.79% 
± 0.16 (SE), 3.99% ± 0.22 (SE), 4.29% ± 0.34 (SE) and 3.83% ± 0.28 (SE) at 3, 8, 18 
and 24 h of co-incubation, respectively. There was no statistically significant 
difference in number of HUVEC attached to PRBC between each time point (Fig 4.1).
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Figure 4.1 Comparison amount of binding of PRBC to HUVEC at different co­
incubation time points. Data are mean ± SE of at least five experiments.
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4.3.2 Mitochondrial membrane potential of HUVEC attached to PRBC
The dissipation of mitochondrial membrane potential of HUVEC attached to PRBC 
was detected by staining cells with the mitochondrial-targeted dye, JC-1. Mitochondria 
of control cells (normal HUVEC) showed either red or green fluorescence. The 
proportions of green and red mitochondria were not evenly distributed in cells. 
Instead, the red-fluorescing, highly energized mitochondria were proportionally more 
prevalent in the periphery of cells (Fig 4.2, panel A). Depolarisation of the 
mitochondrial membrane potential with the H+-uncoupler FCCP resulted in a uniform 
green fluorescence emission from mitochondria (Fig, 4.2, panel B). Mitochondria of 
HUVEC with attached PRBC revealed a depolarisation as indicated by the green 
fluorescence emission (Fig 4.2, Panel C-L).
Cells with green fluorescence, indicating the loss of mitochondrial membrane 
potential, were counted at each co-incubation time point. The degree of unattached 
HUVEC which lost their mitochondrial AW were 0.45% ± 0.09 (SE), 0.52% ±0.17 
(SE), 0.40% ± 0.12 (SE), 1.19% ± 0.31 (SE) and 1.64% ± 0.22 (SE) at 0, 3, 8, 18 and 
24 h of co-incubation, respectively (Fig 4.3). The percentage of HUVEC with attached 
PRBC that lost their mitochondrial AW were 0.00% ± 0.00 (SE), 21.71% ± 3.64 (SE), 
56.70% ± 1.68 (SE), 58.35% ± 0.86 (SE) and 70.94% ± 3.87 (SE) at 0, 3, 8, 18 and 24 
hours of co-incubation, respectively (Fig 4.3). This indicates that the mitochondria are 
affected by binding of PRBC to HUVEC and confirmed the involvement of a 
mitochondrial apoptotic pathway in apoptosis of HUVEC with attached PRBC.
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Figure 4.2 Confocal images of HUVEC stained with JC-1 dye. (A) Healthy normal 
HUVEC showed both red and green fluorescence, (B) HUVEC treated with FCCP 
showed shift in fluorescence from red to green, (C-K) PRBC-adhered HUVEC at 
different time points showed green fluorescence together with membrane blebbing, (L)
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Difference in fluorescence staining of PRBC-adhered HUVEC (green fluorescence) 
compared with surrounding unattached HUVEC (red and green fluorescence).
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Figure 4.3 Comparison the percentage green fluorescence cell of HUVEC with and 
without attached PRBC at different co-incubation time points. Data are mean ± SE of 
at least five experiments. * denotes statistically significant difference (** p < 0.01, *** 
p < 0.001) as analysed by one-way ANOVA with Tukey-Kramer Multiple 
Comparisons post test.
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4.4 DISCUSSION
Energy generated from the mitochondrial respiratory chain is stored as an 
electrochemical gradient consisting of a proton gradient and a transmembrane 
electrical potential (AT) across the inner mitochondrial membrane (Cooper, 2007). 
The dissipation of this potential is often observed in apoptosis. Measurement of this 
event is made possible by the lipophilic cationic dye JC-1 which exists as green 
fluorescent monomer at low membrane potential and as orange/red fluorescent 
aggregates at high membrane potential.
By loading with JC-1, a study revealed a distinct heterogeneity of the mitochondrial 
AT inside HUVEC. The mitochondria did not show a homogeneous red or green JC-1 
fluorescence. They were either green or red with more intensely red-fluorescing, 
highly energized mitochondria at the periphery of cells (Collins et alt 2002). A similar 
pattern was observed in our control HUVEC, indicating that mitochondria were 
heterogeneous with respect to their energetic status. HUVEC showed uniform 
depolarisation of mitochondrial AT when treated with a potent mitochondrial 
uncoupler, FCCP, which can depolarise the mitochondrial membrane potential by 
dissipating the proton gradient across the inner mitochondrial membrane (Park et al, 
2002).
Multiple lines of research demonstrated that collapse of mitochondrial AT is the early, 
obligate event in the apoptotic signalling pathway. Apoptosis of rat embryo cells 
induced by the simian virus 40 large T antigen showed a lowered mitochondrial AT 
and a decrease in mitochondrial respiration, which are detectable early in the apoptotic 
process (Vayssiere et ah, 1994). Thymocytes induced to undergo apoptosis with
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dexamethasone showed an early decrease in mitochondrial A'P and also alteration in 
mitochondrial structure (Petit et al, 1995). Loss of mitochondrial AT indicates the 
opening of a large channel known as the mitochondrial permeability transition pore 
(PTP) leading to release of apoptogenic factors into the cytosol such as cytochrome c. 
In the cytosol, cyotochrome c can form complex with the apoptosis activating factor 1 
(Apaf-1) and activate caspase-9 (Vermeulen et al, 2005).
The data from the previous chapter suggested that the mitochondria are implicated in 
apoptosis of HUVEC induced by PRBC, as shown by activation of caspase-9. Thus 
the status of the mitochondrial AT in PRBC-adhered HUVEC was observed to 
confirm the involvement of mitochondrial pathway in apoptosis of HUVEC. We found 
that loss of mitochondrial AT in the apoptotic HUVEC occurred together with cell 
membrane blebbing. This is in agreement with published data illustrating that malaria 
parasites can reduce mitochondrial AT and lead to apoptosis of host cells (Guha et al, 
2006). Furthermore, the significant amount of PRBC-adhered HUVEC losing their 
mitochondrial AT could be detected immediately after 3 hours of co-culture indicating 
that the dissipation of mitochondrial AT is the early event occurring in apoptosis of 
PRBC-adhered HUVEC. Again, we observed a quantitative relationship between 
cytoadherence, the early collapse of the mitochondrial membrane potential and 
apoptosis.
Taken together, we assume that the adhesion of PRBC to HUVEC induces the opening 
of the mitochondrial transition pore. This leads to a decrease in the mitochondrial AT 
and release of apoptotic inducing factors from mitochondria such as cytochrome c 
which induces the activation of caspase-9.
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CHAPTER 5: MALARIA PARASITE CYTOADHERENCE
INDUCES OXIDATIVE STRESS IN HUMAN ENDOTHELIAL
CELLS
5.1 INTRODUCTION
In aerobic organisms, reactive oxygen species (ROS), including 02", H2O2, hydroxyl 
radical (*OH), and nitric oxide/peroxynitrate (NO/ONOO"), are generated in cells 
through various endogeneous and exogeneous sources. These include the 
mitochondrial electron transport chain, biotransformation of various xenobiotics and 
drugs, inflammation, UV and ionic irradiation, and nitric oxide synthetase (Yang et 
ah, 2003). As ROS are toxic to the cell, mammalian cells have developed a number of 
antioxidant defence mechanisms to detoxify ROS. An imbalance between the pro­
oxidant/antioxidant systems causes oxidative stress in the cells. Oxidative stress 
causes peroxidation of cell membrane lipids as well as damage to DNA or protein, 
culminating in cell death (Catala, 2009). During the process of lipid peroxidation, a 
great diversity of aldehydes such as malonaldehyde, alkaneals, and hydroxyalkenals 
are formed when polyunsaturated fatty acids (PUFAs) in biomembranes are degraded 
(Catala, 2006). The most prominent aldehydes generated during lipid peroxidation are 
4-hydroxy-2-alkenals. The main representative of these aldehydes, 4-hydroxy-2- 
noneal (4-HNE), is the major product formed during lipid peroxidation of n-6 
polyunsaturated fatty acid, such as linoleic acid and arachidonic acid. 4-HNE is 
considered to be a sensitive marker of oxidative damage and lipid peroxidation and 
can be detected by immunocytochemical staining (Catala, 2009).
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The association of oxidative stress in malaria-induced apoptosis of host cells has been 
proposed (Pino et al, 2005). The oxidative stress developed during malarial infection 
induced liver apoptosis in mice through activation of the mitochondrial pathway. 
Apoptosis in the liver of infected animals was prevented by administration of hydroxyl 
radical scavengers and free radical scavengers such as melatonin to the infected 
animals (Guha et al, 2006, Guha et al, 2007). A study by Pino and co-workers 
proposed that apoptosis in human endothelial cells co-cultured with malaria parasites 
was mediated through an oxidative stress pathway. In this study, it was demonstrated 
that inhibition of nitric oxide (NO), which in turn reduces peroxynitrite (ONOO') 
synthesis, and addition of the superoxide dismutase mimetic protected the endothelial 
cells from malaria parasite-induced apoptosis (Pino et al., 2003a). However, there was 
no direct evidence of ROS generation in this study.
During the maturation from ring stage to trophozoite stage, malaria parasites digest up 
to 75% of erythrocyte haemoglobin and polymerize the undigested heme moiety to 
hemozoin (Schwarzer et al, 2003). Hemozoin is a likely generator of oxidative stress 
because it contains redox active iron which can peroxidise PUFAs present in 
membranes (Schwarzer et al., 2003, Skorokhod et al, 2010). It has been found that the 
membrane lipoperoxides and 4-HNE significantly increased in isolated hemozoin-fed 
human monocytes (Schwarzer et al, 1996). In PRBC, the onset of hemozoin 
formation in the parasites was accompanied by the appearance of 4-HNE on the cell 
surface which decreased the deformability of the erythrocytes (Skorokhod et al, 
2007). Furthermore, the oxidative stress generated by hemozoin has been reported to 
play a role in apoptosis of erythroid precursors (Lamikanra et al, 2009).
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In chapter 3, it was shown that HUVEC with attached malaria parasites have the 
propensity to undergo apoptosis. Previously published data (Lamikanra et al., 2009, 
Pino et al., 2003a) have referred to the importance of oxidative stress in apoptosis 
induced by malaria parasites and malarial pigment. In this chapter, we have performed 
an immunocytochemical study using anti-4HNE antibodies to reveal the spatio- 
temporal manifestation of the apoptosis-associated cellular oxidative stress in PRBC- 
adhered HUVEC.
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5.2 MATERIALS AND METHODS
5.2.1 Preparation of HUVEC for co-culturing
HUVEC used in the experiments were from passage 4-6. HUVEC culture 
methodologies have been described in detail in Chapter 2 section 2.2. When HUVEC 
reached to 80-90% confluence, cells were trypsinised and seeded on the gelatin coated 
13 mm round sterile coverslip (Nunc) which were placed in the 24 multiwell plate 
(Nunc). Cells were seeded at a density of 40,000 cells/well. After seeded, cells were 
allowed to settle for 1 h at 37 °C, 5% CO2 in a humidified incubator. The medium was 
then removed and 500 pi of pre-warmed fresh medium was added. Cells were then 
allowed to grow until reach about 90% confluence before used in the experiments.
5.2.2 Preparation of malaria parasites for co-culturing
Malaria parasite used in this experiment was the ITG parasites selected to have 
potential to bind and induce apoptosis of HUVEC as describe in detail in Chapter 7. 
Parasites were cultured, as described in Chapter 2 section 2,1, until they reached 5-8% 
parasitemia (trophozoite or schizont stages). Then, parasites were submitted to 
magnetic separation technique in order to get 80-90% parasitemia. The parasite 
suspension was spun down at 2000 rpm for 5 min. The parasite pellet was re­
suspended in 10 ml of binding solution (IX PBS containing 2% BSA (Sigma) and 20 
mM glucose (Sigma)). The CS column was placed on a VarioMACS magnet (Miltenyi 
Biotec) and pre-washed once with binding solution. The column was not allowed to 
dry at any time during the procedure. The parasite suspension was applied to the top of 
the column and the column was washed with binding solution until the flow through 
was totally clear. The column was removed from the magnet and the effluent
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containing concentrated parasites was eluted by adding 10 ml of binding solution to 
the top of the column. The effluent was spun down at 2000 rpm for 5 min. The pellet 
was washed three times with parasite culture media.
5.2.3 Co-culture of HUVEC with malaria parasites
The concentrated parasites were re-suspended in 1% FCS in medium 199 to get a 
parasitemia of 20% in 1% haematocrit per well. Endothelial medium was removed 
from HUVEC grown on coverslip and the cells were gently washed once with IX 
PBS. Then, the 500 pl/well of parasite suspension were added onto the HUVEC 
monolayer and co-cultured for 3 h at 37 °C, 5% C02 in a humidified incubator. In the 
control group, uninfected red blood cells were re-suspended in 500 pi of 1% FCS in 
medium 199 to get 1% haematocrit and applied onto HUVEC monolayer washed with 
IX PBS. The co-culture were agitated either clockwise or counter clockwise every 10- 
15 min to allow more cell-to-cell contact, until the third hour.
For the positive control, the HUVEC cultured on coverslip were induced to apoptosis 
with camptothecin (Sigma) at the concentration of 5 pM for 24 h at 37 °C, 5% CO2 in 
a humidified incubator. To define the role of hemozoin from ruptured PRBC on the 
induction of oxidative stress in HUVEC, desferrioxamine (DFO) (Sigma), an iron 
chelator (van Zyl et ah, 1993), was added to the co-culture of HUVEC and PRBC at 
concentrations of 20, 50 and 100 pM.
5.2.4 Immunocytochemistry for the detection of 4-HNE formation
To evaluate the formation of 4-hydroxynonenal (4-HNE), a marker of oxidative stress,
co-culture medium was removed from each well after 3 h of co-culture. The coverslip
in each well was removed using forceps. The coverslip was then held vertically and
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dipped gently into a universal containing 25 ml IX PBS to remove excess red blood 
cells. This process was repeated twice more. Then, the coverslip was placed upside 
down on 500 pi medium 199 supplemented with 1% PCS in an angled 24 multiwell 
plate for 30 min. The coverslip was transferred to fresh gravity wash in a clean 24 
multiwell plate for a further 15 min before transferring to clean 24 multiwell plate 
containing 500 pl/well of 4% paraformaldehyde (Gibco). Cells were fixed for 30 min 
at 4 °C. Cells were then washed twice with 1 ml of IX PBS before permeabilising with 
0.5% Triton X-100 in PBS for 15 min at room temperature. Cells were washed twice 
with 1 ml IX PBS and then incubated with PBS containing 3% goat serum for 1 h at 4 
°C. Cells were then washed with 1 ml PBS twice. Thereafter, cells were incubated with 
500 pi of anti-4-hydroxynoneal antibody (Alexis biochemicals) at 1:500 dilution 
overnight at 4 °C. The primary antibody was removed and cells were washed with 
PBS. The secondary antibody, goat anti-rabbit IgG antibody conjugated with Alexa 
Fluor 488 (Molecular Probes), was applied in a dilution of 1:500 and incubated for 1 h 
at room temperature. Washed cells were embedded in Vectashield (Vector 
laboratories), and fluorescence distribution was examined by confocal laser scanning 
microscopy.
5.2.5 Determination of 4-HNE formation using confocal laser scanning 
microscope
Cells embedded in Vectashield on a glass slide were observed using a Zeiss Pascal 
confocal laser scanning microscope (CLSM). Cells were viewed through a Plan- 
Apochromat 63x 1.2 numerical aperture (N.A.) water objective. Fluorescence signals 
were collected by single excitation with an argon ion laser at 488 nm and collection of 
emitted light through a 505-530 nm band pass filter.
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5.3 RESULTS
5.3.1 Malaria parasites induced the formation of 4-HNE in HUVEC
To evaluate the implication of oxidative stress in the malaria parasite-induced 
apoptosis of HUVEC, we used immunocytochemical staining to detect the formation 
of 4-HNE, the marker of oxidative stress. In the control group, HUVEC were co­
cultured with uninfected red blood cells for 3 h. HUVEC in this group showed some 4- 
HNE formation (Fig 5.1 panel D-F) but the degree of adduct formation was not 
different from control HUVEC (Fig 5.1 panel A-C). Significantly, most of HUVEC 
that were co-cultured with PRBC showed a marked increase in 4-HNE formation 
when compare to HUVEC co-cultured with uninfected red blood cell or normal 
HUVEC (Fig 5.1 panel G-I) as well as surrounding HUVEC which unattached to 
PRBC (Fig 5.2).
As a positive control, HUVEC were treated with camptothecin, a known inducer of 
oxidative stress in many cell types (Brea-Calvo et al, 2009). Treatment HUVEC with 
camptothecin caused a profound change in HUVEC morphology. As expected, cells 
showed membrane blebbing and the formation of 4-HNE increased (Fig 5.1 panel J- 
L).
5.3.2 Effect of iron chelator on the formation of 4-HNE in HUVEC co-cultured 
with malaria parasites
As hemozoin composes of large quantities of ferric heme and small amount of free
iron, it is a likely generator of oxidative radicals that can cause lipid peroxidation of
polyunsaturated fatty acids in the biomembrane which results in the formation of 4-
HNE (Schwarzer et al, 1996). To identify whether oxidative stress in HUVEC
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induced by PRBC is due to hemozoin released from the ruptured PRBC or due to the 
binding of PRBC to HUVEC, we co-cultured HUVEC together with PRBC in the 
presence of DFO, the iron chelator. However, we found that the cells treated with 
DFO at different concentration varying from 20 to 100 pM still showed the same 
pattern of 4-HNE formation when compared with cells co-cultured with PRBC in 
absence of DFO (Fig 5.3).
88
Figure 5.1 Confocal images of HUVEC stained with anti-4-hydroxynoneal antibody. 
(A-C) control HUVEC, (D-F) HUVEC co-cultured with uninfected red blood cells, 
(G-I) HUVEC co-cultured with PRBC, (J-L) HUVEC treated with camptothecin. The 
arrows indicate PRBC which attached to HUVEC.
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Figure 5.2 Confocal images of PRBC-adhered HUVEC stained with anti-4- 
hydroxynoneal antibody. Amount of 4-HNE adducts on PRBC-adhered HUVEC 
increased when compared with surrounding HUVEC which unattached to PRBC. The 
arrows indicate PRBC which attached to HUVEC.
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Figure 5.3 Confocal images of PRBC-adhered HUVEC stained with anti-4- 
hydroxynoneal antibody in the presence and absence of DFO. (A-C) HUVEC co­
culture with PRBC in absence of the iron chelator DFO, (D-F) HUVEC co-cultured 
with PRBC in the presence of 20 pM DFO, (G-I) HUVEC co-cultured with PRBC in
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the presence of 50 pM DFO, (J-L) HUVEC co-cultured with PRBC in the presence of 
100 pM DFO. The arrows indicate PRBC which attached to HUVEC.
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5.4 DISCUSSION
Previously published data implicates a role for oxidative stress in apoptosis of 
endothelial cells following cytoadherence by malaria parasites. The study conducted 
by Pino and co-workers showed that malaria parasite-induced apoptosis of endothelial 
cells can be prevented by addition of MnTBAP, a permeable chemical superoxide 
dismutase mimetic, and inhibition of nitric oxide synthesis (which in turn, reduces 
peroxynitrite (ONOO') formation, (Pino et al, 2003a)). The authors suggested that the 
apoptotic process induced by PRBC is mediated by O2' and nitric oxide (NO*). 
Transfection of endothelial cells with the antioxidant enzyme superoxide dismutase 
(SOD1), an antioxidative enzyme that dismutes superoxide anion (O2'), also provided 
the protective effect against P. falciparwn-m&wwd. oxidative stress and apoptosis in 
endothelial cells (Taoufiq et al., 2006). In this chapter, we again confirm the 
implication of oxidative stress in apoptosis of endothelial cell induced by malaria 
parasites. We found a significant increase in formation of 4-HNE in HUVEC co­
cultured with PRBC compared to normal HUVEC and HUVEC co-cultured with 
uninfected red blood cells.
During asexual development of malaria parasites, parasites ingest host cell cytoplasm, 
including haemoglobin to obtain nutrients. However, parasites cannot digest heme 
liberated from haemoglobin which is toxic to parasites. Free heme is polymerised to 
form hemozoin (Mabeza et al, 1999) which has been found to cause oxidative stress 
in host cells, sometimes leading to apoptosis (Lamikanra et al., 2009, Schwarzer et al., 
2003, Schwarzer et al., 1996, Skorokhod et al., 2007). We assessed whether the 
oxidative stress observed in HUVEC co-cultured with PRBC was due to the 
heme/hemozoin release from the rupture of PRBC by adding DFO, which has been
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widely used as an effective iron chelator (Loyevsky et al, 1999, Lytton et ah, 1994, 
van Zyl et al., 1993).
Addition of DFO to the HUVEC-PRBC co-culture had no effect on 4-HNE formation 
when compared to HUVEC-PRBC co-culture in absence of DFO. These data would 
suggest that DFO-chelatable substances such as heme are not responsible for the 
formation of the 4-HNE adducts, and that the lipid peroxidation is caused by the 
HUYEC undergoing apoptosis. These data are consistent with data shown in chapter 
3, that PRBC-cytoadherence is required for the initiation of apoptosis.
Due to the nature of apoptotic cells which detach themselves from coverslips and the 
long fixation and staining processes, many cells were lost, making it difficult to assess 
the quantity of cells with 4-HNE formation. Future work to quantify the 4-HNE 
adducts in positive cells by other techniques such as flow cytometry (Skorokhod et al., 
2010) or ELISA (Borovic et ah, 2006) could be performed.
94
CHAPTER 6: EFFECT OF CELL SIGNALLING INHIBITORS ON
MALARIA PARASITE-INDUCED HUMAN ENDOTHELIAL
CELL APOPTOSIS
6.1 INTRODUCTION
Apoptosis or programmed cell death is a process that plays an important role in 
development and maintenance of tissue homeostasis. The apoptotic process of cells is 
characterized by many morphological changes, for example, cell shrinkage, loss of 
adhesion and rounding (in adherent cells), plasma membrane blebbing, chromatin 
condensation and fragmentation (Zimmermann & Green, 2001). This process has been 
reported to be implicated in the pathogenesis of a number of human diseases including 
cancer, viral infection, autoimmune diseases, and neurodegenerative disorders 
(Thompson, 1995). Recently, apoptosis has also been proposed to be one of the factors 
which might involve in the severe disease of Plasmodium falciparum infection 
(Hemmer et al, 2005, Toure et al, 2008, Wilson et al, 2008).
As described in Chapter 1, apoptosis occurs through two major pathways. The first
pathway is the extrinsic pathway. Activation of this pathway is initiated by binding of
a specific protein ligand to cell surface transmembrane receptor which finally leads to
the activation of caspase-8. The transmembrane receptors that trigger external
apoptosis signalling belong to the tumor necrosis factor (TNF)-receptor superfamily
such as TNF receptor-1 (TNF-R1) and FAS receptor (Schultz & Harrington, 2003).
The second pathway is the intrinsic pathway which mediates the triggering of caspase-
9. The main regulator of intrinsic pathway is the mitochondria. An important event in
the mitochondria mediated apoptosis is mitochondrial outer membrane
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permeabilization (MOMP) which is controlled by Bcl-2 family members (Jin & El- 
Deiry, 2005).
Besides those two main pathways of apoptosis, other signalling pathways leading to 
cell apoptosis are also present. The endoplasmic reticulum (ER) is one of the organelle 
that participates in apoptotic process of cells which is referred to as ER stress-induced 
pathways. ER regulated apoptosis by sensitizing mitochondria to a variety of death 
stimuli and by initiating death signals of its own (Breckenridge et al., 2003). Stress- 
activated protein kinase pathways, the c-Jun N-terminal kinase and p38 MAPK 
pathways, also implicate in apoptosis of cells (Grethe et al, 2004, Karahashi et al., 
2009). However, the role of these two pathways in apoptosis depends on cell type and 
the nature of the death stimuli (Wagner & Nebreda, 2009). The nuclear transcription 
factor NF-kB and transcription factor p53 also play an important role in the regulation 
of apoptosis (Aoki et al, 2001, Kuhnel et al, 2000). Furthermore, important sensors 
of innate immune system, Toll-like receptors (TLR), are capable of controling the 
survival of microbial challenged cells by governing the induction of pro- or 
antiapoptotic signalling pathways (Ruckdeschel et al, 2004).
It has been shown by Pamplona and colleagues that administration of carbon 
monoxide (CO), which is one of the products from catabolism heme by heme 
oxygenase (HO)-l, provides the protective effects to mice induced to have cerebral 
malaria by Plasmodium berghei ANKA (Pamplona et al, 2007). The authors suggest 
that the protective effects of CO are associated with inhibition of the blood-brain 
barrier disruption, brain microvascular congestion and hemorrhage, suppression of 
neuroinflammation, inhibition of adhesion molecule expression in the brain
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microvasculature and suppression of activated CD8+ T cell sequestration in the brain 
(Pamplona et al, 2007).
It is clear from the results in previous chapter (chapter 3) that cytoadhesion of PRBC 
causes apoptosis of HUVEC. However, the subtle signalling pathways which underlie 
apoptosis of HUVEC are not known. As described above that apoptosis can occur 
through several pathways, in this chapter, we used various inhibitors against molecules 
implicated in apoptotic pathway to unveil the mechanism of apoptosis in HUVEC. In 
addition, it was also possible in this chapter of CO on apoptosis of endothelial cell by 
using carbon monoxide releasing molecules (CORMs) which were gifts from 
ALFAMA, Portugal.
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6.2 MATERIALS AND METHODS
6.2.1 Preparation of HUVEC for co-culturing
HUVEC used in the experiments were from passage 4-6. HUVEC were cultured as 
described in detail in Chapter 2 section 2.2. When HUVEC reached to 80-90% 
confluence, cells were trypsinised and seeded on 40 mm diameter gelatin coated 
coverslip (Bioptechs) placed in petri dish (Nunc). The seeding density was 15,000- 
20,000 cells/cm2. Approximately, 500 pi of cell suspension was gently loaded onto the 
coated coverslips. Cells were allowed to settle for 1 h at 37 °C, 5% CO2 in a 
humidified incubator. The medium was then removed and 2 ml of pre-warmed fresh 
medium was added. Cells were then further cultured until they reached 80-90% 
confluence before used in the experiments.
6.2.2 Preparation of malaria parasites for co-culturing
Malaria parasites used in this experiment were ITG parasites and the ITG parasites 
selected to have potential to bind and induce apoptosis of HUVEC as describe in detail 
in Chapter 7. Both parasites were cultured as described in Chapter 2 section 2.1. 
Parasites were cultured until they reached 5-8% parasitemia (trophozoite or schizont 
stages). Then, parasites were submitted to magnetic separation technique in order to 
get 80-90% parasitemia. The parasite suspension was spun down at 2000 rpm for 5 
min. The parasite pellet was re-suspended in 10 ml of binding solution (IX PBS 
containing 2% BSA (Sigma) and 20 mM glucose (Sigma)). The CS column was 
placed on a VarioMACS magnet (Miltenyi Biotec) and pre-washed once with binding 
solution. The column was not allowed to dry at any time during the procedure. The 
parasite suspension was applied to the top of the column and the column was washed
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with binding solution until the flow through was totally clear. The column was 
removed from the magnet and the effluent containing concentrated parasites was 
eluted by adding 10 ml of binding solution to the top of the column. The effluent was 
spun down at 2000 rpm for 5 min. The pellet was washed three times with parasite 
culture media.
6.2.3 Co-culture of HUVEC with malaria parasites
ITG parasites were used in all experiments except the experiments which treated 
HUVEC with MyDBB inhibitor, NF-kB inhibitors and carbon monoxide releasing 
molecules (CORMs) received from ALFAMA (Portugal) where the enriched parasites 
were used instead. The concentrated parasites were re-suspended in 1% FCS in 
medium 199 to get a parasitemia of 50% in 1% haematocrit for ITG parasites and a 
parasitemia of 20% in 1 % haematocrit for the enriched parasites. Endothelial medium 
was removed from HUVEC grown on coverslip at 80-90% confluence and the cells 
were gently washed once with IX PBS. Then, the 2 ml of parasite suspension were 
added onto HUVEC monolayer and co-cultured for 3 h at 37 °C, 5% CO2 in 
humidified incubator. The co-culture dishes were agitated either clockwise or counter 
clockwise every 10-15 min to allow more cell-to-cell contact until the third hour.
6.2.4 Inhibitor treatment
In order to define the signalling pathways underlying apoptosis of HUVEC induced by 
malaria parasites, various apoptotic inhibitors were selected to use in the experiments. 
Inhibitors included c-Jun N-terminal kinase (INK) inhibitor, p38 MAP kinase 
inhibitor, endoplasmic reticulum stress inhibitor, p53 inhibitor, Bax inhibitor, caspase- 
8 inhibitor, caspase-9 inhibitor, pan-caspase inhibitor, intracellular calcium chelator,
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toll-like receptor pathway inhibitor, NF-kB signalling pathway inhibitors and carbon 
monoxide releasing molecules (CORMs). List of inhibitors and their targets were 
summarised in Table 6.1.
In the apoptosis inhibition experiments, HUVEC were treated with the inhibitors as 
described here. HUVEC were pretreated with 10 pM of c-Jun N-terminal kinase 
inhibitor (SP600125) (Sigma) or 10 pM p38 MAP kinase inhibitor (SB202190) 
(Sigma) for 30 min, and HUVEC were co-cultured with PRBC in the presence of these 
inhibitors. Salubrinal (ER stress inhibitor) (Tocris bioscience), Bax inhibiting peptide 
(Calbiochem) and Pifithrin-a (p53 inhibitor) (Calbiochem) were used to pretreat 
HUVEC at the concentration of 50 pM, 200 pM and 30 pM, respectively, for 60 min. 
These inhibitors were also presented in the co-culture medium of HUVEC to PRBC. 
B APT A-AM (intracellular calcium chelator) (Molecular* probes) was used to pretreat 
HUVEC at 100 pM for 45 min. MyD88 homodimerization inhibitor peptide 
(Imgenex) were used to pretreat HUVEC at 200 pM for 24 h and presented in the co­
culture. Z-IETD-FMK (caspase-8 inhibitor) (R&D system), Z-LEHD-FMK (caspase-9 
inhibitor) (R&D system) and Z-VAD-FMK (pan-caspase inhibitor) (Promega) were 
added at the beginning of the co-culture at concentration of 100 pM, 100 pM and 20 
pM, respectively. MG132 and BAY11-7082 (NF-kB inhibitors) (Calbiochem) were 
used to pretreat HUVEC at 10 pM and 4 pM, respectively, for 60 min, and also added 
the co-culture medium. The carbon monoxide releasing molecules which are ALF186 
and ALF466 (gifted from ALFAMA) were added to HUVEC at 100 pM together with 
the co-culture medium.
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Inhibitors Target(s) of inhibitors
SP600125 c-Jun N-terminal kinase (JNK)
SB202190 p3 8 MAP kinase
Salubrinal Cellular phosphatase complexes that
dephosphorylate eukaryotic translation
initiation factor 2 subunit a (eIF2a)
(protect cell from ER stress apoptosis)
Bax inhibiting peptide Bax mediated apoptosis
Pifithrin-a p5 3-mediated apoptosis
Z-IETD-FMK Caspase-8
Z-LEHD-FMK Caspase-9
Z-VAD-FMK General caspase inhibitor
BAPTA-AM Chelator of intracellular Ca2+ stores
MyD88 homodimerization inhibitor peptide MyD88 dependent TLR/IL-1R
signalling
MG132 NF-kB
BAY11-7082 NF-kB
Table 6.1 Summary apoptotic pathway inhibitors used in the experiments and their 
targets
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6.2.5 Determination of apoptotic cells using confocal laser scanning microscope
After 3 h of co-cultivation, the co-culture medium was discarded. HUVEC in all 
groups of experiments were washed twice with IX PBS to remove unbound uninfected 
red blood cells or parasites. HUVEC were double stained with annexin V and 
propidium iodide (8 pi of annexin V and 2 pi of 2.5 pg/ml PI into 2 ml of annexin­
binding buffer). Cells were incubated within this mixture at 37 °C, 5% CO2 in 
humidified incubator for 20 min. The coverslips were gently washed once with 
annexin-binding buffer. The coverslips were assembled into a Bioptechs FCS2 
perfusion chamber (Bioptechs), perfused with annexin-binding buffer and observed 
with Zeiss Pascal confocal laser scanning microscope (CLSM). Cells were viewed 
through a Plan-Apochromat 63x 1.2 numerical aperture (N.A.) water objective. 
Fluorescence signals from annexin V and PI were collected by single excitation with 
argon ion laser at 488 nm and collection of emitted light through a 505-530 nm band 
pass filter and a 650 nm long pass filter, respectively. At least 500 cells were counted 
for each replicate and scored according to the appearance of cells, i.e. 
attached/unattached to PRBC, blebbing and/or annexin V/PI staining.
6.2.6 Statistical analysis
Results were expressed as mean ± standard error of individual experimental groups. 
Statistical analysis was performed with GrapPad InStat version 3.05. Data were 
analysed by Mann-Whitney U test. A value of p < 0.05 was considered significant.
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6.3 RESULTS
6.3.1 Cy to adherence of PRBC and to HUVEC
The percentages of attachment between HUVEC and PRBC in control and inhibitor 
treated groups for all experiment are tabulated in Table 6.2.
Name of inhibitors
Attachment (%)
Control group Inhibitor treated group
SP600125 4.71 ± 0.78 3.97 ±0.30
SB202190 5.62 ± 0.25 5.58 ± 0.32
Salubrinal 3.26 ±0.28 3.39 ±0.36
Bax inhibitor 3.67 ±0.35 3.65 ±0.19
Pifithrin-a 5.14 ±0.25 6.40 ± 0.65
Z-IETD-FMK 5.74 ± 0.34 6.09 ±0.33
Z-LEHD-FMK 5.23 ± 0.39 5.59 ±0.55
Z-VAD-FMK 6.31 ±0.67 5.55 ±0.71
BAPTA-AM 5.65 ± 0.32 5.76 ± 0.72
MyD88 inhibitor 8.27 ± 0.03 8.25 ± 0.07
MG132 9.07 ± 0.42 9.12 ±0.78
BAY11-7082 8.79 ±0.25 9.64 ±0.37
ALF186 8.30 ±0.18 8.17 ±0.26
ALF466 8.03 ± 0.22 7,71 ±0.08
Table 6.2 Comparison the percentage attachment of PRBC to HUVEC in control and
inhibitor treated groups. Data are mean ± SE of at least three experiments.
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As shown in Table 6.2 and Fig 6.1, the addtion of the following inhibitors: c-Jun N- 
terminal kinase inhibitor (SP600125), p38 MAP kinase inhibitor (SB202190), ER 
stress inhibitor (salubrinal), Bax inhibitor, p53 inhibitor (pifithrin-a), caspase-8 
inhibitor (Z-IETD-FMK), caspase-9 inhibitor (Z-LEHD-FMK), pan-caspase inhibitor 
(Z-VAD-FMK), intracellular calcium chelator (B APT A-AM), Toll-like receptor 
signalling pathway inhibitor (MyD88 homodimerization inhibitor peptide), NF-kB 
inhibitors (MG132 and BAY11-7082) or carbon monoxide releasing molecules 
(ALF186 and ALF466) to the F1UVEC-PRBC co-culture had no effect on PRBC 
binding to HUVEC. There was no statistically significant difference among the 
quantity of binding between control and inhibitor treated groups in all cases.
Inhibitors
Figure 6.1 Comparison amount of binding between PRBC and HUVEC in control
group and inhibitors treated groups. Data are mean ± SE of at least three experiments.
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6.3.2 Effect of various apoptotic inhibitors on apoptosis of HUVEC attached to 
PRBC
The capacity of various apoptotic signalling pathway inhibitors to inhibit apoptotic 
effect of PRBC on HUVEC was determined by comparing the degree of apoptosis of 
HUVEC attached to PRBC in control group to inhibitor treated group. The 
percentages of HUVEC undergoing apoptosis when attached to PRBC in control and 
inhibitor treated groups for all experiments are summarised in Table 6.3.
As shown in Table 6.3 and Fig 6.2, among the inhibitors used in our experiments, only 
caspase-8 (Z-IETD-FMK), caspase-9 (Z-LEHD-FMK), pan-caspase inhibitors (Z- 
VAD-FMK), intracellular calcium chelator (B APT A-AM) and NF-kB inhibitors 
(MG132 and BAY11-7082) had ability to significantly decrease the amount of 
apoptosis of HUVEC attached to PRBC.
The quantity of apoptosis was decreased from 84.98% ±0.58 (SE) in control group to 
52.52% ± 1.42 (SE) in Z-IETD-FMK treated group, from 87.98% ± 3.10 (SE) in 
control group to 40.27% ± 2.76 (SE) in Z-LEHD-FMK treated group, from 91.06% ± 
2.14 (SE) in control group to 27.02% ± 3.65 (SE) in Z-VAD-FMK treated group, from 
94.26% ±1.14 (SE) in control group to 40.27% ± 4.28 (SE) in BAPTA-AM treated 
group, from 98.31% ±1.11 (SE) in control group to 35.55% ± 3.09 (SE) in MG132 
treated group, and from 96.15% ± 0.86 (SE) to 58.57% ± 1.25 (SE) in BAY11-7082 
treated group. The confocal images of apoptotic HUVEC induced by PRBC and 
HUVEC attached to PRBC in the presence of caspase-8 inhibitor, caspase-9 inhibitor, 
pan-caspase inhibitor, NF-kB inhibitors and intracellular calcium chelator are shown 
in Fig 6.3.
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Name of inhibitors
Apoptosis among attached cells (%)
Control Inhibitor treated
SP600125 95.01 ±2.00 96.10 ± 1.26
SB202190 92.96 ±3.55 91.28 ±2.85
Salubrinal 93.05 ±2.30 90.76 ± 0.72
Bax inhibitor 85.32 ±4.85 87.97 ±3.26
Pifithrin-a 86.45 ±1.23 88.57 ±3.02
Z-IETD-FMK 84.98 ± 0.58 52.52 ± 1.42*
Z-LEHD-FMK 87.98 ±3.10 40.27 ± 2.76*
Z-VAD-FMK 91.06 ±2.14 27.20 ±3.65*
BAPTA-AM 94.26 ± 1.14 40.27 ± 4.28*
MyD88 inhibitor 99.19 ±0.81 98.79 ±0.82
MG132 98.31 ±1.11 35.55 ±3.09*
BAY11-7082 96.15 ±0.86 58.57 ± 1.25*
ALF186 95.95 ±2.12 94.88 ± 2.95
ALF466 95.95 ±2.12 96.12 ±0.76
Table 6.3 Comparison the percentage apoptosis of HUVEC attached to PRBC in 
control and inhibitor treated groups. Data are mean ± SE of at least three experiments. 
* denotes statistically significant difference (p < 0.05).
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Figure 6.2 Apoptosis of HUVEC attached to PRBC in control groups and apoptotic 
inhibitors treated groups. Data are mean ± SE of at least three experiments. * denotes 
statistically significant difference (p < 0.05).
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Figure 6.3 Confocal images of HUVEC attached to PRBC in control group and in 
presence of inhibitors. (A-B) HUVEC attached to PRBC in control group illustrated 
cell membrane blebbing and/or annexin V positive; (C) HUVEC attached to PRBC in 
the presence of BAPTA-AM (intracellular calcium chelator); (D-H) HUVEC attached
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to PRBC in the presence of MG132 and BAY11-7082 (NF-kB inhibitors), caspase-8 
inhibitor (Z-IETD-FMK), caspase-9 inhibitor (Z-LEHD-FMK) and pan-caspase 
inhibitor (Z-VAD-FMK), respectively.
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6.4 DISCUSSION
Apoptosis of cells can occur through several pathways, for example, extrinsic 
pathway, intrinsic pathway, stress-activated protein kinase pathways and endoplasmic 
reticulum pathway. In order to define the pathway which mediates apoptosis of 
HUVEC induced by attachment of PRBC, various inhibitors against molecules in the 
apoptotic pathway were selected for use in these experiments. Among the inhibitors 
tested in our experiments, only caspase-8 (Z-IETD-FMK), caspase-9 (Z-LEHD-FMK), 
pan-caspase inhibitors (Z-VAD-FMK), intracellular calcium chelator (BAPTA-AM) 
and NF-kB inhibitors (MG 132 and BAY11-7082) had the potential to reduce the 
apoptotic effect of PRBC to HUVEC.
The results showed that the pan-caspase inhibitor (Z-VAD-FMK) significantly 
reduced apoptosis of HUVEC which indicates the role of a caspase dependent 
apoptotic pathway. To sort out the implication of extrinsic and intrinsic apoptotic 
pathways, which mediate through caspase-8 and caspase-9 respectively, specific 
caspase-8 and caspase-9 inhibitors were added to the HUVEC-PRBC co-culture. Both 
caspase-8 and caspase-9 inhibitors were capable of protecting HUVEC from apoptosis 
induced by PRBC. These results are consistent with the finding in Chapter 3 of PhD 
thesis of Dr. Parnpen Viriyavejakul (2007) which showed high activities of caspase-8 
and caspase-9 in HUVEC co-culture with PRBC. Furthermore, the findings are in 
agreement with the work of Pino and colleagues (Pino et al., 2003b). The conclusion 
for the data would be that apoptosis of HUVEC induced by PRBC involves both 
extrinsic (caspase-8) and intrinsic (caspase-9) apoptotic pathways.
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It is well established that calcium plays an important role in the events leading to cell 
apoptosis (Orrenius et al, 2003, Pinton et al, 2002). The calcium dependence of 
apoptosis in endothelial cells after PRBC cytoadherence has not been reported 
previously. However, the implication of a role for Ca2+ in apoptosis of host cells after 
the interaction with other pathogens has been describes in some studies (Buommino et 
al., 1999, Chaibi et al, 2005, Muller et al, 1999). We investigated the involvement of 
intracellular calcium in the apoptosis of HUVEC by using the intracellular calcium ion 
chelator, BAPTA-AM. We found that treatment HUVEC with BAPTA-AM caused 
dramatic decrease in the amount of apoptosis. These results imply that Ca2+ is required 
for the development of apoptosis in HUVEC attached to PRBC.
NF-kB is a nuclear transcription factor which regulates expression of many genes 
involved in the regulation of cell proliferation, inflammation, immune response and 
apoptosis (Kleinberg & Davidson, 2009). In its inactive form, NF-kB is sequestered in 
the cytoplasm, bound to inhibitor proteins of the IkB family. The phosphorylation of 
IkB which is followed by its degradation occurs when NF-kB is activated by various 
stimuli. This results in translocation of NF-kB from the cytoplasm to the nucleus 
where NF-kB regulates expression of various genes (Neumann 8c Naumann, 2007). 
NF-kB has been shown to have both anti- and pro-apoptotic functions which might 
depend on the nature of the death stimulus (Dehio et al, 2005, Grimm et al, 1996, 
Hansberger et al, 2007, Keller et al, 2006). Recently, the activation of NF-kB in 
human brain endothelial in response to PRBC has been reported (Tripathi et al, 2009, 
Tripathi et al, 2006). To investigate the role of NF-kB in malaria parasites induced 
HUVEC apoptosis further, the inhibitor of NF-kB, MG132 and BAY11-7082, were 
added to the co-cultures. Both inhibitors significantly reduce the number of apoptotic
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cells confirming that NF-kB plays a proapoptotic role in the apoptosis of HUVEC 
induced by PRBC.
Carbon monoxide (CO), the product from catabolism of heme by heme oxygenase 
(HO)-l, has been shown to have protective effects in rodent disease models including 
murine cerebral malaria (Pamplona et ah, 2007, Sato et at, 2001, Soares et al, 1998). 
The pathogenesis of cerebral malaria in mice infected with P. berghei can be 
suppressed by administration of exogeneous CO via inhalation (Pamplona et al., 
2007). CO has also been reported to possess the ability to inhibit apoptosis of cells 
(Bainbridge et al, 2006, Liu et al, 2002). Recently, the work of Wei and colleagues 
showed that infusion of carbon monoxide releasing molecules to rats reduced the 
levels of hepatocyte apoptosis after hepatic ischemia-reperfusion injury (Wei et al). 
To determine the effect of CO in apoptosis of HUVEC induced by PRBC, carbon 
monoxide releasing molecules (ALF186 and ALF466) were added to the co-culture 
medium. Unfortunately, in our experiment, these molecules did not protect HUVEC 
interacted with PRBC from undergoing apoptosis. This may be, in part, due to the type 
of apoptotic stimuli. This has been shown by a study on Jurkat cells, which when 
stimulated with a variety of apoptosis-inducing agents elicited different responses to 
CO (Song et al, 2004). In our model, PRBC might trigger an apoptotic signalling 
pathway in HUVEC which is beyond the protective ability of CO.
The initiation of the intrinsic apoptotic pathway is mediated and controlled by Bcl-2 
family members which can be divided according to their function and structure into 
three categories: antiapoptotic members, such as Bcl-2, Bcl-XL and Bcl-w; 
proapoptotic molecules, such as Bax, Bak and Bok; and the BH3-only proteins such as 
Bid and Bim (Jin & El-Deiry, 2005). The current widely accept model of the intrinsic
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pathway suggests an important role for Bax and Bak insertion into the outer 
mitochondrial membrane leading to the release of apoptogenic factors. Our results, 
however, demonstrated that inhibition of Bax cannot protect HUVEC from the 
apoptotic effects of PRBC, although we did find the association of the intrinsic 
apoptotic pathways in apoptosis of HUVEC attached to PRBC. The induction of Bax- 
independent intrinsic apoptotic pathways has been described in which Bax deficient 
cells showed evidence of the intrinsic pathway activation including the release of 
apoptogenic factors including cytochrome c and apoptosis inducing factor (AIF) and 
loss of mitochondrial transmembrane potential (ATV). Apoptosis in those cells was 
suggested to be mediated through the activation and accumulation of multiple BH3- 
only proteins in mitochondria, leading to the release of apoptogenic factors and loss of 
AvPm (Lomonosova et al., 2009), In addition, the intrinsic apoptotic pathway can also 
be mediated by Ca2+ (Orrenius et al, 2003), and our data already demonstrated the 
involvement of Ca2+ in the apoptosis of HUVEC. It is plausible that apoptosis of 
HUVEC attached to PRBC occurs through the calcium- or other Bcl-2 family member 
dependent intrinsic apoptotic pathway.
Stress-activated protein kinase pathways, the c-Jun N-terminal kinase and p38 MAPK 
pathways, can be activated in response to various cellular and environmental stresses 
including changes in osmolarity or metabolism, DNA damage, heat shock, ischemia, 
inflammatory cytokines, UV irradiation and oxidative stress (Wada & Penninger, 
2004). These pathways have been reported to play role in both pro-apoptosis (Grethe 
et al, 2004, Karahashi et al, 2009) and anti-apoptosis (Matusali et al, 2009, Yu et al, 
2004) depending on the type of cell and stimuli (Wada & Penninger, 2004). However, 
in our experiment, neither c-Jun N-terminal kinase (JNK) inhibiton nor p38 MAP
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kinase inhibiton protected HUVEC from apoptosis induced by PRBC. The conclusion 
must be that apoptosis of PRBC-adhered HUVEC occurs through JNK/p38 MAPK- 
independent pathways.
p53 is a transcription factor which plays a role in the response of cells to stress such as 
DNA damaging agents, hypoxia or oncogene activation (Amaral et al, 2009). 
Activation of this transcription factor can lead to cell cycle arrest, DNA repair, cellular 
senescence or apoptosis depend on cell type or stress signal (Haupt et al., 2003, 
Vousden & Lu, 2002). p53 can trigger apoptosis by activating the transcription of 
genes known to protmote apoptosis such as Fas, Bid, NOXA and PUMA (Haupt et al., 
2003, Pietsch et al, 2008). On the other hand, translocation of p53 to the mitochondria 
also leads to the release of apoptotic-inducing factors (Marchenko et al, 2000, 
Nemajerova et al, 2005). Despite inhibiting the function of p53 in HUVEC with 
pifithrin-a, HUVEC still underwent apoptosis after co-culture with PRBC. We must 
assume that apoptosis of PRBC-adhered HUVEC occurs through a p53-independent 
pathway.
One of the main functions of the ER in mammalian cells is for Ca2+ storage and 
signalling as well as the folding, modifying and sorting of newly synthesized proteins. 
The ER stress can occur when any of these functions are disturbed (Breckenridge et 
al., 2003). The ER stress inhibitor, salubrinal, used in our experiment functions on the 
unfolded protein response (UPR) signalling pathway, which is activated in response to 
changes in the capacity of the ER to fold protiens properly (Boyce et al, 2005). Our 
data showed that this inhibitor had no effect on inhibition of HUVEC apoptosis. We 
presume that the UPR signalling pathway in ER is not involved in apoptosis of 
HUVEC attached to PRBC. Nevertheless, the implication of ER stress pathways in
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apoptosis of HUVEC cannot be excluded because, as mentioned above, the ER also 
functions as an intracellular Ca2+ storage organelle, which in turn can play a role in 
apoptosis of HUVEC induced by PRBC.
Toll-like receptors (TLR), the components of the innate immune response, have been 
reported to be involved in apoptosis (Aravalli et al, 2007, Hsu et al, 2004). The 
signalling of TLR is mediated by the myeloid differentiation factor 88 (MyD88)- 
dependent and MyD88-independent pathways (Salaun et al, 2007). The potential role 
of this receptor in malaria infection has been established and involves malarial 
components such as hemozoin complexed to DNA and glycosylphosphatidylinositol 
(GPI) which have been shown to activate MyD88-dependent TLR signalling 
(Krishnegowda et ah, 2005, Parroche et ah, 2007). In addition, HUVEC has been 
reported to express TLR1, TLR2, TLR3, TLR4 and TLR6 (Faure et ah, 2000, 
Livengood et al, 2007) all of which, except TLR3, mediate signalling through the 
MyD88-dependent pathway (Kawai & Akira, 2006). Therefore, to reveal whether the 
MyD8 8-dependent TLR signalling pathway was involved in apoptosis of HUVEC 
induced by PRBC, a peptide which blocks MyD88 homodimerization was added to 
HUVEC-PRBC co-culture medium. The results showed that inhibition of MyD88 was 
unable to suppress the apoptotic effect of PRBC on HUVEC. These data imply that the 
MyD88-dependent TLR signalling pathway is not implicated in PRBC-induced 
HUVEC apoptosis. However, as TLR signalling can also be mediated through a 
MyD88-independent pathway, i.e. TLR3 and TLR4 which are also presented on 
HUVEC (Faure et al., 2000, Livengood et al., 2007), the role of this pathway cannot 
be completely ignored.
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In conclusion, the results in this chapter suggest the role of the extrinsic and intrinsic 
apoptotic pathways as well as calcium and NF-kB signalling pathways in PRBC- 
induced HUVEC apoptosis. We were unable to implicate other well characterised 
pathways despite the use of widely used inhibitor probes at concentrations shown to be 
effective in other mammalian cell systems. Other techniques such as RNA interference 
(Borralho et al., 2007, Liang et al., 2007) could be conducted to further examine the 
signalling pathways involved in the malaria-specific apoptotic phenotype.
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CHAPTER 7: CHARACTERISATION OF HUMAN
ENDOTHELIAL CELL SURFACE MEMBRANE RECEPTORS 
ELICITING CYTOADHERENCE-INDUCED APOPTOSIS
7.1 INTRODUCTION
The pathogenesis of severe malaria is thought to be due to the ability of infected red 
blood cells to sequester in the small blood vessels of various organs. The high level of 
infected red blood cells bound to microvasculature has been shown in post-mortem 
study of patients with severe malaria (Taylor et al., 2004). The adhesion of infected 
red blood cells to endothelial cells lining blood vessels could result in obstruction of 
blood vessels, metabolic disturbances, and release of damaging inflammatory 
mediators (Rowe et al, 2009).
Endothelial cells express several receptors on their surfaces. Some of these molecules 
are constitutively expressed such as CD31/PECAM-1, CD34, and CD105/endoglin. 
Other molecules are expressed only after activation by growth factors or inflammatory 
cytokines, for example, CD54/ICAM-1, CD 106/VCAM-1, CD62E/E-selectin, and 
CD62P/P-selectin (Gaiianda & Dejana, 1997). The adhesion of infected red blood 
cells to endothelial cells is also mediated through cell surface molecules on endothelial 
cells. As described in Chapter 1 (section 1.1.2), several cell adhesion molecules have 
been proposed to be involved in cytoadherence of infected red blood cells, including 
intercellular adhesion molecule-1 (ICAM-1) (Berendt et al, 1989), CD36 (Oquendo et 
al, 1989), and CD31/PECAM-1 (Treutiger etal, 1997).
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Apart from being the mediator of cell-cell interactions, the adhesive cell surface can 
also mediate intracellular signalling in endothelial cells. Cytoadherence of infected red 
blood cells is known to induce signalling events in endothelial cells (Jenkins et at, 
2007, Medana & Turner, 2007). Some of these signalling responses have deleterious 
effect to host cells. The interaction between brain endothelial cells and infected red 
blood cells resulted in increase expression of ICAM-1 which could lead to further 
sequestration of parasites (Tripathi et al, 2006). Parasite cytoadherence also leads to 
apoptosis and leakage in endothelial cells (Pino et al., 2003b, Tripathi et al., 2007).
In our study, we found that adhesion of malaria parasites to HUVEC induces apoptosis 
in the absence of TNF-a activation. However, the endothelial cell surface receptor 
involved in mediating the observed binding and subsequent apoptosis in our system 
has not been characterised. In this final chapter, an attempt has been made to describe 
the HUVEC membrane receptor involved in mediating cytoadherence-dependent 
apoptosis. To aid this work, PRBC were panned on unstimulated HUVEC for their 
ability to cytoadhere and induce apoptosis in unstimulated HUVEC. These enriched 
parasites were subsequently tested in TNF-a unstimulated and stimulated HUVEC in 
the presence of specific cell surface receptor antibodies.
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7.2 MATERIAL AND METHODS
7.2.1 HUVEC-bound malaria parasites selection
As described in the previous sections, the level of binding of PRBC to unstimulated 
HUVEC is low (typically < 4%). In this part of the study, it was therefore decided to 
attempt to enrich the binding phenotype by sub-culturing only bound parasites (see 
below for methodology).
7.2.1.1 Preparation of HUVEC for parasites selection
HUVEC used in the experiment were from passage 4-6. HUVEC were grown in 
gelatin coated T25 cm2 vented cap flasks until 80-90% confluence as described in 
Chapter 2 section 2.2.
7.2.1.2 Preparation of malaria parasites for parasites selection
P. falciparum strain ITG were cultured as described in Chapter 2 section 2.1. Parasites 
were cultured until reached 5-8% parasitemia of trophozoite or schizont stage. Then, 
parasites were submitted to magnetic separation technique in order to get 80-90% 
parasitemia of trophozoite or schizont stage. The parasite suspension was centrifuged 
at 2000 rpm for 5 min. The parasite pellet was re-suspended in 10 ml of binding 
solution (IX PBS containing 2% BSA (Sigma) and 20 mM glucose (Sigma)). The CS 
column was placed on a VarioMACS magnet (Miltenyi Biotec) and pre-washed once 
with binding solution. The column was not allowed to dry at any time during the 
procedure. The parasite suspension was applied to the top of the column and the 
column was washed with binding solution until the flow through was totally clear. The 
column was removed from the magnet and the concentrated parasites were eluted by
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adding 10 ml of binding solution to the top of the column. The eluent was spun down 
at 2000 rpm for 5 min. The pellet was washed three times with parasite culture media.
7.2.1.3 HUVEC-bound malaria parasites selection
The concentrated trophozoite or schizont stage parasites were re-suspended in 1% PCS 
in medium 199 to obtain a parasitemia of 50% in 1% haematocrit. Endothelial medium 
was removed from HUVEC grown in T25 cm2 vented cap flasks at 80-90% confluence 
and cells were gently washed once with IX PBS. Then, 4 ml of parasite suspension 
were added onto HUVEC monolayer and co-cultured for 3 h at 37 °C, 5% CO2 in 
humidified incubator. After 3 h of co-cultured, the binding medium were removed and 
HUVEC were gently washed several times with warm RPMI 1640 medium to 
removed as many unattached PRBC and RBC as possible. Then, HUVEC-bound 
PRBC which remained within the flask were cultured by standard parasite culture 
techniques as described in Chapter 2 section 2.1. These selected parasites (the first 
enriched parasites) were continuously cultured and the selection was repeated to get 
the second enriched parasites.
7.2.1.4 Determination of percentage binding between HUVEC and enriched 
parasites and percentage apoptosis of HUVEC attached to enriched parasites
In order to determine percentage attachment between HUVEC and the selected 
parasites, and also percentage apoptosis of HUVEC attached to the selected parasites, 
the first and second enriched malaria parasites were cultured until reached 5-8% 
parasitemia of trophozoite or schizont stage. Then, the selected parasites were 
submitted to magnetic separation technique in order to achieve 80-90% parasitemia of 
trophozoite or schizont stage as described in section 7.2.1.2. Malaria parasites were
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prepared at 20% parasitemia in 1% haematocrit in medium 199 supplemented with 1% 
FCS. The parasite suspension was added to HUVEC grown on 40 mm coverslips to 
80-90% confluence. HUVEC and malaria parasites were co-cultured for 3 h at 37 °C, 
5% CO2 in humidified incubator. In the control group, unselected ITG parasites were 
enriched for trophozoite or schizont stage by magnetic separation as described in 
section 7.2.1.2. Then, the unselected parasites were prepared at 20% parasitemia in 1% 
haematocrit in medium 199 supplemented with 1% FCS and co-cultured with HUVEC 
for 3 h at 37 °C, 5% CO2 in humidified incubator. The co-culture dishes were agitated 
either clockwise or counter clockwise every 10-15 min to allow more cell-to-cell 
contact until the third hour.
After 3 h of co-cultivation, the co-culture medium was discarded. HUVEC in all 
groups of experiment were washed twice with IX PBS to remove unbound uninfected 
red blood cells or parasites. HUVEC were double stained with annexin V and 
propidium iodide which were prepared by adding 8 pi of annexin V and 2 pi of 2.5 
pg/ml PI into 2 ml of annexin-binding buffer. Cells were incubated in this mixture at 
37 °C, 5% CO2 in humidified incubator for 20 min. The coverslips were gently washed 
once with annexin-binding buffer. The coverslips were assembled into a Bioptechs 
FCS2 perfusion chamber (Bioptechs), perfused with annexin-binding buffer and 
observed with Zeiss Pascal confocal laser scanning microscope (CLSM). Cells were 
viewed through a Plan-Apochromat 63x 1.2 numerical aperture (N.A.) water objective. 
Fluorescence signals from annexin V and PI were collected by single excitation with 
argon ion laser at 488 nm and collection of emitted light through a 505-530 nm band 
pass filter and a 650 nm long pass filter, respectively. At least 500 cells were counted
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for each replicate and scored according to the appearance of cells, i.e. 
attached/unattached to PRBC, blebbing and/or annexin V/PI staining.
7.2.2 Determination the effect of TNF-a on apoptosis of HUVEC
The prolonged exposure of endothelial cells to TNF-a is known to induce apoptosis 
(Polunovsky et al, 1994). To avoid apoptotic induction effect of TNF-a in our 
experiment, we tested whether the concentration of TNF-a used to stimulate the 
expression of ICAM-1 leads to apoptosis of HUVEC.
HUVEC grown on 40 mm coverslip to 80-89% confluence were stimulated with 1 
ng/ml TNF-a (Gibco) for 18 h. Unstimulated HUVEC were used as the control. After 
18 h of stimulation, HUVEC in all groups were washed once with IX PBS and stained 
with annexin V and propidium iodide. The number of apoptotic cells were measured in 
each experimental group by counting at least 500 cells/replicate under confocal laser 
scanning microscope as described in section 7.2.1.4.
7.2.3 HUVEC immunofluorescence staining for ICAM-1 expression analysis by 
FACS
HUVEC grown to 80-90% confluence in T25 cm2 vented cap flasks were treated with
1 ng/ml TNF-a for 18 h. Untreated HUVEC were used as a control group. Cells in
both groups were washed with endothelial cell culture medium followed by sera free
endothelial cell culture medium. Cells were washed again with PBS. Cells were
incubated with accutase (Sigma) to detach cells at 37 °C for 5-10 min. Cells were
observed to rounded up and detached. Equal volume of PBS containing 1% BSA was
then added to neutralise the enzyme. Cell solution was centrifuged at 1500 rpm and
washed with PBS containing 1% BSA. Cells in each group were re-suspended in PBS
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containing 1% BSA and split into two Eppendorf tubes in the volume of 80 pi for each 
Eppendorf tube. One tube of each group was incubated with 20 pi APC mouse anti­
human ICAM-1 (BD biosciences) for 30 min in the dark at room temperature. Another 
tube left in each group was incubated with 20 pi APC mouse IgG isotype control (BD 
biosciences) for 30 min in the dark at room temperature. All Eppendorf tubes were 
centrifuged at 3000 rpm and the pellets were washed with PBS containing 1% BSA, 
Cells were centrifuged again and the pellets were resuspended in 500 pi PBS. ICAM-1 
expression of cells in each tube was measured by FACS.
7.2.4 ICAM-1 inhibition
Malaria parasite ITG strain used in our experiment is known to selectively bind to 
ICAM-1 (Ockenhouse et aL, 1991). In this experiment, we aimed to reveal whether 
ICAM-1 is the receptor that parasites bind to and mediate the death of endothelial 
cells.
HUVEC were grown on 40 mm coverslip to 80-90% confluence. HUVEC were 
stimulated with 1 ng/ml TNF-a for 18 h to induce expression of ICAM-1 or left as 
unstimulated cells in the control group. The enriched parasites and parasites which 
selected to bind to ICAM-1 were submitted to magnetic separation to obtain 
concentrated trophozoite or schizont stage as described in section 7.2.1.2. Malaria 
parasites were prepared at 20% parasitemia in 1% haematocrit in medium 199 
supplemented with 1% FCS. The parasite suspension was added to both unstimulated 
and stimulated HUVEC grown on coverslips. To inhibit binding of parasite to ICAM- 
1 on endothelial cells, HUVEC were pre-treated with 10 pg/ml anti-ICAM-1 
monoclonal antibody [15.2] (Abeam) for 30 min at 37°C. HUVEC were incubated
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with malaria parasites for 3 h at 37 °C, 5% COi in humidified incubator. After that, 
unattached PRBC and uninfected red blood cells were washed out with IX PBS. 
HUVEC were stained with annexin V and propidium iodide, and observed under 
confocal scanning microscopeas described in section 7.2.1.4. At least 500 cells were 
counted for each replicate and scored according to the appearance of cells, i.e. 
attached/unattached to PRBC, blebbing and/or annexin V/PI staining.
7.2.5 CD31, CD36 and CD105 inhibition
To inhibit binding of PRBC to CD31, CD36 and CD 105, 10 pg/ml of anti-CD31 
monoclonal antibody [JC/70A] (Abeam), lOpg/ml of anti-CD36 monoclonal antibody 
[FA6-152] (Abeam), and 50 pg/ml of anti-CD 105 polyclonal antibody (Abeam) were 
added to HUVEC grown on 40 mm coverslip. HUVEC were pre-treated with the 
antibodies for 30 min at 37 °C. The enriched malaria parasites were submitted to 
magnetic separation technique in order to achieve 80-90% parasitemia of trophozoite 
or schizont stage as described in section 7.2.1.2. Malaria parasites were prepared at 
20% parasitemia in 1% haematocrit in medium 199 supplemented with 1% PCS. The 
parasite suspension was added to HUVEC grown on 40 mm coverslips to 80-90% 
confluence. HUVEC and malaria parasites were co-cultured for 3 h at 37 °C, 5% CO2 
in humidified incubator. After 3 h of co-culture, HUVEC were washed with IX PBS 
and stained with annexin V and propidium iodide. Then, HUVEC were observed 
under confocal scanning microscope as described in section 7.2.1.4. At least 500 cells 
were counted for each replicate and scored according to the appearance of cells, i.e. 
attached/unattached to PRBC, blebbing and/or annexin V/PI staining.
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7,2.6 Statistical analysis
Results were expressed as mean ± standard error of individual experimental groups. 
Statistical analysis was performed using GrapPad InStat version 3.05. Data were 
analysed by Mann-Whitney U test or one-way ANOVA with Tukey-Kramer Multiple 
Comparisons post test. A value of p < 0.05 was considered significant.
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7.3 RESULTS
7.3.1 Attachment between HUVEC and PRBC
After selection, parasites have more ability to bind to HUVEC when compared to 
parasites in control group. The amount of binding between HUVEC and PRBC were 
7.99% ± 0.47 (SE) and 7.05% ± 0.45 (SE) for the first and the second parasite 
enrichment, respectively, whereas the amount of binding between non-enriched 
control PRBC and HUVEC was 1.67% ± 0.13 (SE) (the difference following 
enrichment was shown to be statistically significant, Fig 7.1).
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Figure 7.1 Comparison amount of binding of PRBC to HUVEC in the control 
parasites, the first and the second enriched parasites. Data are mean ± SE of at least 
five experiments. ** denotes statistical difference (p < 0.01) as analysed by one-way 
ANOVA with Tukey-Kramer Multiple Comparisons post test.
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7.3.2 Apoptosis of HUVEC attached to PRBC
Besides the increase in amount of binding, the selected parasites also have the 
potential to induce apoptosis of HUVEC (Fig 7.2). The amount of apoptosis among 
attached HUVEC were 90.18% ± 6.08 (SE) in the control group, and 91.90% ± 2.58 
(SE) and 94.19% ±1.61 (SE) in the first enriched and second enriched parasite groups, 
respectively. There was no statistically significant difference in the amount of 
apoptosis among attached HUVEC in the control group, the first enriched parasite 
group and the second enriched parasite group (Fig 7.3).
Figure 7.2 Apoptosis of HUVEC induced by cytoadherence of (A) control (non- 
enriched), (B) the first enriched and (C) the second enriched parasites. Apoptotic cells 
displayed cell membrane blebbing and annexin V positivity.
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Figure 7.3 Comparison of apoptosis (%) of HUVEC attached and unattached to PRBC 
in control, the first enriched parasite and the second enriched parasite group. Data are 
mean ± SE of at least five experiments.
7.3.3 Effect of TNF-a on apoptosis of HUVEC
It is known that TNF-a can promote apoptosis of endothelial cell when exposed for 
prolonged periods (Polunovsky et al., 1994). TNF-a is also used to stimulated ICAM-1 
expression on endothelial cells. To avoid the effect of apoptosis induction by TNF-a in 
our experiments, we also tested the concentration of TNF-a used to stimulate ICAM-1 
expression of HUVEC in our experiments.
The morphology of HUVEC in unstimulated and TNF-a stimulated group looked 
similar. HUVEC appeared in attached monolayer cells. Some apoptotic cells can be 
seen in both groups. The apoptotic cells found in both groups appear as detached, 
membrane blebbing and/or annexin V positive cells. Fig 7.4 shows the images of
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HUVEC in unstimulated and TNF-a stimulated groups taken with an inverted 
microscope and a confocal laser scanning microscope.
After treating HUVEC with 1 ng/ml TNF-a for 18 h, the quantity of apoptotic 
HUVEC was slightly increased when compare with control group. The percentage of 
apoptotic HUVEC were 1.73% ± 0.41 (SE) and 2.23% ± 0.20 (SE) in unstimulated 
and TNF-a stimulated groups, respectively (Fig 7.5). However, there was no 
statistically significant difference in the number of HUVEC showing signs of 
apoptosis in the unstimulated and TNF-a stimulated groups.
Figure 7.4 HUVEC morphology. (A) image of unstimulated HUVEC under inverted 
microscope, (B) image of TNF-a stimulated HUVEC under inverted microscope, (C) 
confocal image of monolayer cells in the unstimulated group, (D) confocal image of 
apoptotic HUVEC in 1 ng/ml TNF-a stimulated group. Apoptotic cell shows 
membrane blebbing together with annexin V positivity.
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Figure 7.5 The degree of apoptosis in unstimulated and TNF-a stimulated HUVEC
groups. Data are mean ± SE of at least three experiments.
7.3.4 Quantitative measurement of ICAM-1 expression
To confirm the expression of ICAM-1 on HUVEC after stimulation with TNF-a, we 
measured the expression of ICAM-1 on HUVEC using FACS. Following stimulation 
of HUVEC with TNF-a, the mean fluorescence intensity (MFI) of ICAM-1 was shown 
to increase by approximately ten-fold (1,345.50 MFI ± 16.91 (SE)) compared to 
unstimulated HUVEC (100.17 MFI ± 2.77 (SE)) (Fig 7.6).
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Figure 7.6 ICAM-1 expression on HUVEC measured by FACS. (A) Representative 
histogram of mean fluorescence intensity of (a) control (unstimulated HUVEC) and 
(b) Ing/ml TNF-a stimulated HUVEC. (B) Mean fluorescence intensity of ICAM-1 
positive population of control and Ing/ml TNF-a stimulated HUVEC. Data are mean ± 
SE. ** denotes statistical difference (p < 0.01) as analysed by Mann-Whitney U test.
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7.3.5 Inhibition of binding of PRBC to ICAM-1 on HUVEC
To reveal whether ICAM-1 is an important receptor for the observed cytoadherence- 
mediated apoptosis of HUVEC, unstimulated and TNF-a stimulated HUVEC were 
treated with an anti-ICAM-1 monoclonal antibody to block the binding of PRBC to 
ICAM-1 on HUVEC. The degree of PRBC binding for both ITG and enriched 
parasites to unstimulated and TNF-a stimulated HUVEC in the presence and absence 
of anti-ICAM, is given in Table 7.1 and Fig 7.7.
The amount of binding between HUVEC and the enriched parasites were almost the 
same quantity in all groups of the experiment. In contrast, the amount of binding 
between HUVEC and ICAM-1 selected parasites was increased when HUVEC were 
stimulated with TNF-a, then decreased to almost the same amount as control group 
when ICAM-1 mAb was added to TNF-a stimulated HUVEC. Furthermore, blocking 
of ICAM-1 in unstimulated HUVEC had no effect on binding between the ICAM-1 
selected parasites and HUVEC.
There was no statistically significant difference in the percentage binding of the 
enriched parasites among experimental groups. However, there were statistically 
significant differences in the percentage binding of the ICAM-1 selected parasites 
among experimental groups (p < 0.0001). The post-test showed that there were 
statistically significant differences in the degree of binding between the following 
groups; unstimulated HUVEC and TNF-a stimulated HUVEC, TNF-a stimulated 
HUVEC and TNF-a stimulated HUVEC + ICAM-1 mAb, and TNF-a stimulated 
HUVEC and unstimulated HUVEC + ICAM-1 mAb (p < 0.001) (Fig 7.7).
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HUVEC
Unstimulated TNF-a
stimulated
Unstimulated
+ICAM-1
mAb
TNF-a
stimulated
+ICAM-1 mAb
Enriched ITG 9.65% ± 0.20 11.53% ±0.47 9.07% ± 0.04 10.13% ±0.69
ICAM-1
selected ITG
4.09% ± 0.26 9.27% ± 0.47 3.64% ±0.13 4.62% ±0.19
Table 7.1 The percentage of adhesion of the enriched parasites and the ICAM-1
selected parasites to unstimualted HUVEC and TNF-a stimulated HUVEC in the 
presence or absence of anti-ICAM-1 mAb. Data are mean ± SE of at least five 
experiments.
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Figure 7.7 Cytoadherence of the enriched parasite and the ICAM-1 selected parasites 
to unstimualted HUVEC and TNF-a stimulated HUVEC in the presence or absence of 
anti-ICAM-1 mAb. Data are mean ± SE. *** denotes statistical difference (p < 0.001) 
as analysed by one-way ANOVA with Tukey-Kramer Multiple Comparisons post test.
The degree of apoptosis of HUVEC attached to both parasite lines is shown in Table 
7.2 and Fig 7.8. The amount of apoptosis in almost all experimental groups when 
attached to both parasite lines were approximately 90%, however, in TNF-a stimulated 
HUVEC the amount of apoptosis when HUVEC attached to both parasite lines 
decreased. This can be explained by the increase in the amount of binding of both 
parasite lines to stimulated HUVEC but some parasites failed to induce apoptosis of 
attached HUVEC. The morphology of apoptotic and non-apoptotic HUVEC in TNF-a 
stimulated group which attached to both parasite lines was shown in Fig 7.9.
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There were statistically significant differences in percentage apoptosis of HUVEC 
attached to both parasite lines among experimental groups (p < 0.0001). The post-test 
showed that there were statistically significant differences in percentage apoptosis of 
HUVEC attached to both parasite lines between the following groups; unstimualted 
HUVEC and TNF-a stimulated HUVEC, TNF-a stimulated HUVEC and TNF-a 
stimulated HUVEC + ICAM-1 mAh, and TNF-a stimulated HUVEC and unstimulated 
HUVEC + ICAM-1 mAh (p < 0.001) (Fig 7.8).
HUVEC
Unstimulated TNF-a
stimulated
Unstimulated
+ICAM-1
mAb
TNF-a
stimulated
+ICAM-1 mAb
Enriched ITG 94.06%±0.72 78.84%±2.48 95.51%±1.27 93.80%±0.83
ICAM-1
selected ITG
89.69%±2.17 67.90%±2.38 92.78%±1.66 92.09%±1.23
Table 7.2 The percentage apoptosis of unstimualted HUVEC and TNF-a stimulated
HUVEC attached to the enriched parasites and the ICAM-1 selected parasites in the 
presence or absence of anti-ICAM-1 mAh. Data are mean ± SE of at least five 
experiments.
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Figure 7.8 Apoptosis of unstimualted HUVEC and TNF-a stimulated HUVEC 
attached to the enriched parasites or the ICAM-1 selected parasites in the presence or 
absence of anti-ICAM-1 mAh. Data are mean ± SE. *** denotes statistical difference 
(p < 0.001) as analysed by one-way ANOVA with Tukey-Kramer Multiple 
Comparisons post test.
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Figure 7.9 The morphology of HUVEC in TNF-a stimulated group attached to 
enriched parasites or ICAM-1 selected parasites. (A-B) Apoptosis of TNF-a 
stimulated FRJVEC induced by enriched and ICAM-1 selected parasites, respectively. 
Apoptotic cells shows cell membrane blebbing together with annexin V positive. (C- 
D) Attachment of enriched and ICAM-1 selected parasites, respectively, to TNF-a 
stimulated HUVEC failed to induce HUVEC apoptosis.
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7.3.6 Inhibition of binding of PRBC to CD31, CD36 and CD105 on HUVEC
According to the results from the previous experiment (section 7.3.5), the inducible 
receptor ICAM-1 might not be the receptor that mediates cytoadherence-induced 
apoptosis of HUVEC, as there was no difference in the amount of binding of the 
enriched parasites to HUVEC in unstimualted and TNF-a stimulated HUVEC. We 
assume that the enriched parasites do not bind to an inducible cell receptor, but that 
they bind to a cell surface receptor which is constitutively expressed on HUVEC. In 
the next experiment, we tried to block binding of parasites to HUVEC by using 
antibodies raised against constitutively expressed endothelial cell receptors; CD31, 
CD36 and CD105.
The quantity of binding of the enriched parasites to HUVEC in the presence or 
absence of antibodies was shown in Table 7.3. The antibodies used in our experiments 
had no effect on blocking the binding between parasites and HUVEC as the amount of 
binding after HUVEC was treated with the antibodies remained the same as in the 
control group. There was no statistically significant difference in percentage binding 
between control HUVEC and HUVEC blocked with the antibody in all experiments.
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Cell surface receptor
CD31 CD36 CD105
Control 8.23% ±0.35 8.67% ±0.19 8.22% ± 0.20
Ab treatment 8.46% ±0.12 8.66% ±0.10 8.35% ±0.27
Table 7.3 The percentage of binding between the enriched parasites and HUVEC in 
the presence or absence of anti-CD31 mAh, anti-CD36 mAh, and anti-CD 105 pAb. 
Data are mean ± SE of at least three experiments.
The quantity of apoptosis of HUVEC attached to parasites is illustrated in Table 7.4. 
Up to 90% of HUVEC with attached parasites in all experimental groups were 
observed to be undergoing apoptosis. There was no statistically significant difference 
in percentage apoptosis between control HUVEC and HUVEC blocked with the 
antibody in all experiments. Fig 7.10 shows PRBC cytoadherence-induced apoptosis 
of HUVEC in the presence or absence of antibodies against CD31, CD36 and CD 105.
Cell surface receptors
CD31 CD36 CD105
Control 93.28% ±1.35 97.67% ± 0.77 95.53% ± 0.45
Ab treatment 93.01% ±0.89 98.15% ±0.46 95.92% ± 0.90
Table 7.4 The percentage of apoptosis of the HUVEC attached to the enriched 
parasites in the presence or absence of CD31 mAb, CD36 mAb, and CD 105 pAb. Data 
are mean ± SE of at least three experiments.
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Figure 7.10 Cytoadherence of enriched parasites induced apoptosis of HUVEC in 
presence or absence of cell receptors specific antibodies. (A) control group (absence of 
any antibodies), (B) presence of anti-CD-31 mAb, (C) presence of anti-CD36 mAb, 
and (D) presence of anti-CD 105 pAb.
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7.4 DISCUSSION
The enrichment of adhesive phenotype malaria parasites can be achieved by a panning 
procedure, where PRBC are incubated either on isolated receptor molecules coated on 
plates (Ockenhouse et al., 1991, Salanti et at, 2003) or on receptor-expressing cells 
such as Saimiri brain endothelial cells (SBEC) expressing CSA and/or CDS 6 and 
ICAM-1 (Gay et al, 1995), human lung endothelial cells (HLEC) expressing CDS6 
and ICAM-1 (Muanza et al, 1996), human choriocarcinoma cells expressing CSA and 
CDS6 (Viebig et al, 2006) or Chinese hamster ovary cells (CHO) transfected with the 
respective receptors (Hasler et al, 1993). In this final chapter, by panning ITG 
parasites on unstimulated HUVEC, PRBC with the cytoadherence-mediated apoptosis 
phenotype were successfully enriched (Fig. 7.1 and 7.3). After selection, parasites not 
only retained the potential to induce apoptosis of HUVEC but also displayed a greater 
ability to attach to HUVEC. With these improved properties, the enriched PRBC 
provide a better experimental strain to study the cytoadherence-induced apoptosis 
phenomenon.
Generally, TNF-a is used to activated expression of inducible adhesion molecules,
including ICAM-1, on endothelial cells (Viebig et al, 2005). As expected, when we
treated HUVEC with TNF-a, we also observed increased ICAM-1 dependent PRBC
binding (Table 7.1, Fig 7.7). However, TNF-a has been reported to induce apoptosis
of endothelial cells in a concentration- and time-dependent fashion (Polunovsky et al.,
1994, Robaye et al, 1991). To avoid this potential effect in our experiments, we
assessed the effect of TNF-a on our HUVEC. After stimulation of HUVEC with TNF-
a, the degree of apoptosis (described by cell membrane blebbing and/or annexin V
positivity) was only slightly higher compared to HUVEC in the control group (Fig
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7.5), however, this was not statistically significant. We therefore considered that under 
our experimental conditions, our experiments were not affected by the duration and 
concentration of TNF-a used to activate ICAM-1 expression.
The unique ability of infected red blood cells to sequester in the microvasculature is 
associated with severe malaria. This process is thought to be mediated by the 
Plasmodium derived protein and modified erythrocyte protein on infected red blood 
cells and ligands on endothelial cells (Newton et al., 2000). Several adhesion 
molecules on endothelial cells have been identified, including ICAM-1 (Berendt et al, 
1989), CD36 (Oquendo et al, 1989), and CD31/PEC AM-1 (Treutiger et al, 1997). It 
is known that cytoadherence of infected red blood cells induces signalling in 
endothelial cells, for example, apoptosis of endothelial cells (Medana & Turner, 
2007). Therefore, it is important to identify the adhesion molecules on endothelial 
cells mediating the cytoadhesion of infected red blood cells, hi this chapter, we tried to 
block some molecules on HUYEC to reveal the receptors that parasites bound in order 
to induce apoptosis of HUVEC.
We first investigated the role of ICAM-1 in cytoadherence of infected red blood cells
as our experiment involved HUVEC, which constitutively express small amounts of
ICAM-1 on their surface, and the ITG parasite line, which is a strong ICAM-1 binder
(Gray et al, 2003, Phiri et al, 2009). When HUVEC were activated to express ICAM-
1, the binding of our enriched parasites was only slightly increased, whereas binding
was highly increased for ICAM-1 selected parasites (Table 7.1, Fig 7.7). Although the
ICAM-1 selected parasites showed a considerable increase in amount of binding to
HUVEC, the majority of attached parasites failed to induce apoptosis of HUVEC.
Furthermore, the anti-ICAM-1 antibody failed to inhibit the cytoadhesion, which
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induced apoptosis of HUVEC, of both parasite lines. Taken together, these data 
suggest that ICAM-1 is unlikely to be the target of cytoadhesion and furthermore that 
the cytoadherence-induced apoptotic phenotype is ICAM-1-independent.
TNF-a activation of HUVEC was unable to increase the degree of cytoadhesion which 
induce apoptosis of HUVEC. Therefore, it can be hypothesised that the adhesive 
receptor on HUVEC mediated apoptosis is not a TNF-a inducible molecule(s).
As inducible receptors seems unlikely to be the target of binding of our enriched 
parasites, the constitutively expressed receptors on endothelial cells, including 
PECAM-1/CD31, CD36 and CD105, were investigated. PECAM-1/CD31 is a member 
of the immunoglobulin gene superfamily which is widely expressed on endothelial 
cells, granulocytes, monocytes and platelet (Treutiger et al., 1997). The monoclonal 
antibody which has been reported to be able to block the cytoadhesion of PRBC was 
used in our experiment (Treutiger et ah, 1997, Vogt et al, 2003). Unfortunately, this 
antibody failed to inhibit binding. Another main cytoadherence receptor CD36 which 
is expressed on several endothelial cells was also blocked with the monoclonal 
antibody. The antibody was also unable to inhibit binding of PRBC to HUVEC. The 
failure of anti-CD36 antibody to block binding might due to the lack of CD36 on 
HUVEC (Swerlick et al, 1992). Although, the binding of malaria parasites to CD 105 
on endothelial cell has never been reported, this molecule is predominantly expressed 
on endothelial cells (Fonsatti & Maio, 2004). It is possible that parasites bound to this 
receptor and induce apoptosis of HUVEC. However, the selected antibody failed to 
inhibit cytoadhesion of parasites.
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From all the evidence presented here, it can be concluded that cytoadhesion of 
enriched parasites did not involve ICAM-1, CD36, CD31 or CD 105 based on our 
antibody inhibition studies. However, as a note of caution, it should be considered that 
receptors have a very large structure (approximately 90 kDa on average). Antibodies 
are likely only to inhibit part of the receptor and therefore more work will be required 
to conclusively rule out the involvement of any receptors. This notwithstanding, the 
data presented here suggest that the cytoadherence-mediated apoptotic phenotype of 
the enriched parasites probably operates via a hitherto unknown or poorly studied cell- 
membrane receptor and signalling pathway.
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CHAPTER 8: GENERAL DISCUSSION
Cerebral malaria is a complex syndrome and it is reasoned that no one single process 
is responsible for all of its pathogenesis. It has been proposed that the pathogenesis of 
cerebral malaria can be better explained by the integration of three processes, i.e. 
hemostasis, inflammation and PRBC sequestration. This unifying hypothesis suggests 
that parasite antigens activate the host inflammatory response leading to increased 
levels of endothelial cell adhesion molecules. This, in turn, results in a further increase 
in level of PRBC sequestration in the brain microvasculature (van der Heyde et al, 
2006). It has been shown that the interaction between PRBC and endothelial cells 
lining blood vessels can result in activation of intracellular signalling pathways in 
endothelial cells (Jenkins et al, 2007, Taoufiq et al, 2008) including apoptotic 
pathways which could be directly involved in the disruption of the blood-brain barrier 
(Pino et al, 2003b). The work described in this thesis aims to understand the 
signalling events that follow the cytoadherence of PRBC to endothelial cells in order 
to provide a better understanding of the pathogenesis of CM.
In chapter 3, we addressed the question of what happens after cytoadherence of PRBC 
to endothelial cells. We demonstrated that PRBC adhesion induced apoptosis in 
HUVEC. This event occurred rapidly within a few hours of co-culture in the absence 
of any TNF-a activation. The morphological changes observed in the apoptotic cells 
included annexin V binding, cell membrane blebbing and the shedding of 
microparticles (MP). We found that the ability of parasites to induce endothelial 
apoptosis is dependent on the PRBC membrane remaining intact but independent of 
viability of the parasites. The level of apoptosis was markedly reduced when a pan-
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caspase inhibitor (Z-VAD-FMK) was added to the co-culture. This suggested that 
apoptosis induced by PRBC is mediated by a caspase-dependent pathway. By 
measuring caspase-8 and -9 activities and using Z-IETD-FMK and Z-LEHD-FMK, 
which are specific inhibitors of caspase-8 and -9, respectively, we found that PRBC- 
induced apoptosis involves both receptor-mediated (caspase-8) and mitochondrial- 
mediated (caspase-9) pathways. These findings are in agreement with the published 
data of Pino and colleagues (Pino et al., 2003b). However, in contrast to their studies, 
we used the co-culture model of PRBC and HUVEC coupled with confocal 
microscopy to observe the apoptosis process happening in HUVEC after the adhesion 
of PRBC. This technique allows us to study this phenomenon at the single cell level 
without the interfering effect from normal HUVEC without attached PRBC. This 
advantage makes the single cell approach a powerful tool for the study of this process 
where only a variable proportion of the population of cells is undergoing change.
In the mitochondrial apoptotic pathway, there is the formation of the mitochondrial 
permeability transition pore which leads to a loss of mitochondrial AT and the releases 
of many apoptotic inducing factors from the mitochondria including cytochrome c 
which forms a complex with other proteins in the cytosol and activates caspase-9 
(Vermeulen et al, 2005). In chapter 4, we demonstrated a rapid collapse of the 
mitochondrial AT within 3 hours of co-culture in those HUVEC with adhered PRBC 
and which go on to demonstrate apoptosis. This observation is further confirmation of 
the role of the mitochondrial pathway in apoptosis of HUVEC attached to PRBC 
supporting the conclusions of Chapter 3.
Oxidative stress can cause peroxidation of cell membrane lipids which generates
various products including 4-hydroxy-2-noneal (4-HNE). The formation of 4-HNE is
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considered to be a sensitive marker of this oxidative damage (Catala, 2009). The role 
of oxidative stress has been implicated in PRBC-induced host cell apoptosis (Guha et 
ah, 2006, Guha et al, 2007, Pino et al, 2003a, Taoufiq et al, 2006). In chapter 5, we 
used immunocytochemical staining of 4-HNE to reveal the involvement of oxidative 
stress in the apoptosis of HUVEC induced by PRBC. We found that the adhesion of 
PRBC to HUVEC led to the prominent increase of 4-HNE formation. Furthermore, 
DFO-chelatable substances such as heme are not responsible for this event. This data 
suggest that cytoadherence of PRBC induces oxidative stress in HUVEC that leads to 
HUVEC apoptosis.
Besides receptor-mediated and mitochondrial-mediated pathways, apoptosis can occur 
through several pathways, for example, ER stress-induced pathways, stress-activated 
protein kinase pathways and a p5 3-mediated pathway. In chapter 6, we tried to unveil 
other potential pathways which might be involved in HUVEC apoptosis induced by 
PRBC. To do this, we deployed various known inhibitors of these specific pathways 
into our co-culture system at pharmacologically relevant concentrations. The results 
from this chapter indicated a role for calcium signalling and NF-kB signalling 
pathways in the apoptotic phenomenon we were studying.
The results in previous chapters showed that cytoadherence of PRBC to HUVEC can
trigger apoptosis signalling pathways in HUVEC. However, the endothelial cell
receptor mediating PRBC binding and triggering apoptosis in our system has not been
verified yet. In the final chapter, we attempted to identify the HUVEC membrane
receptor involving in cytoadherence-dependent apoptosis. To aid this work, PRBC
were enriched for their ability to bind and induce apoptosis in TNF-a unstimulated
HUVEC. The enriched parasites displayed a greater ability to attach to HUVEC and
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still retained the potential to induce apoptosis, as measured by the proportion of 
HUVEC with bound PRBC. Because the parasites used for enrichment originated from 
the ITG isolate which is a strong ICAM-1 binder (Gray et al., 2003), it was possible 
that the enriched parasites were more efficient ICAM-1 binders and as such binding of 
PRBC onto the ICAM-1 expressed on the HUVEC was sufficient to trigger apoptosis 
and explain the data. To reveal the role of ICAM-1 in the apoptosis of PRBC-adhered 
HUVEC, the enriched parasites were co-cultured with TNF-a un-stimulated and TNF- 
a stimulated HUVEC in the presence or absence of anti-ICAM-1 monoclonal 
antibodies. The results showed that ICAM-1 and other inducible receptors are unlikely 
to mediate this apoptotic event. We then tried to block other constitutively expressed 
endothelial cell receptors which have been reported to play role in binding of PRBC, 
i.e. CD31 (Treutiger et al, 1997) and CD 36 (Oquendo et al, 1989). Unfortunately, 
the antibodies which successfully inhibited PRBC binding in other studies (Treutiger 
et al, 1997, Vogt et al, 2003) failed to inhibit PRBC binding in our system. The 
antibody against CD 105, which is another constitutively expressed receptor on 
endothelial cells, was also used even though it has never been reported to mediate 
binding of PRBC to endothelial cells. However, this antibody also failed to block 
PRBC binding to HUVEC. From all the results found in this final chapter, we 
concluded that the receptor responsible for apoptosis of HUVEC induced by PRBC is 
unlikely to be the inducible receptors. One limitation is that as these receptors are 
large (approximately 90 kDa), the antibodies may only bind to small regions of the 
receptor. Therefore, more work is required to conclusively rule out the involvement of 
any receptors. However, we should remember the fact that at least for the antibodies to
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CD31, CDS 6 and ICAM-1, literature data indicates they can functionally block 
binding.
The cytoadherence of PRBC to endothelial cells lining brain microvessel is an 
important process leading to the pathology of cerebral malaria. Our in vitro model 
demonstrated that the binding of PRBC to a receptor on endothelial cells triggers 
apoptosis of endothelial cells. This involved receptor-mediated and mitochondrial- 
mediated pathways as well as calcium signalling, oxidative stress and the activation of 
NF-kB. This deleterious effect of PRBC on endothelial cells could be directly 
involved in the breakdown of the blood-brain barrier, which results in the 
micro vascular bleeding seen in brain autopsy (Haidar et ah, 2007). Although the fine 
mechanisms and signalling pathways implicating in this process remain to be further 
defined, the data presented here could provide a better understanding of cerebral 
malaria, which in turn might lead to the new therapeutic intervention for the disease.
The proposed mechanism of PRBC-induced endothelial apoptosis
Based on the results generated from this thesis, the proposed mechanism of endothelial 
apoptosis induced by PRBC was developed and illustrated in Fig 8.1. The 
cytoadherence of PRBC to HUVEC might occur through the interaction between 
parasite ligand (probably PfEMP-1) and endothelial receptor (perhaps ICAM-1 
independent). This interaction leads to the activation of caspase-8 which can cleave 
Bid. The truncated Bid induces the translocation and insertion of other Bcl-2 family 
members to the mitochondrial membrane leading to the leakage of pro-apoptotic 
proteins from mitochondria. Reactive oxygen species (ROS) and calcium can also
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induce the formation of mitochondrial permeability transition pore (PTP) resulting in 
the dissipation of the mitochondrial transmembrane potential (A'Pm) and releasing pro- 
apoptotic proteins such as cytochrome c, which can activate caspase-9. Furthermore, 
the activation of NF- kB up-regulates the pro-apoptotic genes that can aggravate 
apoptosis of endothelial cell.
As we have shown in Fig 8.1, there are many the missing links among the pathways. 
For example, the endothelial receptor and parasite ligand responsible for endothelial 
apoptosis still need to be defined. The source of calcium is not known, whether it is 
from intracellular store (endoplasmic reticulum) or extracellular source. Thus future 
work proposed in the next section could be performed in order to better describe the 
mechanism of PRBC-induced endothelial apoptosis.
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Figure 8.1 The proposed mechanism of PRBC-induced endothelial apoptosis.
Potential future work derived from this thesis
The BBB is the specialized interface between the vascular space and the brain 
parenchyma playing role in regulating solute and cellular transport into the brain 
(Hawkins & Davis, 2005). This barrier is the results of the tight junctions forming
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between endothelial cells lining brain microvessels (Kniesel & Wolburg, 2000). It has 
been reported that a unique model of the BBB can be established by co-culturing 
endothelial cells together with astrocytes (Gaillard et al., 2001, Garcia et ai., 2004, 
Jeliazkova-Mecheva & Bobilya, 2003). The contact between astrocytes and 
endothelial cells induced the BBB properties in endothelial cells. Endothelial cells 
showed significant increase in transendothelial electrical resistance (TEER), decrease 
in paracellular transport as well as increase in levels of occludin which is an integral 
membrane protein localized to tight junctions and contributing the barrier properties of 
endothelial cells (Gaillard et al., 2001, Garcia et ah, 2004, Jeliazkova-Mecheva & 
Bobilya, 2003), In addition, the co-culture of astrocyte with endothelail cells also 
resulted in an increase in the activity of endothelial cell y-glutamyl-transferase (GGT), 
a characteristic of the differentiated BBB (Garcia et al, 2004). For future work, it 
would be interesting to use this endothelial cells-astrocytes model to study the 
interaction of PRBC to the BBB, as it could provide the results which reflect the 
physiological situation occurring in vivo.
In a previous study, apoptosis of endothelial cells induced by PRBC was reported after 
4 hours of co-culture (Pino et al., 2003b), but this process was found after 3 hours post 
co-culture in our study. Therefore, real-time experiments could be done to determine 
more precisely the time in which apoptosis occurs after HUVEC-PRBC binding.
The results presented in this thesis were performed under static conditions using 
HUYEC grown on coverslips co-cultured with PRBC. In a future study, endothelial 
grown on microslides or parallel plate chambers and the cytoadherence assay carried 
out under laminar flow conditions could be done to mimic physiologically relevant 
wall shear stresses in the microvasculature (Chakravorty et al, 2008).
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Cytoadherence of PRBC to HUVEC resulted in apoptosis of HUVEC which 
implicated both receptor-mediated and mitochondrial-mediated pathways. As 
described in Chapterl (section 1.2.1), these pathways are complicated and consist of 
several components. By the aid of RNA silencing technology, we can selectively 
suppress the specific components in the apoptosis pathway (Liang et al., 2007, Wilson 
et al, 2005). Thus this technique could be used in a future study to define the fine 
signalling events of the pathways involving in apoptosis induced by PRBC. Our 
results also showed the involvement of calcium and NF-kB in HUVEC apoptosis 
induced by PRBC. The next phase of study could be done to determine the source of 
calcium, whether it derived from intracellular stores or extracellular source. This could 
be done by treating HUVEC with EGTA (an extracellular calcium chelator) (Arimoto 
et al, 2006) or Thapsigargin (depleting intracellular calcium store) (Treiman et al, 
1998). The direct visualisation of NF-kB translocation from the cytoplasm to the 
nucleus using GFP fusion protein could help confirm our finding and determine the 
timing when the activation of NF-kB occurs after binding of PRBC to HUVEC 
(Bartfeld et al, 2010).
In our final chapter, we failed in an attempt to define the endothelial cell surface 
receptor responsible for PRBC cytoadherence and apoptosis by using specific 
antibodies. As discussed in the chapter, this might be because the antibody can only 
block part of the large and complex molecule of the receptor. Many investigators have 
reported that the expression of cell surface receptors can be successfully suppressed by 
RNA silencing techniques (Nishiwaki et al, 2003, Walker et al, 2005, Walker et al, 
2007). This technique could be used in our further works to describe the endothelial
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cell adhesion receptor which plays a role in PRBC attachment and inducing HUVEC 
apoptosis.
In conclusion, we have taken a single cell imaging approach to help understand the 
interaction between endothelial cells (in our case HUVEC) and the PRBC. We can 
confirm adhesion depended cell death which has elements of the well accepted 
apoptotic pathways. Adhesion and apoptosis requires intact PRBC but does not require 
living viable parasites, suggesting a simple receptor-ligand trigger rather than a cell­
cell signalling event. We were able to selectively enhance binding by panning 
suggesting that the extent of adhesion is derived from the expression of parasite 
expressed ligands but we could not identify the binding receptor on the HUVEC.
154
REFERENCES
Akira, S. & K. Takeda, (2004) Toll-like receptor signalling. Nat Rev Immunol 4: 499- 
511.
Amaral, J. D., R. E. Castro, C. J. Steer & C. M. Rodrigues, (2009) p53 and the 
regulation of hepatocyte apoptosis: implications for disease pathogenesis. 
Trends Mol Med 1S\ 531-541.
Antonsson, B., (2004) Mitochondria and the Bcl-2 family proteins in apoptosis 
signaling pathways. Mol Cell Biochem 256-257: 141-155.
Aoki, M., T. Nata, R. Morishita, H. Matsushita, H. Nakagami, K. Yamamoto, K. 
Yamazaki, M. Nakabayashi, T. Ogihara & Y. Kaneda, (2001) Endothelial 
apoptosis induced by oxidative stress through activation of NF-kappaB: 
antiapoptotic effect of antioxidant agents on endothelial cells. Hypertension 38: 
48-55.
Aravalli, R. N., S. Hu & J. R. Lokensgard, (2007) Toll-like receptor 2 signaling is a 
mediator of apoptosis in herpes simplex virus-infected microglia. J 
Neuroinflammation 4: 11.
Arimoto, E., S. Iwai, T. Sumi, Y. Ogawa & Y. Yura, (2006) Involvement of 
intracellular free Ca2+ in enhanced release of herpes simplex virus by 
hydrogen peroxide. Virol J3\ 62.
Armah, H. B., N. O. Wilson, B. Y. Sarfo, M. D. Powell, V. C. Bond, W. Anderson, A. 
A. Adjei, R. K. Gyasi, Y. Tettey, E. K. Wiredu, J. E. Tongren, V. 
Udhayakumar & J. K. Stiles, (2007) Cerebrospinal fluid and serum biomarkers 
of cerebral malaria mortality in Ghanaian children. Malar J 6: 147.
Bainbridge, S. A., L. Belkacemi, M. Dickinson, C. H. Graham & G. N. Smith, (2006) 
Carbon monoxide inhibits hypoxia/reoxygenation-induced apoptosis and 
secondary necrosis in syncytiotrophoblast. Am J Pathol 169: 774-783.
Bartfeld, S., S. Hess, B. Bauer, N. Machuy, L. A. Ogilvie, J. Schuchhardt & T. F. 
Meyer, (2010) High-throughput and single-cell imaging of NF-kappaB 
oscillations using monoclonal cell lines. BMC Cell Biol 11: 21.
Baruch, D. L, J. A. Gormely, C. Ma, R. J. Howard & B. L. Pasloske, (1996) 
Plasmodium falciparum erythrocyte membrane protein 1 is a parasitized 
erythrocyte receptor for adherence to CD36, thrombospondin, and intercellular 
adhesion molecule 1, Proc Natl Acad Sci USA 93: 3497-3502.
155
Beare, N. A., T. E. Taylor, S. P. Harding, S. Lewallen & M. E. Molyneux, (2006) 
Malarial retinopathy: a newly established diagnostic sign in severe malaria. Am 
J Trop MedHyg 75: 790-797.
Berendt, A. R., A. McDowall, A. G. Craig, P. A. Bates, M. J. Sternberg, K. Marsh, C.
I. Newbold & N. Hogg, (1992) The binding site on ICAM-1 for Plasmodium 
falciparum-infected erythrocytes overlaps, but is distinct from, the LFA-1- 
binding site. Cell 68: 71-81.
Berendt, A. R., D. L, Simmons, J. Tansey, C. I. Newbold & K. Marsh, (1989) 
Intercellular adhesion molecule-1 is an endothelial cell adhesion receptor for 
Plasmodium falciparum. Nature 341: 57-59.
Berendt, A. R., G. D. Turner & C. I. Newbold, (1994) Cerebral malaria: the 
sequestration hypothesis. Parasitol Today 10: 412-414.
Berridge, M. J., M. D. Bootman & H. L. Roderick, (2003) Calcium signalling: 
dynamics, homeostasis and remodelling. Nat Rev Mol Cell Biol 4: 517-529.
Berridge, M. J., P. Lipp & M. D. Bootman, (2000) The versatility and universality of 
calcium signalling. Nat Rev Mol Cell Biol 1: 11-21.
Biswas, A. K., A. Hafiz, B. Banerjee, K, S. Kim, K. Datta & C. E. Chitnis, (2007) 
Plasmodium falciparum uses gClqR/HABPl/p32 as a receptor to bind to 
vascular endothelium and for platelet-mediated clumping. PLoS Pathog 3: 
1271-1280.
Bootman, M. D., T. J. Collins, C. M. Peppiatt, L. S. Prothero, L. MacKenzie, P. De 
Smet, M. Travers, S. C. Tovey, J. T. Seo, M. J. Berridge, F. Ciccolini & P. 
Lipp, (2001) Calcium signalling—an overview. Semin Cell Dev Biol 12: 3-10.
Borovic, S., F. Rabuzin, G. Waeg & N. Zarkovic, (2006) Enzyme-linked 
immunosorbent assay for 4-hydroxynonenal-histidine conjugates. Free Radio 
Res 40: 809-820.
Borralho, P. M., I. B. Moreira da Silva, M. M. Aranha, C. Albuquerque, C. Nobre 
Leitao, C. J. Steer & C. M. Rodrigues, (2007) Inhibition of Fas expression by 
RNAi modulates 5-fluorouracil-induced apoptosis in HCT116 cells expressing 
wild-type p53. Biochim Biophys Acta 1772: 40-47.
Bortner, C. D., N. B. Oldenburg & J. A. Cidlowski, (1995) The role of DNA 
fragmentation in apoptosis. Trends Cell Biol 5: 21-26.
Boyce, M., K. F. Bryant, C. Jousse, K. Long, H. P. Harding, D. Scheuner, R. J. 
Kaufman, D. Ma, D. M. Coen, D. Ron & J. Yuan, (2005) A selective inhibitor
156
of eIF2alpha dephosphorylation protects cells from ER stress. Science 307: 
935-939.
Bratton, D. L., V. A. Fadok, D. A. Richter, J. M. Kailey, L. A. Guthrie & P. M. 
Henson, (1997) Appearance of phosphatidylserine on apoptotic cells requires 
calcium-mediated nonspecific flip-flop and is enhanced by loss of the 
aminophospholipid translocase. JihW Chem 272: 26159-26165.
Brea-Calvo, G., E. Siendones, J. A. Sanchez-Alcazar, R. de Cabo & P. Navas, (2009) 
Cell survival from chemotherapy depends on NF-kappaB transcriptional up- 
regulation of coenzyme Q biosynthesis. PLoS One 4: e5301.
Breckenridge, D. G., M. Germain, J. P. Mathai, M. Nguyen & G. C. Shore, (2003) 
Regulation of apoptosis by endoplasmic reticulum pathways. Oncogene 22: 
8608-8618.
Brown, H., S. Rogerson, T. Taylor, M. Tembo, J. Mwenechanya, M. Molyneux & G. 
Turner, (2001) Blood-brain barrier function in cerebral malaria in Malawian 
children. Am J Prop Med Hyg 64: 207-213.
Brown, H., T. T, Hien, N. Day, N. T. Mai, L. V. Chuong, T. T. Chau, P. P. Loc, N. H. 
Phu, D. Bethell, J. Farrar, K. Gatter, N. White & G. Turner, (1999) Evidence of 
blood-brain barrier dysfunction in human cerebral malaria. Neuropathol Appl 
Neurobiol 25: 331-340.
Buommino, E., F. Morelli, S. Metafora, F. Rossano, B. Perfetto, A. Baroni & M. A. 
Tufano, (1999) Porin from Pseudomonas aeruginosa induces apoptosis in an 
epithelial cell line derived from rat seminal vesicles. Infect Immun 67: 4794- 
4800.
Catala, A., (2006) An overview of lipid peroxidation with emphasis in outer segments 
of photoreceptors and the chemiluminescence assay. Int J Biochem Cell Biol 
38: 1482-1495.
Catala, A., (2009) Lipid peroxidation of membrane phospholipids generates hydroxy- 
alkenals and oxidized phospholipids active in physiological and/or pathological 
conditions. Chem Phys Lipids 157: 1-11.
Chaibi, C., J. Cotte-Laffitte, C. Sandre, A. Esclatine, A. L. Servin, A. M. Quero & M. 
Geniteau-Legendre, (2005) Rotavirus induces apoptosis in fully differentiated 
human intestinal Caco-2 cells. Virology 332: 480-490.
Chakravorty, S. J., K. R. Hughes Sc A. G. Craig, (2008) Host response to 
cytoadherence in Plasmodium falciparum. Biochem Soc Trans 36: 221-228.
157
Chang-Ling, T., A. L. Neill & N. H. Hunt, (1992) Early microvascular changes in 
murine cerebral malaria detected in retinal wholemounts. Am J Pathol 140: 
1121-1130.
Cirimotich, C. M, Y. Dong, L. S. Garver, S. Sim & G. Dimopoulos, (2010) Mosquito 
immune defenses against Plasmodium infection. Dev Comp Immunol 34: 387- 
395.
Clark, I. A. & K. A. Rockett, (1994) The cytokine theory of human cerebral malaria. 
Parasitol Today 10: 410-412.
Glutton, S., (1997) The importance of oxidative stress in apoptosis. Br Med Bull 53: 
662-668.
Coban, C., K. J. Ishii, T. Kawai, H. Hemmi, S. Sato, S. Uematsu, M. Yamamoto, O. 
Takeuchi, S. Itagaki, N. Kumar, T. Horii & S. Akira, (2005) Toll-like receptor 
9 mediates innate immune activation by the malaria pigment hemozoin. J Exp 
Med 201: 19-25.
Coban, C., Y. Igari, M. Yagi, T. Reimer, S. Koyama, T. Aoshi, K. Ohata, T. Tsukui, F. 
Takeshita, K. Sakurai, T. Ikegami, A. Nakagawa, T. Horii, G. Nunez, K. J. 
Ishii & S. Akira, (2010) Immunogenicity of whole-parasite vaccines against 
Plasmodium falciparum involves malarial hemozoin and host TLR9. Cell Host 
Microbe 7: 50-61.
Collins, T. J., M. J. Berridge, P. Lipp & M. D. Bootman, (2002) Mitochondria are 
morphologically and functionally heterogeneous within cells. EMBO J 21: 
1616-1627.
Coltel, N., V. Combes, S. C. Wassmer, G. Chimini & G. E. Grau, (2006) Cell 
vesiculation and immunopathology: implications in cerebral malaria. Microbes 
Infect 8: 2305-2316.
Combes, V., N. Coltel, D. Faille, S. C. Wassmer & G. E. Grau, (2006) Cerebral 
malaria: role of microparticles and platelets in alterations of the blood-brain 
barrier. Int J Parasitol 36: 541-546.
Combes, V., T. E. Taylor, I. Juhan-Vague, J. L. Mege, J. Mwenechanya, M. Tembo, 
G. E. Grau & M. E. Molyneux, (2004) Circulating endothelial microparticles in 
malawian children with severe falciparum malaria complicated with coma. 
JAMA 291: 2542-2544.
Connolly, J. L., S. E. Rodgers, P. Clarke, D. W. Ballard, L. D. Kerr, K. L. Tyler & T. 
S. Dermody, (2000) Reovirus-induced apoptosis requires activation of 
transcription factor NF-kappaB. J Virol 74: 2981-2989.
158
Cooper, G. M., (2007) The cell A molecular approach 4th edition: 434-451.
Cory, S. & J. M. Adams, (2002) The Bcl2 family: regulators of the cellular life-or- 
death switch. Nat Rev Cancer 2: 647-656.
Cossarizza, A., M. Baccarani-Contri, G. Kalashnikova & C. Franceschi, (1993) A new 
method for the cytofluorimetric analysis of mitochondrial membrane potential 
using the J-aggregate forming lipophilic cation 5,5',6,6'-tetrachloro-l,r,3,3'- 
tetraethylbenzimidazolcarbocyanine iodide (JC-1). Btochem Biophys Res 
Commun 197: 40-45.
Cowan, K. J. & K. B. Storey, (2003) Mitogen-activated protein kinases: new signaling 
pathways functioning in cellular responses to environmental stress. J Exp Biol 
206: 1107-1115.
Cox-Singh, J., J. Hiu, S. B. Lucas, P. C. Divis, M. Zulkarnaen, P. Chandran, K. T. 
Wong, P. Adem, S. R. Zaki, B. Singh & S. Krishna, (2010) Severe malaria - a 
case of fatal Plasmodium knowlesi infection with post-mortem findings: a case 
report. Malar J9: 10.
Cox-Singh, J., T. M. Davis, K. S. Lee, S. S. Shamsul, A. Matusop, S. Ratnam, H. A. 
Rahman, D. J. Conway & B. Singh, (2008) Plasmodium knowlesi malaria in 
humans is widely distributed and potentially life threatening. Clin Infect Dis 
46: 165-171.
de Souza, J. B. & E. M. Riley, (2002) Cerebral malaria: the contribution of studies in 
animal models to our understanding of immunopathogenesis. Microbes Infect 
4: 291-300.
Dehio, M., M. Quebatte, S. Foser & U. Certa, (2005) The transcriptional response of 
human endothelial cells to infection with Bartonella henselae is dominated by 
genes controlling innate immune responses, cell cycle, and vascular 
remodelling. Thromb Haemost 94: 347-361.
Deng, Y., X. Ren, L. Yang, Y. Lin & X. Wu, (2003) A JNK-dependent pathway is 
required for TNFalpha-induced apoptosis. Cell 115: 61-70.
Eda, S. & I. W. Sherman, (2002) Cytoadherence of malaria-infected red blood cells 
involves exposure of phosphatidylserine. Cell Physiol Biochem 12: 373-384.
Eda, S. & I. W. Sherman, (2004) Plasmodium falciparum-infected erythrocytes bind to 
the RGD motif of fibronectin via the band 3-related adhesin. Exp Parasitol 
107: 157-162.
159
Eda, S., J. Lawler & L W. Sherman, (1999) Plasmodium falciparum-infected 
erythrocyte adhesion to the type 3 repeat domain of thrombospondin-1 is 
mediated by a modified band 3 protein. Mol Biochem Parasitol 100: 195-205.
Elmore, S., (2007) Apoptosis: a review of programmed cell death. Toxicol Pathol 35: 
495-516.
Equils, O., D. Lu, M. Gatter, S. S. Witkin, C. Bertolotto, M. Arditi, J. A. McGregor, C. 
F. Simmons & C. J. Hobel, (2006) Chlamydia heat shock protein 60 induces 
trophoblast apoptosis through TLR4. J Immunol 177: 1257-1263.
Fadok, V. A., D. R. Voelker, P. A. Campbell, J. J. Cohen, D. L. Bratton & P. M. 
Henson, (1992) Exposure of phosphatidylserine on the surface of apoptotic 
lymphocytes triggers specific recognition and removal by macrophages. J 
Immunol 148: 2207-2216,
Faure, E., O. Equils, P. A. Sieling, L. Thomas, F. X. Zhang, C. J. Kirschning, N. 
Polentarutti, M. Muzio & M. Arditi, (2000) Bacterial lipopolysaccharide 
activates NF-kappaB through toll-like receptor 4 (TLR-4) in cultured human 
dermal endothelial cells. Differential expression of TLR-4 and TLR-2 in 
endothelial cells. J Biol Chem 275: 11058-11063.
Fischer, S. F., M. Rehm, A. Bauer, F. Hofling, S. Kirschnek, M. Rutz, S. Bauer, H. 
Wagner & G. Hacker, (2005) Toll-like receptor 9 signaling can sensitize 
fibroblasts for apoptosis. Immunol Lett 97: 115-122.
Fonsatti, E. & M. Maio, (2004) Highlights on endoglin (CD 105): from basic findings 
towards clinical applications in human cancer. J Transl Med 2: 18.
Gaillard, P. J., L. H. Voorwinden, J. L. Nielsen, A. Ivanov, R. Atsumi, H. Engman, C. 
Ringbom, A. G. de Boer & D. D. Breimer, (2001) Establishment and 
functional characterization of an in vitro model of the blood-brain barrier, 
comprising a co-culture of brain capillary endothelial cells and astrocytes. Eur 
JPharm Sci 12: 215-222.
Garcia, C. M., D. C. Darland, L. J. Massingham & P. A. D'Amore, (2004) Endothelial 
cell-astrocyte interactions and TGF beta are required for induction of blood- 
neural barrier properties. Brain Res Dev Brain Res 152: 25-38.
Garlanda, C. & E. Dejana, (1997) Heterogeneity of endothelial cells. Specific markers. 
Arterioscler Thromb Vase Biol 17: 1193-1202.
Gaur, D., D. C. Mayer & L. H. Miller, (2004) Parasite ligand-host receptor 
interactions during invasion of erythrocytes by Plasmodium merozoites. Int J 
Parasitol 34: 1413-1429.
160
Gay, F., C. Robert, B. Pouvelle, S. Peyrol, A. Scherf & J. Gysin, (1995) Isolation and 
characterization of brain microvascular endothelial cells from Saimiri 
monkeys. An in vitro model for sequestration of Plasmodium falciparum- 
infected erythrocytes. J Immunol Methods 184: 15-28.
Glover, S. J., R. J. Maude, T. E. Taylor, M. E. Molyneux & N. A. Beare, (2010) 
Malarial retinopathy and fluorescein angiography findings in a Malawian child 
with cerebral malaria. Lancet Infect Dis 10: 440.
Gowda, D. C., (2007) TLR-mediated cell signaling by malaria GPIs. Trends Parasitol 
23: 596-604.
Grau, G. E., C. D. Mackenzie, R. A, Carr, M. Redard, G. Pizzolato, C. Allasia, C. 
Cataldo, T. E. Taylor & M. E. Molyneux, (2003) Platelet accumulation in brain 
microvessels in fatal pediatric cerebral malaria. J Infect Dis 187: 461-466.
Gray, C., C. McCormick, G. Turner & A. Craig, (2003) ICAM-1 can play a major role 
in mediating P. falciparum adhesion to endothelium under flow. Mol Biochem 
Parasitol 128: 187-193.
Green, D. R. & G. Kroemer, (2004) The pathophysiology of mitochondrial cell death. 
Science 305: 626-629.
Greenwalt, D. E., R. H. Lipsky, C. F. Ockenhouse, H. Ikeda, N. N. Tandon & G. A. 
Jamieson, (1992) Membrane glycoprotein CD36: a review of its roles in 
adherence, signal transduction, and transfusion medicine. Blood 80: 1105- 
1115.
Grethe, S., M. P. Ares, T. Andersson & M. I. Porn-Ares, (2004) p38 MAPK mediates 
TNF-induced apoptosis in endothelial cells via phosphorylation and 
downregulation of Bcl-x(L). Exp Cell Res 298: 632-642.
Grimm, S., M. K. Bauer, P. A. Baeuerle & K. Schulze-Osthoff, (1996) Bcl-2 down- 
regulates the activity of transcription factor NF-kappaB induced upon 
apoptosis. J Cell Biol 134: 13-23.
Guha, M., P. Maity, V. Choubey, K. Mitra, R. J. Reiter & U. Bandyopadhyay, (2007) 
Melatonin inhibits free radical-mediated mitochondrial-dependent hepatocyte 
apoptosis and liver damage induced during malarial infection. J Pineal Res 43: 
372-381.
Guha, M., S. Kumar, V. Choubey, P. Maity & U. Bandyopadhyay, (2006) Apoptosis 
in liver during malaria: role of oxidative stress and implication of 
mitochondrial pathway. FASEB J2fS: 1224-1226.
161
Haidar, K., S. C. Murphy, D. A, Milner & T. E. Taylor, (2007) Malaria: mechanisms 
of erythrocytic infection and pathological correlates of severe disease. Annu 
Rev Pathol 2: 211-249.
Hansberger, M. W., J. A. Campbell, P. Danthi, P. Arrate, K. N. Pennington, K. B. 
Marcu, D. W. Ballard & T. S. Dermody, (2007) IkappaB kinase subunits alpha 
and gamma are required for activation of NF-kappaB and induction of 
apoptosis by mammalian reovirus. J Virol 81: 1360-1371.
Hasier, T., G. R. Albrecht, M. R. Van Schravendijk, J. C. Aguiar, K. E. Morehead, B. 
L. Pasloske, C. Ma, J. W. Barnwell, B. Greenwood & R. J. Howard, (1993) An 
improved microassay for Plasmodium falciparum cytoadherence using stable 
transformants of Chinese hamster ovary cells expressing CD36 or intercellular 
adhesion molecule-1. Am J Prop Med Hyg 48: 332-347.
Haupt, S., M. Berger, Z. Goldberg & Y. Haupt, (2003) Apoptosis - the p53 network. J 
Cell Sci 116: 4077-4085.
Hawkins, B. T. & T. P. Davis, (2005) The blood-brain barrier/neurovascular unit in 
health and disease. Pharmacol Rev 57: 173-185.
Hayden, M. S. & S. Ghosh, (2008) Shared principles in NF-kappaB signaling. Cell 
132: 344-362.
Hemmer, C. J., A. Vogt, M. Unverricht, R. Krause, M. Lademann & E. C. Reisinger, 
(2008) Malaria and bacterial sepsis: similar mechanisms of endothelial 
apoptosis and its prevention in vitro. Crit Care Med 36: 2562-2568.
Hemmer, C. J., H. A. Lehr, K. Westphal, M. Unverricht, M. Kratzius & E. C. 
Reisinger, (2005) Plasmodium falciparum Malaria: reduction of endothelial 
cell apoptosis in vitro. Infect Immun 73: 1764-1770.
Hengartner, M. O., (2000) The biochemistry of apoptosis. Nature 407: 770-776.
Ho, M., B. Singh, S. Looareesuwan, T. M, Davis, D. Bunnag & N. J. White, (1991) 
Clinical correlates of in vitro Plasmodium falciparum cytoadherence. Infect 
Immun 59: 873-878.
Ho, M., T. Schollaardt, X. Niu, S. Looareesuwan, K. D. Patel & P. Kubes, (1998) 
Characterization of Plasmodium falciparum-infected erythrocyte and P-selectin 
interaction under flow conditions. Blood 91: 4803-4809.
Hsu, L. C., J. M. Park, K. Zhang, J. L. Luo, S. Maeda, R. J. Kaufman, L. Eckmann, D. 
G. Guiney & M. Karin, (2004) The protein kinase PKR is required for
162
macrophage apoptosis after activation of Toll-like receptor 4. Nature 428: 341- 
345.
Hughes, K. R., G. A. Biagini & A. G. Craig, (2010) Continued cytoadherence of 
Plasmodium falciparum infected red blood cells after antimalarial treatment. 
Mol Biochem Parasitol 169: 71-78.
Jacobi, J., B. Kristal, J. Chezar, S. M. Shaul & S. Sela, (2005) Exogenous superoxide 
mediates pro-oxidative, proinflammatory, and procoagulatory changes in 
primary endothelial cell cultures. Free Radio Biol Med 39: 1238-1248.
Jain, V., H. B. Armah, J. E. Tongren, R. M. Ned, N. O. Wilson, S. Crawford, P. K. 
Joel, M. P. Singh, A. C. Nagpal, A. P. Dash, V. Udhayakumar, N. Singh & J. 
K. Stiles, (2008) Plasma IP-10, apoptotic and angiogenic factors associated 
with fatal cerebral malaria in India. Malar Jl\ 83.
Jeliazkova-Mecheva, V. V. & D. J. Bobilya, (2003) A porcine astrocyte/endothelial 
cell co-culture model of the blood-brain barrier. Brain Res Brain Res Protoc 
12: 91-98.
Jenkins, N., Y. Wu, S. Chakravorty, O. Kai, K. Marsh & A. Craig, (2007) Plasmodium 
falciparum intercellular adhesion molecule-1-based cytoadherence-related 
signaling in human endothelial cells. J Infect Dis 196: 321-327.
Jiang, S., S. C. Chow, P. Nicotera & S. Orrenius, (1994) Intracellular Ca2+ signals 
activate apoptosis in thymocytes: studies using the Ca(2+)-ATPase inhibitor 
thapsigargin. Exp Cell Res 212: 84-92.
Jin, Z. & W. S. El-Deiry, (2005) Overview of cell death signaling pathways. Cancer 
Biol Ther 4: 139-163.
John, C. C., (2007) Cerebral malaria pathogenesis: what can we learn from microarray 
analysis? Am J Pathol 171: 1729-1732.
Joza, N., S. A. Susin, E. Daugas, W. L. Stanford, S. K. Cho, C. Y. Li, T. Sasaki, A. J. 
Elia, H. Y. Cheng, L. Ravagnan, K. F. Ferri, N. Zamzami, A. Wakeham, R. 
Hakem, H. Yoshida, Y. Y. Kong, T. W. Mak, J. C. Zuniga-Pflucker, G. 
Kroemer & J. M. Penninger, (2001) Essential role of the mitochondrial 
apoptosis-inducing factor in programmed cell death. Nature 410: 549-554.
Kaneko, Y. & A. Tsukamoto, (1994) Thapsigargin-induced persistent intracellular 
calcium pool depletion and apoptosis in human hepatoma cells. Cancer Lett 
79: 147-155.
163
Karahashi, H., K. S. Michelsen & M. Arditi, (2009) Lipopolysaccharide-induced 
apoptosis in transformed bovine brain endothelial cells and human dermal 
microvessel endothelial cells: the role of JNK. JImmunol 182: 7280-7286.
Kawai, T. & S. Akira, (2006) TLR signaling. Cell Death Differ 13: 816-825.
Keller, S. A., D. Hemandez-Hopkins, J. Vider, V. Ponomarev, E. Hyjek, E. J. 
Schattner & E. Cesarman, (2006) NF-kappaB is essential for the progression of 
KSHV- and EBV-infected lymphomas in vivo. Blood 107: 3295-3302.
Kirchgatter, K. & H. A. Del Portillo, (2005) Clinical and molecular aspects of severe 
malaria. An Acad Bras Cienc 77: 455-475.
Kleinberg, L. & B. Davidson, (2009) Cell survival and apoptosis-related molecules in 
cancer cells in effusions: a comprehensive review. Diagn Cytopathol 37: 613- 
624.
Kniesel, U. & H. Wolburg, (2000) Tight junctions of the blood-brain barrier. Cell Mol 
Neurobiol 20: 57-76.
Krishnegowda, G., A. M. Hajjar, J. Zhu, E. J. Douglass, S. Uematsu, S. Akira, A. S. 
Woods & D. C. Gowda, (2005) Induction of proinflammatory responses in 
macrophages by the glycosylphosphatidylinositols of Plasmodium falciparum: 
cell signaling receptors, glycosylphosphatidylinositol (GPI) structural 
requirement, and regulation of GPI activity. JBiol Chem 280: 8606-8616.
Kuhnel, F., L. Zender, Y. Paul, M. K. Tietze, C. Trautwein, M. Manns & S. Kubicka, 
(2000) NFkappaB mediates apoptosis through transcriptional activation of Fas 
(CD95) in adenoviral hepatitis. Chem 275: 6421-6427.
Lackner, P., C. Burger, K. Pfaller, V. Heussler, R. Helbok, M. Morandell, G. 
Broessner, E. Tannich, E. Schmutzhard & R. Beer, (2007) Apoptosis in 
experimental cerebral malaria: spatial profile of cleaved caspase-3 and 
ultrastructural alterations in different disease stages. Neuropathol Appl 
Neurobiol 33: 560-571.
Lambros, C. & J. P. Vanderberg, (1979) Synchronization of Plasmodium falciparum 
erythrocytic stages in culture. JParasitol 65: 418-420.
Lamikanra, A. A., M. Theron, T. W. Kooij & D. J. Roberts, (2009) Hemozoin 
(malarial pigment) directly promotes apoptosis of erythroid precursors. PLoS 
One 4: e8446.
164
Levick, V., H. Coffey & S. R. D'Mello, (1995) Opposing effects of thapsigargin on the 
survival of developing cerebellar granule neurons in culture. Brain Res 676: 
325-335.
Li, L. Y., X. Luo & X. Wang, (2001) Endonuclease G is an apoptotic DNase when 
released from mitochondria. Nature 412: 95-99.
Liang, X., Y. Liu, Q. Zhang, L. Gao, L. Han, C. Ma, L. Zhang, Y. H. Chen & W. Sun, 
(2007) Hepatitis B virus sensitizes hepatocytes to TRAIL-induced apoptosis 
through Bax. JImmunol 178: 503-510.
Lin, K. I., S. H. Lee, R. Narayanan, J. M. Baraban, J. M. Hardwick & R. R. Ratan, 
(1995) Thiol agents and Bcl-2 identify an alphavirus-induced apoptotic 
pathway that requires activation of the transcription factor NF-kappa B. J Cell 
Biol 131: 1149-1161.
Liu, J. & A. Lin, (2005) Role of JNK activation in apoptosis: a double-edged sword. 
Cell Res 15: 36-42.
Liu, X. M., G. B, Chapman, K. J. Peyton, A. I. Schafer & W. Durante, (2002) Carbon 
monoxide inhibits apoptosis in vascular smooth muscle cells. Cardiovasc Res 
55: 396-405.
Liu, Z. G., H. Hsu, D. V. Goeddel & M. Karin, (1996) Dissection of TNF receptor 1 
effector functions: JNK activation is not linked to apoptosis while NF-kappaB 
activation prevents cell death. Cell 87: 565-576.
Livengood, A. J., C. C. Wu & D. A. Carson, (2007) Opposing roles of RNA receptors 
TLR3 and RIG-I in the inflammatory response to double-stranded RNA in a 
Kaposi's sarcoma cell line. Cell Immunol 249: 55-62.
Lomonosova, E., J. Ryerse & G. Chinnadurai, (2009) BAX/BAK-independent 
mitoptosis during cell death induced by proteasome inhibition? Mol Cancer 
Res 7: 1268-1284.
Lopez, M., L. M. Sly, Y. Luu, D. Young, H. Cooper & N. E. Reiner, (2003) The 19- 
kDa Mycobacterium tuberculosis protein induces macrophage apoptosis 
through Toll-like receptor-2. J Immunol 170: 2409-2416.
Lovegrove, F. E., S. A. Gharib, S. N. Patel, C. A. Hawkes, K. C. Kain & W. C. Liles, 
(2007) Expression microarray analysis implicates apoptosis and interferon- 
responsive mechanisms in susceptibility to experimental cerebral malaria. Am J 
Pathol 171: 1894-1903.
165
Loyevsky, M., C. John, B. Dickens, V. Hu, J. H. Miller & V. R. Gordeuk, (1999) 
Chelation of iron within the erythrocytic Plasmodium falciparum parasite by 
iron chelators. Mol Biochem Parasitol 101: 43-59.
Lytton, S. D., B. Mester, J. Libman, A. Shanzer & Z. I. Cabantchik, (1994) Mode of 
action of iron (III) chelators as antimalarials: II. Evidence for differential 
effects on parasite iron-dependent nucleic acid synthesis. Blood 84: 910-915.
Ma, Y., J. Li, I. Chiu, Y. Wang, J. A. Sloane, J. Lu, B. Kosaras, R. L. Sidman, J. J. 
Volpe & T. Vartanian, (2006) Toll-like receptor 8 functions as a negative 
regulator of neurite outgrowth and inducer of neuronal apoptosis. J Cell Biol 
175:209-215.
Mabeza, G. F., M. Loyevsky, V. R. Gordeuk & G. Weiss, (1999) Iron chelation 
therapy for malaria: a review. Pharmacol Ther 81: 53-75.
Marchenko, N. D., A. Zaika & U. M. Moll, (2000) Death signal-induced localization 
of p53 protein to mitochondria. A potential role in apoptotic signaling. J Biol 
Chem 275: 16202-16212.
Martikainen, P. & J. Isaacs, (1990) Role of calcium in the programmed death of rat 
prostatic glandular cells. Prostate 17: 175-187.
Mattson, M. P. & S. L. Chan, (2003) Calcium orchestrates apoptosis. Nat Cell Biol 5: 
1041-1043.
Matusali, G., G. Arena, A. De Leo, L. Di Renzo & E. Mattia, (2009) Inhibition of p38 
MAP kinase pathway induces apoptosis and prevents Epstein Barr vims 
reactivation in Raji cells exposed to lytic cycle inducing compounds. Mol 
Cancer 8: 18.
Maude, R. J., A. M. Dondorp, A. Abu Sayeed, N. P. Day, N. J. White & N. A, Beare, 
(2009) The eye in cerebral malaria: what can it teach us? Trans R Soc Prop 
MedHyg 103: 661-664.
Medana, I. M. & G. D. Turner, (2006) Human cerebral malaria and the blood-brain 
barrier. Int J Parasitol 36: 555-568.
Medana, I. M. & G. D. Turner, (2007) Plasmodium falciparum and the blood-brain 
barrier—contacts and consequences. J Infect Dis 195: 921-923.
Medana, I. M., N. T. Mai, N. P. Day, T. T. Hien, D. Bethell, N. H. Phu, J. Farrar, N. J. 
White & G. D. Turner, (2001) Cellular stress and injury responses in the brains 
of adult Vietnamese patients with fatal Plasmodium falciparum malaria. 
Neuropathol Appl Neurobiol 27: 421-433.
166
Meguro, T., B. Chen, J. Lancon & J. H. Zhang, (2001) Oxyhemoglobin induces 
caspase-mediated cell death in cerebral endothelial cells. J Neurochem 77: 
1128-1135.
Miu, J., N. H. Hunt & H. J. Ball, (2008) Predominance of interferon-related responses 
in the brain during murine malaria, as identified by microarray analysis. Infect 
Immunlfr. 1812-1824.
Montgomery, J., F. A. Mphande, M. Berriman, A. Pain, S. J. Rogerson, T. E. Taylor, 
M. E. Molyneux & A. Craig, (2007) Differential var gene expression in the 
organs of patients dying of falciparum malaria. Mol Microbiol 65: 959-967.
Muanza, K., F. Gay, C. Behr & A. Scherf, (1996) Primary culture of human lung 
microvessel endothelial cells: a useful in vitro model for studying Plasmodium 
falciparum-infected erythrocyte cytoadherence. Res Immunol 147: 149-163.
Muller, A., D. Gunther, F. Dux, M. Naumann, T. F. Meyer & T. Rudel, (1999) 
Neisserial porin (PorB) causes rapid calcium influx in target cells and induces 
apoptosis by the activation of cysteine proteases. EMBO J18: 339-352.
Nemajerova, A., S. Wolff, O. Petrenko & U. M, Moll, (2005) Viral and cellular 
oncogenes induce rapid mitochondrial translocation of p53 in primary 
epithelial and endothelial cells early in apoptosis. FEES Lett 579: 6079-6083.
Neumann, M. & M. Naumann, (2007) Beyond IkappaBs: alternative regulation of NF- 
kappaB activity. FASEBJ 21\ 2642-2654.
Newbold, C., P. Warn, G. Black, A. Berendt, A. Craig, B. Snow, M. Msobo, N. Peshu 
& K. Marsh, (1997) Receptor-specific adhesion and clinical disease in 
Plasmodium falciparum. Am J Trop MedHyg 57: 389-398.
Newhouse, K., S. L. Hsuan, S. H. Chang, B. Cai, Y. Wang & Z. Xia, (2004) 
Rotenone-induced apoptosis is mediated by p38 and JNK MAP kinases in 
human dopaminergic SH-SY5Y cells. Toxicol Sci 79: 137-146.
Newton, C. R., T. T. Hien & N. White, (2000) Cerebral malaria. J Neurol Neurosurg 
Psychiatry 69: 433-441.
Nishiwaki, Y., T. Yokota, M. Hiraoka, M. Miyagishi, K. Taira, M. Isobe, H. 
Mizusawa & M. Yoshida, (2003) Introduction of short interfering RNA to 
silence endogenous E-selectin in vascular endothelium leads to successful 
inhibition of leukocyte adhesion. Biochem Biophys Res Commun 310: 1062- 
1066.
167
Ockenhouse, C. F., M. Ho, N. N. Tandon, G. A. Van Seventer, S. Shaw, N. J. White, 
G. A. Jamieson, J. D. Chulay & H. K. Webster, (1991) Molecular basis of 
sequestration in severe and uncomplicated Plasmodium falciparum malaria: 
differential adhesion of infected erythrocytes to CD36 and ICAM-1. J Infect 
Dis 164: 163-169.
Ockenhouse, C. F., R. Betageri, T. A. Springer & D. E. Staunton, (1992a) Plasmodium 
falciparum-infected erythrocytes bind ICAM-1 at a site distinct from LFA-1, 
Mac-1, and human rhino virus. Cell 68: 63-69.
Ockenhouse, C. F., T. Tegoshi, Y. Maeno, C. Benjamin, M. Ho, K. E. Kan, Y. Thway, 
K. Win, M. Aikawa & R. R. Lobb, (1992b) Human vascular endothelial cell 
adhesion receptors for Plasmodium falciparum-infected erythrocytes: roles for 
endothelial leukocyte adhesion molecule 1 and vascular’ cell adhesion molecule 
\.JExp Medina 1183-1189.
Oquendo, P., E. Hundt, J. Lawler & B. Seed, (1989) CD36 directly mediates 
cytoadherence of Plasmodium falciparum parasitized erythrocytes. Cell 58: 95- 
101.
Orrenius, S., B. Zhivotovsky & P. Nicotera, (2003) Regulation of cell death: the 
calcium-apoptosis link. Nat Rev Mol Cell Biol 4: 552-565.
Pamplona, A., A. Ferreira, J. Balia, V. Jeney, G. Balia, S. Epiphanio, A. Chora, C. D. 
Rodrigues, I. P. Gregoire, M. Cunha-Rodrigues, S. Portugal, M. P. Soares & 
M. M. Mota, (2007) Heme oxygenase-1 and carbon monoxide suppress the 
pathogenesis of experimental cerebral malaria. Nat Med 13: 703-710.
Park, K. S., I. Jo, K. Pak, S. W. Bae, H. Rhim, S. H. Suh, J. Park, H. Zhu, I. So & K. 
W. Kim, (2002) FCCP depolarizes plasma membrane potential by activating 
proton and Na+ currents in bovine aortic endothelial cells. Pflugers Arch 443: 
344-352.
Parroche, P., F. N. Lauw, N. Goutagny, E. Latz, B. G. Monks, A. Visintin, K. A. 
Halmen, M. Lamphier, M. Olivier, D. C. Bartholomeu, R. T. Gazzinelli & D. 
T. Golenbock, (2007) Malaria hemozoin is immunologically inert but radically 
enhances innate responses by presenting malaria DNA to Toll-like receptor 9. 
Proc Natl Acad Sci USA 104: 1919-1924.
Pasternak, N. D. & R. Dzikowski, (2009) PfEMPl: an antigen that plays a key role in 
the pathogenicity and immune evasion of the malaria parasite Plasmodium 
falciparum. Int JBiochem Cell Biol 41: 1463-1466.
168
Paul, F., S. Roath, D. Melville, D. C. Warhurst & J. O. Osisanya, (1981) Separation of 
malaria-infected erythrocytes from whole blood: use of a selective high- 
gradient magnetic separation technique. Lancet 2: 70-71.
Petit, P. X., H. Lecoeur, E. Zorn, C. Dauguet, B. Mignotte & M. L. Gougeon, (1995) 
Alterations in mitochondrial structure and function are early events of 
dexamethasone-induced thymocyte apoptosis. J Cell Biol 130: 157-167.
Phiri, H., J. Montgomery, M. Molyneux & A. Craig, (2009) Competitive endothelial 
adhesion between Plasmodium falciparum isolates under physiological flow 
conditions. Malar 214.
Pietsch, E. C., S. M. Sykes, S. B. McMahon & M. E. Murphy, (2008) The p53 family 
and programmed cell death. Oncogene 27: 6507-6521.
Pino, P., I. Vouldoukis, J. P. Kolb, N. Mahmoudi, I. Desportes-Livage, F. Bricaire, M. 
Danis, B. Dugas & D. Mazier, (2003b) Plasmodium falciparum--infected 
erythrocyte adhesion induces caspase activation and apoptosis in human 
endothelial cells. J Infect Dis 187: 1283-1290.
Pino, P., I. Vouldoukis, N. Dugas, G. Hassani-Loppion, B. Dugas & D. Mazier, 
(2003a) Redox-dependent apoptosis in human endothelial cells after adhesion 
of Plasmodium falciparum-infected erythrocytes. Ann NY Acad Sci 1010: 582- 
586.
Pino, P., Z. Taoufiq, J. Nitcheu, I. Vouldoukis & D. Mazier, (2005) Blood-brain 
barrier breakdown during cerebral malaria: suicide or murder? Thromb 
Haemost 94: 336-340.
Pinton, P., D. Ferrari, E. Rapizzi, F. Di Virgilio, T. Pozzan Sc R. Rizzuto, (2002) A 
role for calcium in Bcl-2 action? Biochimie 84: 195-201.
Polunovsky, V. A., C. H. Wendt, D. H. Ingbar, M. S. Peterson & P. B. Bitterman, 
(1994) Induction of endothelial cell apoptosis by TNF alpha: modulation by 
inhibitors of protein synthesis. Exp Cell Res 214: 584-594.
Pongponratn, E., G. D. Turner, N. P. Day, N. H. Phu, J. A. Simpson, K. Stepniewska, 
N. T. Mai, P. Viriyavejakul, S. Looareesuwan, T. T. Hien, D. J. Ferguson & N. 
J. White, (2003) An ultrastructural study of the brain in fatal Plasmodium 
falciparum malaria. Am J Trop MedHyg 69: 345-359.
Potter, S. M., T. Chan-Ling, E. Rosinova, H. J. Ball, A. J. Mitchell & N. H. Hunt, 
(2006) A role for Fas-Fas ligand interactions during the late-stage 
neuropathological processes of experimental cerebral malaria. J Neuroimmunol 
173: 96-107.
169
Potter, S., T. Chan-Ling, H. J. Ball, H. Mansour, A. Mitchell, L. Maluish & N. H. 
Hunt, (2006) Perforin mediated apoptosis of cerebral microvascular endothelial 
cells during experimental cerebral malaria. Int JParasitol 36: 485-496.
Pouvelle, B., V. Matarazzo, C. Jurzynski, J. Nemeth, M. Ramharter, G. Rougon & J. 
Gysin, (2007) Neural cell adhesion molecule, a new cytoadhesion receptor for 
Plasmodium falciparum-infected erythrocytes capable of aggregation. Infect 
Immun 75: 3516-3522.
Prudencio, M., A. Rodriguez & M. M. Mota, (2006) The silent path to thousands of 
merozoites: the Plasmodium liver stage. Nat Rev Microbiol 4: 849-856.
Rai, N. K., K. Tripathi, D. Sharma & V. K. Shukla, (2005) Apoptosis: a basic 
physiologic process in wound healing. Int J Low Extrem Wounds 4: 138-144.
Rao, R. V., H. M. Ellerby & D. E. Bredesen, (2004) Coupling endoplasmic reticulum 
stress to the cell death program. Cell Death Differ 11: 372-380.
Robaye, B., R. Mosselmans, W. Piers, J. E. Dumont & P. Galand, (1991) Tumor 
necrosis factor induces apoptosis (programmed cell death) in normal 
endothelial cells in vitro. Am J Pathol 138: 447-453.
Roberts, D. D., J. A. Sherwood, S. L. Spitalnik, L. J. Panton, R. J. Howard, V. M. 
Dixit, W. A. Frazier, L. H. Miller & V. Ginsburg, (1985) Thrombospondin 
binds falciparum malaria parasitized erythrocytes and may mediate 
cytoadherence. Nature 318: 64-66.
Roberts, D. J., A. G. Craig, A. R. Berendt, R. Pinches, G. Nash, K. Marsh & C. I. 
Newbold, (1992) Rapid switching to multiple antigenic and adhesive 
phenotypes in malaria [see comments]. Nature 357: 689-692.
Rock, E. P., E. F. Roth, Jr., R. R. Rojas-Corona, J. A. Sherwood, R. L. Nagel, R. J. 
Howard & D. K. Kaul, (1988) Thrombospondin mediates the cytoadherence of 
Plasmodium falciparum-infected red cells to vascular endothelium in shear 
flow conditions. Blood 71: 71-75.
Rogerson, S. J., R. Tembenu, C. Dobano, S. Plitt, T. E. Taylor & M. E. Molyneux, 
(1999) Cytoadherence characteristics of Plasmodium falciparum-infected 
erythrocytes from Malawian children with severe and uncomplicated malaria. 
Am J Prop Med Hyg 61: 467-472.
Rowe, J. A., A. Claessens, R. A. Corrigan & M. Arman, (2009) Adhesion of 
Plasmodium falciparum-infected erythrocytes to human cells: molecular 
mechanisms and therapeutic implications. Expert Rev Mol Med 11: el 6.
170
Ruckdeschel, K.} G. Pfaffinger, R. Haase, A. Sing, H. Weighardt, G. Hacker, B. 
Holzmann & J. Heesemann, (2004) Signaling of apoptosis through TLRs 
critically involves toll/IL-1 receptor domain-containing adapter inducing IFN- 
beta, but not MyD88, in bacteria-infected murine macrophages. J Immunol 
173: 3320-3328.
Salanti, A., T. Staalsoe, T. Lavstsen, A. T. Jensen, M. P. Sowa, D. E. Arnot, L. Hviid 
& T. G. Theander, (2003) Selective upregulation of a single distinctly 
structured var gene in chondroitin sulphate A-adhering Plasmodium falciparum 
involved in pregnancy-associated malaria. Mol Microbiol 49: 179-191,
Salaun, B., I. Coste, M. C. Rissoan, S. J. Lebecque & T. Renno, (2006) TLR3 can 
directly trigger apoptosis in human cancer cells. J Immunol 176: 4894-4901.
Salaun, B., P. Romero & S. Lebecque, (2007) Toll-like receptors' two-edged sword: 
when immunity meets apoptosis. Eur J Immunol 37: 3311-3318.
Sato, K., J. Balia, L. Otterbein, R. N. Smith, S. Brouard, Y. Lin, E. Csizmadia, J. 
Sevigny, S. C. Robson, G. Vercellotti, A. M. Choi, F. H. Bach & M. P. Soares, 
(2001) Carbon monoxide generated by heme oxygenase-1 suppresses the 
rejection of mouse-to-rat cardiac transplants. J Immunol 166: 4185-4194.
Scherf, A., J. J. Lopez-Rubio & L. Riviere, (2008) Antigenic variation in Plasmodium 
falciparum. Annu Rev Microbiol 62: 445-470.
Schimmer, A. D., (2004) Inhibitor of apoptosis proteins: translating basic knowledge 
into clinical practice. Cancer Res 64: 7183-7190.
Schroder, M. & R. J. Kaufman, (2005) The mammalian unfolded protein response. 
Annu Rev Biochem 74: 739-789.
Schultz, D. R. & W. J. Harrington, Jr., (2003) Apoptosis: programmed cell death at a 
molecular level. Semin Arthritis Rheum 32: 345-369.
Schwarzer, E., H. Kuhn, E. Valente & P. Arese, (2003) Malaria-parasitized 
erythrocytes and hemozoin nonenzymatically generate large amounts of 
hydroxy fatty acids that inhibit monocyte functions. Blood 101: 722-728.
Schwarzer, E., O. Muller, P. Arese, W. G. Siems & T. Grune, (1996) Increased levels 
of 4-hydroxynonenal in human monocytes fed with malarial pigment 
hemozoin. A possible clue for hemozoin toxicity. FEBS Lett 388: 119-122.
Serghides, L., T. G. Smith, S. N. Patel & K. C. Kain, (2003) CD36 and malaria: 
friends or foes? Trends Parasitol 19: 461-469.
171
Siano, J. P., K. K. Grady, P. Millet & T. M. Wick, (1998) Short report; Plasmodium 
falciparum: cytoadherence to alpha(v)beta3 on human microvascular 
endothelial cells. Am J Trop MedHyg 59: 77-79.
Simak, J., K. Holada & J. G. Vostal, (2002) Release of annexin V-binding membrane 
microparticles from cultured human umbilical vein endothelial cells after 
treatment with camptothecin. BMC Cell Biol 3:11.
Singh, B., L. Kim Sung, A. Matusop, A. Radhakrishnan, S. S. Shamsul, J. Cox-Singh,
A. Thomas & D. J. Conway, (2004) A large focus of naturally acquired 
Plasmodium knowlesi infections in human beings. Lancet 363: 1017-1024.
Skaug, B., X. Jiang & Z. J. Chen, (2009) The role of ubiquitin in NF-kappaB 
regulatory pathways. Annu Rev Biochem 78: 769-796.
Skorokhod, A., E. Schwarzer, G. Gremo & P. Arese, (2007) HNE produced by the 
malaria parasite Plasmodium falciparum generates HNE-protein adducts and 
decreases erythrocyte deformability. Redox Rep 12: 73-75.
Skorokhod, O, A., L. Caione, T. Marrocco, G. Migliardi, V. Barrera, P. Arese, W. 
Piacibello & E. Schwarzer, (2010) Inhibition of erythropoiesis in malaria 
anemia: role of hemozoin and hemozoin-generated 4-hydroxynonenal. Blood.
Smith, J. D., B. Gamain, D. I. Baruch & S. Kyes, (2001) Decoding the language of var 
genes and Plasmodium falciparum sequestration. Trends Parasitol 17: 538- 
545.
Soares, M. P., Y, Lin, J. Anrather, E. Csizmadia, K. Takigami, K. Sato, S. T. Grey, R.
B. Colvin, A. M. Choi, K. D. Poss & F. H. Bach, (1998) Expression of heme 
oxygenase-1 can determine cardiac xenograft survival. Nat Med 4: 1073-1077.
Song, R., Z. Zhou, P. K. Kim, R. A. Shapiro, F. Liu, C. Ferran, A. M. Choi & L. E. 
Otterbein, (2004) Carbon monoxide promotes Fas/CD95-induced apoptosis in 
Jurkat cells. JBiol Chem 279: 44327-44334.
Springer, A. L., L. M. Smith, D. Q. Mackay, S. O. Nelson & J. D. Smith, (2004) 
Functional interdependence of the DBLbeta domain and c2 region for binding 
of the Plasmodium falciparum variant antigen to ICAM-1. Mol Biochem 
Parasitol 137: 55-64.
Stark, L. A., K. Reid, O. J. Sansom, F. V. Din, S. Guichard, I. Mayer, D. I. Jodrell, A, 
R. Clarke & M. G. Dunlop, (2007) Aspirin activates the NF-kappaB signalling 
pathway and induces apoptosis in intestinal neoplasia in two in vivo models of 
human colorectal cancer. Carcinogenesis 28: 968-976.
172
Sutherland, C. J., N. Tanomsing, D. Nolder, M. Oguike, C. Jennison, S. 
Pukrittayakamee, C. Dolecek, T. T. Hien, V. E. do Rosario, A. P. Arez, J. 
Pinto, P. Michon, A. A. Escalante, F. Nosten, M. Burke, R. Lee, M. Blaze, T. 
D. Otto, J. W. Barnwell, A. Pain, J. Williams, N. J. White, N. P. Day, G. 
Snounou, P. J. Lockhart, P. L. Chiodini, M. Imwong & S. D. Polley, (2010) 
Two nonrecomhining sympatric forms of the human malaria parasite 
Plasmodium ovale occur globally. J Infect Dis 201: 1544-1550.
Swerlick, R. A., K. H. Lee, T. M. Wick & T. J. Lawley, (1992) Human dermal 
microvascular endothelial but not human umbilical vein endothelial cells 
express CD36 in vivo and in vitro. J Immunol 148: 78-83.
Takeda, K., T. Kaisho & S. Akira, (2003) Toll-like receptors. Annu Rev Immunol 21: 
335-376.
Taoufiq, Z., F. Gay, J. Balvanyos, L. Ciceron, M. Tefit, P. Lechat & D. Mazier, (2008) 
Rho kinase inhibition in severe malaria: thwarting parasite-induced collateral 
damage to endothelia. J Infect Dis 197: 1062-1073.
Taoufiq, Z., P. Pino, N. Dugas, M. Conti, M. Tefit, D. Mazier & I. Vouldoukis, (2006) 
Transient supplementation of superoxide dismutase protects endothelial cells 
against Plasmodium falciparum-induced oxidative stress. Mol Biochem 
Parasitol 150: 166-173.
Taylor, T. E., W, J. Fu, R. A. Carr, R. O. Whitten, J. S. Mueller, N. G. Fosiko, S. 
Lewallen, N. G. Liomba & M. E. Molyneux, (2004) Differentiating the 
pathologies of cerebral malaria by postmortem parasite counts. Nat Med 10: 
143-145.
Thompson, C. B., (1995) Apoptosis in the pathogenesis and treatment of disease. 
Science 267: 1456-1462.
Thumwood, C. M., N. H. Hunt, I. A. Clark & W. B. Cowden, (1988) Breakdown of 
the blood-brain barrier in murine cerebral malaria. Parasitology 96 ( Pt 3): 
579-589.
Toure, F. S., O. Ouwe-Missi-Oukem-Boyer, U. Bisvigou, O. Moussa, C. Rogier, P. 
Pino, D. Mazier & S. Bisser, (2008) Apoptosis: a potential triggering 
mechanism of neurological manifestation in Plasmodium falciparum malaria. 
Parasite Immunol 30: 47-51.
Trager, W. & J. B. Jensen, (1976) Human malaria parasites in continuous culture. 
Science 193: 673-675.
173
Treeratanapiboon, L., K. Psathaki, J. Wegener, S. Looareesuwan, H. J. Galla & R. 
Udomsangpetch, (2005) In vitro study of malaria parasite induced disruption of 
blood-brain barrier. Biochem Biophys Res Commun 335: 810-818.
Treiman, M., C. Caspersen & S. B. Christensen, (1998) A tool coming of age: 
thapsigargin as an inhibitor of sarco-endoplasmic reticulum Ca(2+)-ATPases. 
Trends Pharmacol Sci 19\ 131-135.
Treutiger, C. J., A. Heddini, V. Fernandez, W. A. Muller & M. Wahlgren, (1997) 
PECAM-1/CD31, an endothelial receptor for binding Plasmodium falciparum- 
infected erythrocytes. Nat Med 3: 1405-1408.
Tripathi, A. K., D. J. Sullivan & M. F. Stins, (2006) Plasmodium falciparum-infected 
erythrocytes increase intercellular adhesion molecule 1 expression on brain 
endothelium through NF-kappaB. Infect Immun 74: 3262-3270.
Tripathi, A. K., D. J. Sullivan & M. F. Stins, (2007) Plasmodium falciparum-infected 
erythrocytes decrease the integrity of human blood-brain barrier endothelial 
cell monolayers. J Infect Dis 195: 942-950.
Tripathi, A. K., W. Sha, V. Shulaev, M. F. Stins & D. J. Sullivan, Jr., (2009) 
Plasmodium falciparum-infected erythrocytes induce NF-kappaB regulated 
inflammatory pathways in human cerebral endothelium. Blood 114: 4243- 
4252.
Turner, G. D., H. Morrison, M. Jones, T. M. Davis, S. Looareesuwan, I. D. Buley, K. 
C. Gatter, C. I. Newbold, S. Pukritayakamee, B. Nagachinta & et al., (1994) 
An immunohistochemical study of the pathology of fatal malaria. Evidence for 
widespread endothelial activation and a potential role for intercellular adhesion 
molecule-1 in cerebral sequestration. Am J Pathol 145: 1057-1069.
Udomsangpetch, R., P. H. Reinhardt, T. Schollaardt, J. F. Elliott, P. Kubes 8c M. Ho, 
(1997) Promiscuity of clinical Plasmodium falciparum isolates for multiple 
adhesion molecules under flow conditions. J Immunol 158: 4358-4364.
Van Antwerp, D. J., S. J. Martin, T. Kaffi, D. R. Green & I. M. Verma, (1996) 
Suppression of TNF-alpha-induced apoptosis by NF-kappaB. Science 274: 
787-789.
van der Heyde, H. C., J. Nolan, V. Combes, I. Gramaglia & G. E. Grau, (2006) A 
unified hypothesis for the genesis of cerebral malaria: sequestration, 
inflammation and hemostasis leading to microcirculatory dysfunction. Trends 
Parasitol 22\ 503-508.
174
van Loo, G., M. van Gurp, B. Depuydt, S. M. Srinivasula, I. Rodriguez, E. S. Alnemri, 
K. Gevaert, J. Vandekerckhove, W. Declercq & P. Vandenabeele, (2002) The 
serine protease Omi/HtrA2 is released from mitochondria during apoptosis. 
Omi interacts with caspase-inhibitor XIAP and induces enhanced caspase 
activity. Cell Death Differ 9: 20-26.
van Zyl, R. L., I. Havlik, E. Hempelmann, A. P. MacPhail & L. McNamara, (1993) 
Malaria pigment and extracellular iron. Possible target for iron chelating 
agents. Biochem Pharmacol 45: 1431-1436.
Vayssiere, J. L., P. X. Petit, Y. Risler & B. Mignotte, (1994) Commitment to apoptosis 
is associated with changes in mitochondrial biogenesis and activity in cell lines 
conditionally immortalized with simian virus 40. Proc Natl Acad Sci USA 91: 
11752-11756.
Vermes, I., C. Haanen, H. Steffens-Nakken & C. Reutelingsperger, (1995) A novel 
assay for apoptosis. Flow cytometric detection of phosphatidylserine 
expression on early apoptotic cells using fluorescein labelled Annexin V. J 
Immunol Methods 184: 39-51.
Vermeulen, K., D. R. Van Bockstaele & Z. N. Berneman, (2005) Apoptosis: 
mechanisms and relevance in cancer. Ann Hematol 84: 627-639.
Viebig, N. K., M. C. Nunes, A. Scherf & B. Gamain, (2006) The human placental 
derived Be Wo cell line: a useful model for selecting Plasmodium falciparum 
CSA-binding parasites. Exp Parasitol 112: 121-125.
Viebig, N. K., U. Wulbrand, R. Forster, K. T. Andrews, M. Lanzer & P. A. Knolle, 
(2005) Direct activation of human endothelial cells by Plasmodium 
falciparum-infected erythrocytes. Infect Immun 73: 3271-3277.
Vogt, A. M., A. Barragan, Q. Chen, F. Kironde, D. Spillmann & M. Wahlgren, (2003) 
Heparan sulfate on endothelial cells mediates the binding of Plasmodium 
falciparum-infected erythrocytes via the DBL1 alpha domain of PfEMPl. 
Blood 101: 2405-2411.
Vousden, K. H. & X. Lu, (2002) Live or let die: the cell's response to p53. Nat Rev 
Cancer 2: 594-604.
Wada, T. & J. M. Penninger, (2004) Mitogen-activated protein kinases in apoptosis 
regulation. Oncogene 23: 2838-2849.
Wagner, E. F. & A. R. Nebreda, (2009) Signal integration by JNK and p38 MAPK 
pathways in cancer development. Nat Rev Cancer 9: 537-549.
175
Walker, T., H. P, Wendel, L. Tetzloff, C. Raabe, 0. Heidenreich, P. Simon, A. M. 
Scheule & G. Ziemer, (2007) Inhibition of adhesion molecule expression on 
human venous endothelial cells by non-viral siRNA transfection. J Cell Mol 
Med 11: 139-147.
Walker, T., H. P. Wendel, L. Tetzloff, O. Heidenreich & G. Ziemer, (2005) 
Suppression of ICAM-1 in human venous endothelial cells by small interfering 
RNAs. Eur J Cardiothorac Surg 28: 816-820.
Wang, C. Y., M. W. Mayo & A. S. Baldwin, Jr., (1996) TNF- and cancer therapy- 
induced apoptosis: potentiation by inhibition of NF-kappaB. Science 274: 784- 
787.
Wang, S., Z. Liu, L. Wang & X. Zhang, (2009) NF-kappaB signaling pathway, 
inflammation and colorectal cancer. Cell Mol Immunol 6: 327-334.
Warren, M. C., E. A. Bump, D. Medeiros & S. J. Braunhut, (2000) Oxidative stress- 
induced apoptosis of endothelial cells. Free Radic Biol Med 29: 537-547.
Wassmer, S. C., C. Lepolard, B. Traore, B. Pouvelle, J. Gysin & G. E. Grau, (2004) 
Platelets reorient Plasmodium falciparum-infected erythrocyte cytoadhesion to 
activated endothelial cells. J Infect Dis 189: 180-189.
Wassmer, S. C., J. B. de Souza, C. Frere, F. J. Candal, I. Juhan-Vague & G. E. Grau, 
(2006b) TGF-betal released from activated platelets can induce TNF- 
stimulated human brain endothelium apoptosis: a new mechanism for 
microvascular lesion during cerebral malaria. J Immunol 176: 1180-1184.
Wassmer, S. C., V. Combes, F. J. Candal, I. Juhan-Vague & G. E. Grau, (2006a) 
Platelets potentiate brain endothelial alterations induced by Plasmodium 
falciparum. Infect Immun 74: 645-653.
Wei, Y., P. Chen, M. de Brayn, W. Zhang, E. Bremer & W. Helfrich, Carbon 
monoxide-releasing molecule-2 (CORM-2) attenuates acute hepatic ischemia 
reperfusion injury in rats. BMC Gastroenterol 10: 42.
White, N. J., G. D. Turner, I. M. Medana, A. M. Dondorp & N. P. Day, (2009a) The 
murine cerebral malaria phenomenon. Trends Parasitol 26: 11-15.
White, V. A., S. Lewallen, N. A. Beare, M. E. Molyneux & T, E. Taylor, (2009b) 
Retinal pathology of pediatric cerebral malaria in Malawi. PLoS One 4: e4317.
Wilson, C., G. H. Foster & M. Bitzan, (2005) Silencing of Bak ameliorates apoptosis 
of human proximal tubular epithelial cells by Escherichia coli-derived Shiga 
toxin 2. Infection 33: 362-367.
176
Wilson, N. O., M. B. Huang, W. Anderson, V. Bond, M. Powell, W. E. Thompson, H. 
B. Armah, A. A. Adjei, R. Gyasi, Y. Tettey & J. K. Stiles, (2008) Soluble 
factors from Plasmodium falciparum-infected erythrocytes induce apoptosis in 
human brain vascular endothelial and neuroglia cells. Mol Biochem Parasitol 
162: 172-176.
Win, T. T., A. Jalloh, I. S. Tantular, T. Tsuboi, M. U. Ferreira, M. Kimura & F. 
Kawamoto, (2004) Molecular analysis of Plasmodium ovale variants. Emerg 
Infect Dis 10: 1235-1240.
Wu, G. D., H. J. Zhou & X. H. Wu, (2004) Apoptosis of human umbilical vein 
endothelial cells induced by artesunate. Vascul Pharmacol 41: 205-212.
Yang, Y., R. Sharma, A. Sharma, S. Awasthi & Y. C. Awasthi, (2003) Lipid 
peroxidation and cell cycle signaling: 4-hydroxynonenal, a key molecule in 
stress mediated signaling. Acta Biochim Pol 50: 319-336.
Yipp, B. G., M. J. Hickey, G. Andonegui, A. G. Murray, S. Looareesuwan, P. Kubes 
& M. Ho, (2007) Differential roles of CD36, ICAM-1, and P-selectin in 
Plasmodium falciparum cytoadherence in vivo. Microcirculation 14: 593-602.
Yu, C., Y. Minemoto, J. Zhang, J. Liu, F. Tang, T. N. Bui, J. Xiang & A. Lin, (2004) 
JNK suppresses apoptosis via phosphorylation of the proapoptotic Bcl-2 family 
protein BAD. Mol Cell 13: 329-340.
Zang-Edou, E. S., U. Bisvigou, Z. Taoufiq, F. Lekoulou, J. B. Lekana-Douki, Y. 
Traore, D. Mazier & F. S. Toure-Ndouo, (2010) Inhibition of Plasmodium 
falciparum field isolates-mediated endothelial cell apoptosis by Fasudil: 
therapeutic implications for severe malaria. PLoS One 5: el3221.
Zeng, H., H. Wu, V. Sloane, R. Jones, Y. Yu, P. Lin, A. T. Gewirtz & A. S. Neish, 
(2006) Flagellin/TLR5 responses in epithelia reveal intertwined activation of 
inflammatory and apoptotic pathways. Am J Physiol Gastrointest Liver Physiol 
290: G96-G108.
Zimmermann, K. C. & D. R. Green, (2001) How cells die: apoptosis pathways. J 
Allergy Clin Immunol 108: S99-103.
177
